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Abstract 
Heterocyclic compounds are extensively present in natural products and bioactive 
compounds, the synthesis of these compounds attracts attention from synthetic 
chemists. Although various methods have been established to prepare heterocyclic 
compounds, limited functional group tolerance and the requirement for a 
prefunctionalized starting material weaken the synthetic value of those methods. 
Therefore, new approaches for the straightforward synthesis and functionalization of 
these compounds are highly desirable. 
Based on transition-metal catalysis, two novel reaction methodologies for the 
synthesis of C7-substituted indoles were developed. The first method was conducted 
via rhodium(III)-catalyzed regioselective alkenylation and subsequent oxidation in a 
one-pot fashion; the second method was accomplished by iridium(III)-catalyzed 
regioselective amination using sulfonyl azides as a nitrogen source. Both protocols 
feature excellent regioselectivity, high efficiency and good tolerance with different 
functional groups. Subsequently, two novel approaches to construct 
nitrogen-containing heterocycles were achieved through direct functionalization of 
C(sp
3
)–H bond at a-position of tertiary amines. Cyclizations between tertiary 
arylamines and electron-deficient alkenes via α-aminoalkyl radicals, which were 
generated by TBAI/TBHP, laid the groundwork for the described transformation. 
Tertiary arylamines even with strong electron-withdrawing groups yielded the desired 
products under this newly developed reaction condition. The other described approach 
was the construction of imidazo[4,5-b]pyridines through iminium ion intermediates, 
which were in situ formed by oxidation of electron-deficient amines. 3-Amino 
pyridines with dialkyl amino groups at the C2-postion rapidly delivered the desired 
products using T
+
BF4
-
 as oxidant at ambient temperature. 
A series of compounds were synthesized by these novel strategies. All of them were 
subjected to various cell-based assays to investigate potential modulation of important 
biological pathways. 
  
Kurzfassung 
Indole und dessen Derivate sind ein häufiger Bestandteil von Naturstoffen und 
bioaktiven Verbindungen. Auch wenn bereits erfolgreich Methoden zur Synthese 
heterocyclischer Verbindungen etabliert wurden, ist deren synthetischer Nutzen häufig 
durch ein limitiertes Substratspektrum oder das Erfordernis eines prefunktionalisierten 
Startmaterials begrenzt. Aus diesem Grund sind neue und zielgerichtete Methoden zur 
Synthese und Funktionalisierung dieser Verbindungen von hohem Interesse.  
Basierend auf Übergangsmetallkatalyse wurden zwei neue Reaktionsmethoden zur 
Synthese von C7-substutierten Indolen entwickelt. Die erste Methode wurde mittels 
Rhodium(III)-katalysierter Alkenylierung mit anschließender Oxidation im 
Ein-Topf-Verfahren durchgeführt. Die zweite Methode basierte auf einer 
Iridium(III)-katalysierten regioselektiven Aminierung, wobei Sulfonylazide als 
Stickstoffquelle verwendet wurden. Beide Protokolle erzielten exzellente 
Regioselektivität, hohe Atomeffizienz und gute Toleranz gegenüber verschiedenen 
funktionellen Gruppen. 
Zwei neue Ansätze zur Konstruktion Stickstoff-haltiger Heterocyclen, durch die 
direkte Funktionalisierung einer C(sp
3
)-H Bindung, in Nachbarschaft zu einem 
Stickstoffatom, wurden im Folgenden etabliert. Cyclisierung eines tertiären 
Arylamines und elektron-armen Alkenen, durch die Bildung eines 
α-Aminoalkylradikals mit TBAI/TBHP, stellte die Grundlage für die entwickelte 
Transformation dar. Tertiäre Arylamine, sogar mit stark elektronen-ziehenden 
Gruppen, bildeten die gewünschten Produkte mit Hilfe der neuentwickelten 
Reaktionsbedingungen. Der zweite Ansatz erzielte die Konstruktion von 
Imidazo[4,5-b]pyridinen durch die in situ Generierung eines Iminiumions, durch die 
Oxidation von elektronenarmen Aminen. 3-Aminopyridine ausgestattet mit 
Dialkylaminogruppen an der C2-Position lieferten die Zielverbindungen bei 
Raumtemperatur unter Verwendung von T
+
BF4
- 
als Oxidationsmittel in kurzer 
Reaktionszeit. 
Eine Vielzahl an interessanten Verbindungen wurde mit Hilfe dieser neuen Strategien 
synthetisiert. Alle Verbindungen wurden auf potentielle Modulierung von wichtigen 
biologischen Signalwegen in verschiedenen Zell-basierten Assays getestet. 
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1. Introduction 
 
1.1 Transition-Metal-Catalyzed C–H Bond Activation 
As an efficient synthetic tool, transition-metal-catalyzed cross-coupling
[1]
 is 
frequently used to the synthesis and functionalization of heterocyclic compounds 
which are widely present in natural products and bioactive compounds.
[2]
 This 
strategy requires prefunctionalized starting materials for the reactivity and selectivity 
of reactions. The extra steps for the functionalization of starting materials usually 
limit their applicability, increasing the number of reaction steps and produce waste. In 
contrast to it, transition-metal-catalyzed C–H bond activation[3] allows the use of 
starting materials without prefunctionalization in the reactions (Scheme 1.1). This 
new strategy not only improves the efficiency of multistep reactions, but also enlarges 
the substrate scope of reactions.
 
 
 
 
Scheme 1.1 Comparison between traditional cross-coupling and direct C–H bond 
activation. 
 
In 1960s, methods for activation of inert C–H bond using stoichiometric amounts of 
transition-metal complexes were developed.
[4]
 After 20 years, catalytic amounts of 
transition-metal complexes were used to the reactions of C–H bond cleavage.[5] Since 
then, substantial methods via catalytic C–H bond functionalization to form C–C and 
C–heteroatom bonds were reported.[5–7] Accordingly, numerous pharmaceutically 
2                                                         Introduction 
active compounds and natural products had been synthesized on the basis of this 
strategy.
[6]
 The mechanism of C–H bond metalation has various pathways, depending 
on the nature of the metal, ligand and other parameters.
[3,5–7]
 Four different routes are 
frequently used for the C–H bond insertion of metals (Scheme 1.2): a) oxidative 
addition for electron rich late transition metals;
[7a]
 b) σ-bond metathesis for early 
transition metals;
[7f]
 c) electrophilic activation for late or post transition metals;
[7b] 
d) 
1,2-addition for early to middle transition metals with unsaturated M=X bond.
[7c]
 
 
 
 
Scheme 1.2 Simplified presentation of different mechanisms for C–H bond 
metalation.
[3,5,6,7]
 
 
There are two main challenges should be overcome before the 
transition-metal-catalyzed C–H bond functionalization becomes a feasible tool in 
synthetic chemistry. The first one is the reactivity of C–H bond, as most of them are 
inert. In recent years, numerous remarkable results of the inert C–H bond activation 
were obtained using late transition metals, such as copper,
[8]
 palladium,
[8,9]
 
ruthenium,
[10] 
rhodium,
[11]
 iridium
[12]
 and so on.
[13]
 Iron, cobalt, nickel as 
earth-abundant transition metals were also successful in these transformations.
[14]
 
The other challenge is the site selectivity which includes regio- and stereoselectivity. 
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It is very difficult to be controlled due to the ubiquity and inertness of C–H bond. Of 
all strategies addressing this problem, the use of DG (directing group) was 
demonstrated as an efficient way to control it. The [C–H⋯M] σ-complex, which 
formed after the initial coordination of a DG and a transition metal, activated the 
proper site (Scheme 1.3).
[15]
 Numerous regioselective reactions were developed using 
various functional groups as directing groups.
[16]
 Transition-metal-catalyzed C–H 
bond activation also showed high potential in controlling stereoselectivity and 
enantioselectivity.
[17]
 
 
 
 
Scheme 1.3 Site selectivity controlled by the assistance of directing groups.
[15]
 
 
 
 
 
1.1.1 Rh(III)-Catalyzed Direct C(sp
2
)–H Bond Oxidative Alkenylation 
Rhodium(III) catalysis, which includes the Rh(III)/Rh(I) redox cycle, is broadly used 
in the functionalization of C–H bond.[18] Although rhodium complexes are relatively 
expensive compared to the palladium and ruthenium catalysts, the rhodium catalysts 
have high demand in C–H bond functionalization due to their capability to activate 
substrates.
[18c] 
Substantial reactions of C–H bond functionalization with rhodium(III) 
catalysts, especially Cp*Rh(III) (Cp*=pentamethylcyclopentadienyl) catalysts have 
been developed in recent years.
[18b]
 The remarkable reactivity of Cp*Rh(III) catalysts 
is because of the following reasons: (1) coordination of Rh(III) complexes with 
unsaturated compounds is able to activate the related bonds; (2) organorhodium 
intermediates are stabilized by coordination with electron-rich Cp* moiety; (3) the 
appropriate size of Cp* helps the elimination or insertion of organorhodium(III) 
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complexes; (4) Cp*Rh(III)Ar species is octahedral, and only one position can be 
coordinated. Thus no additional ligand is needed. Among all of Cp*Rh(III) catalysts, 
[RhCp*Cl2]2 complex is often used for the C–H bond activation. In 2007, Miura and 
Satoh reported the first example of [RhCp*Cl2]2-catalyzed C−H bond activation with 
arenes.
[19]
 Since then, significant achievements were gained in this field. Various 
C(sp
2
)–H bond oxidative alkenylation reactions were developed using the 
[RhCp*Cl2]2 complex. 
In 2010, Glorious et al. reported reactions of olefins 2 with various acetanilides 1 
(Scheme 1.4).
[20]
 The reactions proceeded smoothly, and alkenes with different 
substituents were tolerated in this transformation. The corresponding alkenylated 
products 3 were provided with moderated to good yields. 
 
 
 
Scheme 1.4 Rh(III)-catalyzed alkenylation of unactivated acetanilides.
[20]
 
 
Using ketones and amides as directing groups, Glorious et al. successfully developed 
a selective rhodium(III)-catalyzed alkenylation reaction with different acetophenones 
and benzamides.
[21]
 The reactions proceeded successfully with both styrenes and 
acrylate esters, and no dialkenylation product was detected. As a removable directing 
group, carboxylic acids were also successfully applied in alkenylation reactions. After 
the reactions completed, carboxylic groups can be retained or removed depending on 
the desired products.
[22]
 Chang's group
[23]
 and other groups
[24]
 reported alkenylation 
reactions using esters as directing group. Results showed that esters either from acids 
or from aryl phenols behaved well in reactions. Aldehydes were rarely used as 
directing groups due to their weak coordination ability. Impressively, Chang's group 
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achieved the alkenylation of benzaldehydes, although isolated yields were low, and 
decarbonylation products were observed under the oxidative condition (Scheme 
1.5).
[23]
 
 
 
 
Scheme 1.5 Carbonyl-based directing groups in C(sp
2
)–H bond alkenylation.[21-24] 
 
Nitrogen-heterocycles,
[25]
 oximes,
[26]
 triazenes
[27]
 and nitroso
[28]
 were also reported as 
directing groups in alkenylation reactions by different research groups (Scheme 1.6). 
Interestingly, Shi and co-workers accomplished the alkenylation of 2-arylpyridines 
under a competition between C–H and C–C bonds activation. The C–C bond 
activation occurred with high selectivity.
[29]
 Li et al. demonstrated peri oxidative 
olefination of N-(1-naphthyl)sulfonamide using [RhCp*Cl2]2 as catalyst and 
Cu(OAc)2 as oxidant. In this transformation, the directing group was sulfonamide 
which was rare in Rh(III) complexes catalyzed reactions (Scheme 1.6).
[30]
 
 
 
Scheme 1.6 Nitrogen-containing directing groups in C(sp
2
)–H bond 
alkenylation.
[25–30] 
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The mechanism of these rhodium(III)-catalyzed oxidative alkenylation reactions 
includes metalation/deprotonation, alkene insertion, β-hydrogen elimination and the 
regeneration of the catalyst (Scheme 1.7).
[21–30]
 
 
 
Scheme 1.7 Catalytic cycle of rhodium(III)-catalyzed oxidative alkenylation.
[21–30] 
 
Recently, C–H bond functionalization has been studied using π-coordinating 
functional groups as directing groups. In comparison to the σ-bond coordination, 
π-bonding electron pairs offer weak coordination with metals due to their lower 
energy. In 2014, Miura et al. reported a heterocyclic π-bond assisted C–H bond 
alkenylation reaction. The thiophene π-bond functioned as the directing group in this 
transformation (Scheme 1.8).
[31]
 
 
Scheme 1.8 Rhodium(III)-catalyzed C–H bond alkenylation with assistance of 
thiophene.
[31]
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An olefination reaction, which did not have directing groups, was developed by 
Glorious and co-workers. The formation of desired products was proposed by the 
interaction between the easily accessible C–H bond and the rhodium catalyst (Scheme 
1.9).
[32]
 
 
 
 
Scheme 1.9 C–H alkenylation without chelation assistance.[32] 
 
In contrast to the majority of reports on Rh(III) complexes catalyzed alkenylation with 
external oxidants, reports about the use of directing groups as internal oxidants in 
reactions were rare. In 2011, Glorious et al. reported a Rh(III)-catalyzed ortho C–H 
bond olefination of aromatic benzamides 15 under mild reaction condition. It was 
demonstrated that the cleavage of the N–O bond of benzamide 15 oxidized Rh(I) 
species to Rh(III) species (Scheme 1.10).
[33]
 Later, You and co-workers achieved the 
alkenylation of tertiary aniline N-oxides. In this reaction, the N–O bond was identified 
to act as an internal oxidant.
[34]
 
 
 
Scheme 1.10 Directing groups act as internal oxidants in C–H bond alkenylation.[33] 
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1.1.2 Iridium(III)-Catalyzed C–N Bond Formation 
C–N bond formation is one of the most important transformation of organic 
synthesis,
[35,36]
 the development of efficient and convenient methodologies for this 
transformation is highly interesting. Due to the broad application of transition-metal 
catalysis in organic synthesis, the generation of C–N bond is also widely explored 
with this strategy. Early results of this exploration were based on the use of 
prefunctionalized starting materials, such as Ullmann's and Goldberg's methods of 
N-arylations with stoichiometric copper,
[37]
 Buchwald's and Hartwig's methods of 
palladium- and copper-catalyzed N-arylation reactions,
[38]
 Chan-Lam coupling 
reaction.
[39]
 Consequently, straightforward approaches for the generation of C–N bond 
with non-prefunctionalized starting materials were in high demand. 
In recent years, various transition metals were used for the investigation of C–H bond 
amination. Elegant methods for the direct C–N bond formation were developed using 
azides as a nitrogen source, which only released dinitrogen as byproduct.
[40–43]
 Early 
development in this area was provided by Chang et al.
[44,45]
 They successfully 
achieved the Ir(III)-catalyzed C−H bond amidation of arenes 18 and alkenes 21 using 
acyl azides 19 and 22 as nitrogen sources (Scheme 1.11).
[45]
 The reactions smoothly 
proceeded when [IrCp*Cl2]2 was employed as catalyst along with AgNTf2, and no 
external oxidants were required. 
Scheme 1.11 Ir(III)-catalyzed amidation with acyl azides.
[45]
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Subsequently, amidation of diverse substrates, like ethyl benzoates 25,
[46a]
 quinoline 
N-oxides 26,
[46b]
 benzoic acids 27,
[47a]
 phenyl(trialkylsilyl)methanone 28
[47b]
 with 
tosyl azides were developed by [IrCp*Cl2]2 catalysis (Scheme 1.12). It was found that 
additives played a very important role in these reactions. In the absence of additives, 
these reactions did not proceed or just produce little amounts of desired products. 
Very recently, Bolm and co-workers performed the amidation of benzamides with 
sulfonyl azides in a ball mill without solvents.
[48]
 
 
 
Scheme 1.12 Ir(III)-Catalyzed amidation of tosyl azides with various substrates.
[46,47] 
 
Aryl azides 34, alkyl azides 35 and phosphoryl azides 36 as efficient amino sources 
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were also employed in different reactions. The corresponding products were obtained 
in good yields with diverse functional groups (Scheme 1.13).
[49]
 
 
Scheme 1.13 Ir(III)-Catalyzed amidation of different azides.
[49] 
 
Chang et al. developed asymmetric C–H bond amidation of diarylphosphoryl 
compounds 40. Experimental results and mechanistic studies suggested that the 
formation of an iridacycle was the diastereo-determining step. It was assumed that the 
pseudo-diastereomeric environment of the substrate controlled the stereoselectivity of 
this transformation (Scheme 1.14).
[50] 
 
Scheme 1.14 Ir(III)-Catalyzed asymmetric C–H bond amidation of diarylphosphoryl 
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compounds.
[50] 
 
Iridium(III) catalysts were not only used for the amidation of aromatic compounds, 
but also used for unreactive C(sp
3
)–H bond amidation. Chang et al. developed direct 
amidation of methyl C(sp
3
)–H bond using [IrCp*Cl2]2 as catalyst. Reactions 
proceeded smoothly under mild reaction conditions, providing desired products with 
diverse functional groups in good to excellent yields. These results further 
demonstrated the high applicability of Ir(III) catalysis in organic synthesis (Scheme 
1.15).
[51]
 
 
Scheme 1.15 Ir(III)-catalyzed C(sp
3
)–H bond amidation.[51] 
 
The use of anilines as a nitrogen source for direct C–H bond amination by 
cross-dehydrogenative coupling (CDC) is highly desirable due to their availability. 
However, the biggest issue in this process is the lower activity of the employed 
catalytic system in the presence of aniline, mostly because of its high 
nucleophilicity.
[52]
 In 2014, Chang and co-workers reported the first example of 
Ir(III)-catalyzed C–H bond amination with anilines 47 at room temperature (Scheme 
1.16).
[53] 
Later, amination with alkylamines 50 was also demonstrated by the same 
group using Ir(III) catalyst and external oxidant under mild reaction condition 
(Scheme 1.16).
[54]
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Scheme 1.16 Ir(III)-catalyzed amination with anilines and alkylamines.
[53,54]
 
In both reactions, Ir(III) catalytic systems were well compatible with external oxidants. 
Mechanistic studies suggested that the catalytic cycle involved Ir(V) species III 
(Scheme 1.17).
[53,54] 
 
Scheme 1.17 Ir(III)-catalyzed amination with anilines and alkylamines.
[53,54]
 
Introduction                                                         13 
 
N-Substituted hydroxylamines were also successfully applied in the Ir(III)-catalyzed 
direct C–H bond amination of arenes as an alternative nitrogen source. The reactions 
of hydroxyamines with different substituents on nitrogen, such as Boc 
(tert-butyloxycarbonyl), Cbz (carboxybenzyl), Troc (trichloroethyl carbamate), Bz 
(benzoyl), Ts (para-toluenesulfonyl) and Ac (acetyl), were developed at ambient 
temperature, and the corresponding products were obtained in good to excellent yields 
(Scheme 1.18).
[55]
 
 
Scheme 1.18 Ir(III)-catalyzed amination with N-substituted hydroxylamines.
[55]
 
 
 
 
 
1.2 Direct Functionalization of C(sp
3
)–H Bond at a-Position of Tertiary Amines 
Direct functionalization of C(sp
3
)−H bond at a-position of tertiary amines, which has 
two possible transformation pathways, has been considered as a straightforward 
strategy to synthesize nitrogen-containing compounds in recent years (Scheme 
1.19).
[56]
 The one involves the formation of α-aminoalkyl radical C[56d] through one 
electron oxidation/deprotonation or hydrogen abstraction of amine 55. The formed 
α-aminoalkyl radical C as a nucleophile reacts with different electrophiles to produce 
the related nitrogen-containing heterocycles. The other one involves the formation of 
iminium ion D
[56c]
 through single electron transfer and hydrogen abstraction of amine 
or further one electron oxidation of α-aminoalkyl radical C. The formed iminium ion 
D as an electrophile reacts with various nucleophiles to afford the corresponding 
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nitrogen-containing heterocycles. 
 
 
 
Scheme 1.19 Formation of α-aminoalkyl radicals and iminium ions from tertiary 
amines.
[56b−56d]
 
Based on this strategy, numerous methods were developed to generate α-aminoalkyl 
radicals and iminium ions from tertiary amines under different reaction conditions, 
and they were successfully applied in the construction of nitrogen-containing 
compounds.
[56b−56d]
 
 
 
 
 
1.2.1 Formation and Application of α-Aminoalkyl Radicals in Synthetic 
Chemistry 
α-Aminoalkyl radicals can be formed from tertiary amines by single electron 
transfer/deprotonation or hydrogen abstraction (Scheme 1.20).
[57−67]
 Generally, the 
former pathway is common in the photochemical reactions,
[57−66]
 the latter pathway is 
present in the thermal reactions.
[67]
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Scheme 1.20 Formation of α-Aminoalkyl radicals from tertiary amines.[57−67] 
 
Transformation of amines to α-aminoalkyl radicals via single electron transfer has 
been extensively studied with visible-light-induced photoredox catalysis in recent 
decades. The formation of α-aminoalkyl radicals by direct irradiation with visible 
light has limited application in organic photochemical reactions, because most of the 
organic compounds do not tend to absorb photons between 400 nm to 800 nm.
[57]
 
Therefore, photocatalysts, which can convert sunlight to electrochemical potential by 
visible light irradiation, are usually required in such processes. 
Photoredox catalysts contain organic compounds and inorganic compounds. Organic 
photoredox catalysts are organic compounds which have aromatic ring or conjugated 
unsaturated bonds (like double bonds, triple bonds) in their structures. Energy can be 
stored by means of quantum vibration. Normally, organic photoredox catalysts are 
strongly colored. In 2010, Tan and co-workers reported a visible-light-mediated 
Aza-Henry reaction. The α-aminoalkyl radical C was formed using Rose Bengal (RB) 
which is an organic photoredox catalyst (Scheme 1.21).
[58]
 Later, Zhang's group
[59]
 
and Itoh's group
[60]
 achieved the related reactions with Eosin Y and 
4,4′-dichlorobenzophenone (DCBP) (Scheme 1.21). 
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Scheme 1.21 Formation of α-aminoalkyl radicals by organic photoredox catalysts and 
visible light.
[58−60] 
 
Metal-ligand complexes as one kind of inorganic photoredox catalysts are used in 
numerous reactions for producing α-aminoalkyl radicals. The photoredox process is 
initiated by excitation of metal-ligand. Subsequently, one electron moves between 
metals and substrates. During the movement, the electron will reduce 
electron-deficient substrates or oxidize electron-rich substrates. Accordingly, two 
different pathways are introduced to describe the mechanism of this process. The 
former one is called photoreductive quenching, the latter one is called photooxidative 
quenching (Scheme 1.22).
[61]
 
 
 
Scheme 1.22 Metal-ligand photocatalysts in photoredox reactions.
[61] 
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So far, various metal-ligand photocatalysts were applied in the reactions with the 
formation of α-aminoalkyl radicals. The majority of these catalysts are ruthenium and 
iridium complexes (Scheme 1.23).
[61]
 A series of nitrogen-containing heterocycles 
were constructed from the reactions of α-aminoalkyl radicals with diverse 
electron-deficient alkenes using these catalysts.
[61]
 
 
 
 
Scheme 1.23 Metal-ligand photocatalysts.
[61]
 
 
In 2011, MacMillan and co-workers reported an impressive way to construct benzylic 
amines 58 from electron-deficient cyanoarenes 56 and tertiary amines 57 by a 
photocatalyst and visible light (Scheme 1.24).
[62]
 According to the mechanism of this 
process, a radical anion A and an α-amino radical C were initially produced with the 
recycle of the photocatalyst. The coupling of the A and C delivered an intermediate 
anion D which followed by elimination of CN-, leading to the product 58. Later, the 
use of the similar reaction condition, they achieved α-vinylation of N-aryl tertiary 
amines with vinyl sulfones.
[63]
 In 2015, Xiao et al. accomplished α-allylation of 
tertiary amines by the use of a palladium catalyst and a visible-light photoredox 
catalyst. In this transformation, the photoredox catalyst was regenerated by the 
formation of α-amino radicals and allyl radicals.[64] 
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Scheme 1.24 C–H Bond arylation using visible-light photoredox catalysis.[62] 
 
In 2013, Rueping et al. reported an intriguing C–H bond functionalization of tertiary 
amines 59 with visible-light photoredox catalysis. It was found that in the absence of 
oxygen, inter-molecular addition reactions occurred between α-aminoalkyl radicals 
and electron-deficient alkenes 60. In contrast, in the presence of oxygen, inter- and 
intra-molecular reactions through addition/cyclization sequences occurred and 
afforded the corresponding tetrahydroquinoline derivatives 62 (Scheme 1.25).
[65]
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Scheme 1.25 Photoredox-catalyzed radical addition and addition/cyclization 
reactions.
[65]
 
 
Very recently, Hashmi and co-workers developed an efficient alkynylation reaction of 
tertiary amines 63 with 1-iodoalkynes 64 using [Au2(µ-dppm)2]
2+
 as photoredox 
catalyst. The coupling of alkynyl and α-aminoalkyl radicals, which were generated by 
the gold catalyst, delivered the desired products 65 (Scheme 1.26).
[66]
 
 
 
 
Scheme 1.26 α-C(sp3)–H Alkynylation of tertiary amines by gold-catalyzed 
photoredox catalysis.
[66] 
 
Comparing to the reports of α-aminoalkyl radicals formation by one electron 
oxidation/deprotonation with photoredox catalysis, reports about the generation of 
α-aminoalkyl radicals through hydrogen abstraction are relatively rare. For such 
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reactions, special reagents are required as initiators. They react with additives and 
provide corresponding radicals. The formed radicals abstract hydrogen at the 
α-position of nitrogen and produce α-aminoalkyl radicals which attacked to 
electrophiles, providing the desired products. 
Nagaoka et al. developed a method to form α-aminoalkyl radicals using Et3B and air 
(oxygen), reactions of these radicals with aldehydes and isocyanates afforded the 
desired products in good yields (Scheme 1.27).
[67a,67b] 
AIBN (azobisisobutyronitrile) 
and oxygen, KO
t
Bu and DMF were also successfully applied in the formation of 
α-aminoalkyl radicals from tertiary amines by different research groups (Scheme 
1.27).
[67c,67d]
 
 
 
 
Scheme 1.27 Formation of α-aminoalkyl radicals through hydrogen abstraction 
pathway.
[67]
 
 
 
 
 
1.2.2 Formation and Application of Iminium Ions in Synthetic Chemistry 
The formation of iminium ions involves single electron transfer and hydrogen 
abstraction sequences. According to different reaction conditions and substrates, the 
order of the pathway is either single electron transfer/hydrogen abstraction or 
hydrogen abstraction/single electron transfer. 
Iminium ions, which are involved in photochemical reactions, frequently undergo 
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single electron transfer/hydrogen abstraction pathway. In 2010, Stephenson et al. 
developed visible-light-mediated oxidative coupling of nitroalkanes 67 with tertiary 
N-arylamines 66 via α-aminoalkyl radicals (Scheme 1.28).[68] According to the 
plausible mechanism of this process, a radical cation A was initially formed by single 
electron transfer from excited photoredox catalyst to 66. Subsequent hydrogen 
abstraction at the α-position of the radical cation A by [O].- led to an iminium ion B. 
Nucleophilic attack of 67 to B delivered the desired products 68. 
 
 
 
Scheme 1.28 Aza-Henry reaction via iminium ions using visible-light photoredox 
catalysis.
[68] 
 
Recently, CCl4 and BrCCl3 were also applied in the formation of iminium ions in 
photochemical reactions as initiators.
[69]
 The formed ·CCl3 radicals accomplished 
hydrogen abstraction in the transformations. Using this strategy, several inter- and 
intra-molecular reactions were successfully developed to synthesize interesting 
compounds by different research groups.
[69]
 Zeitler et al. reported a novel method to 
form iminium ions using CBrCl3 and visible light, and no photocatalyst was required 
in this reaction.
[70]
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Actually, most of the reported reactions, which included the formation of iminium ion 
intermediates from tertiary amines or amides, were accomplished under thermal 
reaction conditions. Li and others reported numerous reactions for the construction of 
nitrogen-containing heterocycles.
[71]
 The transformation underwent the CDC 
(cross-dehydrogenative coupling) process with iminium ion intermediates. The related 
reactions were achieved by coupling with C(sp)–H bond, C(sp2)–H bond and 
C(sp
3
)–H bond. Different catalysts (copper salts, iron salts, I2, iodide reagents and so 
on) and different oxidants (air or oxygen, DDQ 
(2,3-dichloro-5,6-dicyano-1,4-benzoquinone), peroxides and so on) were employed in 
these reactions (Scheme 1.29).
[71]
  
 
 
 
Scheme 1.29 Cross-dehydrogenative coupling of tertiary amines via iminium ions.
[71]
 
 
In 2012, Mancheño and co-workers developed an interesting method to construct 
heterocycles via iminium ions. Various polycyclic tetrahydro-1,3-oxazin-2-one 
derivatives 78 were synthesized in the presence of oxidant NHAcT
+
BF4
-
 
(4-acetamido-2,2,6,6-tetramethylpiperidine-1-oxoammoniumtetrafluoro borate) 77 at 
room temperature. It was assumed that the iminium ion A was formed through SET 
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and hydrogen abstraction of 75 by the oxidation of 77. The hydrogen abstraction step 
was proposed to be the rate-determining step (Scheme 1.30).
[72]
 
 
 
 
Scheme 1.30 Cyclization between N-benzyl carbamates and alkenes via iminium 
ions.
[72]
 
 
Asymmetric C–C bond formation via iminium ions were also explored by different 
research groups. Several chiral heterocycles were successfully obtained using various 
catalysts and chiral ligands.
[73]
 The chirality was induced through the interaction 
between iminium ions and chiral ligands. An elegant asymmetric intra-molecular 
cross-dehydrogenative coupling reaction was reported by Toste et al. in 2013. In this 
transformation, the enantioselectivity was obtained with a chiral catalyst 81 which 
bearing 1,2,3-triazoles at the 3 and 3′ positions. It was found that conventional PAs 
(phosphoric acid) was not able to provide the enantioselectivity under the same 
reaction condition. Consequently, it was assumed that the chirality was induced under 
the organization of triazoles (Scheme 1.31).
[74]
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Scheme 1.31 Formation of asymmetric C–C bond via iminium ions using chiral 
phosphoric acids.
[74]
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2. Objectives 
Transition-metal-catalyzed C–H bond functionalization has been applied in the 
organic synthesis as an efficient and robust tool. In the last few decades, significant 
achievements had been obtained in this area. Numerous natural products and bioactive 
compounds were successfully constructed under this strategy. 
Indole scaffolds as a core structure are ubiquitously present in natural products 
and biologically active compounds. Substantial methods have been developed 
to construct substituted indoles via transition-metal catalysis by different 
research groups in these decades. Comparing to the functionalization of indoles 
at other positions, reports about the functionalization at the C7-position of 
indoles are rare. In this context, we devised a novel approach for the efficient 
synthesis of 7-substituted indoles 85 (Scheme 2.1). It included 
transition-metal-catalyzed regioselective olefination of indolines 83 and subsequent 
oxidation. The prime challenges of this methodology were the control of 
regioselectivity and combination of these two steps reaction in a one-pot fashion. 
 
 
 
Scheme 2.1 Synthesis of 7-substituted indoles via olefination/oxidation. 
 
Next, a new approach for the direct regioselective sulfonamidation of indoles 86 at the 
C7-position by transition-metal catalysis was proposed. The biggest challenge of this 
strategy was the regioselective functionalization, as three positions were likely to be 
functionalized in this case. This methodology was possible to be applied for the 
synthesis of bioactive compounds (Scheme 2.2). 
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Scheme 2.2 Regioselective sulfonamidation of indoles at the C7-position. 
 
As an efficient synthetic strategy, the direct functionalization of C(sp
3
)–H bond at 
a-position of tertiary amines has been extensively studied in recent years. Abundant 
reactions involving α-aminoalkyl radicals, that were formed by direct 
functionalization of tertiary amines, were reported. Nevertheless, the application of 
α-aminoalkyl radicals in synthetic chemistry is limited due to their easy oxidation to 
iminium ions. This issue is special for α-aminoalkyl radicals which are formed from 
electron-poor amines, as strong oxidants are required in the transformation. Hence, 
novel approaches to produce α-aminoalkyl radicals are highly expected. 
During our study, it was found that α-aminoalkyl radicals could be formed by KI and 
TBHP, which was frequently used to generate iminium ions. Compared to the addition 
reactions with α-aminoalkyl radicals, annulation reactions with α-aminoalkyl radicals 
were less studied. It was wonder if this new approach could be applied in radical 
reactions, especially in radical annulation reactions. Thus an annulation reaction 
between tertiary amines 90 and electron-deficient alkenes 89 was proposed to 
synthesize polycyclic compounds 91 using iodides as catalyst and peroxides as 
oxidant (Scheme 2.3). 
 
 
 
Scheme 2.3 Iodide/Peroxide catalyzed annulation between tertiary amines and 
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electron-deficient alkenes via α-aminoalkyl radicals. 
Imidazo[4,5-b]pyridine derivatives are extensively present in natural products and 
bioactive compounds. However, reported synthetic methods for these compounds 
need long synthetic steps, harsh reaction conditions and have limited substrate scopes. 
Therefore, practical and efficient approaches to prepare such compounds are highly 
desirable. Based on the strategy of direct functionalization of C(sp
3
)–H bond at 
a-position of tertiary amines, a novel route to synthesize imidazo[4,5-b]pyridine 
derivatives 93 via iminium ions A was devised (Scheme 2.4). The biggest challenge 
of this method was the formation of the radical cation by single electron transfer at the 
initial step. This is due to the nitrogen, which is at the C2-position of pyridines, is 
electron-deficient, and it is difficult to be oxidized to the corresponding iminium ion. 
 
 
 
Scheme 2.4 Synthesis of imidazo[4,5-b]pyridine derivatives via iminium ions. 
 
Compounds, which synthesized by these newly developed methods, are contained in 
natural products and bioactive compounds as a key part, thus the bioactivity of these 
compounds would be investigated in different cell-based assays. 
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III Results and Discussion 
 
3.1 Regioselective Synthesis of 7-Substituted Indoles 
 
3.1.1 Synthesis of 7-Substituted Indoles by Rhodium(III)-Catalyzed 
Regioselective Alkenylation
 
 
 
 
 
 
 
3.1.1.1 Introduction for the Regioselective Alkenylation of Indoles 
Indole and its derivatives as privileged scaffolds are substantially present in 
natural products and pharmaceutical compounds.
[75]
 The preparation of 
substituted indole derivatives draws intensive attention from organic chemists. 
Numerous methodologies about the construction of diverse indole derivatives 
have been reported.
[75e,75h]
 However, the methods for efficiently and rapidly 
constructing various indole derivatives, through direct regioselective 
functionalization of indoles are highly expected. In the past decades, numerous 
reactions regarding transition-metal-catalyzed C–H bond activation of indoles at the 
C2-
[76]
 and C3-positions
[77]
 have been studied. 2- or 3-Alkenylated indole derivatives 
95 or 96 were successfully prepared from indoles 94 and alkenes 84 through 
inter-molecular oxidative coupling reactions.
[78,79]
 A method to access 4-substituted 
indole derivatives 98 was also successfully developed using a transition-metal catalyst 
(Scheme 3.1).
[80]
 
The following chapter is related to: 
Rhodium(III)-Catalyzed Direct Regioselective Synthesis of 7‑
Substituted Indoles 
Zengqiang Song, Rajarshi Samanta, Andrey P. Antonchick 
Org. Lett. 2013, 15, 5662–5665 
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Scheme 3.1 Regioselective Alkenylation of Indoles.
[78−80]
 
 
Compared to the other substituted indole derivatives, 7-substituted indole derivatives 
are especially important due to their wide presence in natural products and 
pharmaceutical compounds (Figure 3.1).
[81]
 Nevertheless, reports about the direct 
preparation of 7-substituted indoles through regioselective oxidative functionalization 
of indoles at the C7-position are rare.
[82]
 
 
 
 
Figure 3.1 Representative natural products and bioactive compounds containing 
7-substituted indoles.
[81]
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Due to the importance of 7-substituted indoles, an efficient method for the preparation 
of these compounds was explored using transition-metal catalysis. 
 
3.1.1.2 Optimization Studies for the Synthesis of 7-Alkenylated Indoles 
Initially, we examined the coupling reaction of N-acetylindoline 83 with styrene 84a 
in DCE (1,2-dicholoroethane) at 120 
o
C, using [RuCl2(p-cymene)]2 as catalyst and 
anhydrous Cu(OAc)2 as oxidant.
[10]
 Gratifyingly, the desired product 99a was 
obtained in 24% isolated yield after 24 h (Table 3.1, entry 1). Subsequently, different 
solvents were screened, but none of them improved the yield of the desired product 
(Table 3.1, entries 2–12). Further screening was conducted with different oxidants. 
However, the desired product was obtained with trace amounts in most cases. No 
desired product was formed when CsOAc was used as oxidant (Table 3.1, entries 
13–16). Indoles with different directing groups were also subjected to this reaction. 
To our delight, N,N-diethylcarbamoyl protected indoline 83d afforded the desired 
product 99d in 53% yield (Table 3.1, entry 19). Indolines with other protecting groups, 
such as pivaloyl 83b, 2-pyridylcarbonyl 83c and 2-pyridylsulfonyl 83e, did not 
provide any desired products (Table 3.1, entries 17, 18 and 20). 
 
Table 3.1 Optimization of conditions for the Ru(II)-catalyzed alkenylation of 
indolines at the C7-position.
a
 
 
Entry Indoline (DG) Oxidant Solvent Product (DG) Yield (%)
b
 
1 Ac (83a) Cu(OAc)2 DCE Ac (99a) 24 
2 Ac (83a) Cu(OAc)2 EtOAc Ac (99a) trace 
3 Ac (83a) Cu(OAc)2 1,4-dioxane Ac (99a) trace 
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4 Ac (83a) Cu(OAc)2 t-AmOH Ac (99a) 14 
5 Ac (83a) Cu(OAc)2 CH3CN Ac (99a) trace 
6 Ac (83a) Cu(OAc)2 toluene Ac (99a) trace 
7 Ac (83a) Cu(OAc)2 
fluorobenzen
e 
Ac (99a) trace 
8 Ac (83a) Cu(OAc)2 DMF Ac (99a) 20 
9 Ac (83a) Cu(OAc)2 DMSO Ac (99a) n.d.
c
 
10 Ac (83a) Cu(OAc)2 AcOH Ac (99a) n.d.
c
 
11 Ac (83a) Cu(OAc)2 
1,1,2,2-tetrac
hloroethane 
Ac (99a) trace 
12 Ac (83a) Cu(OAc)2 t-butanol Ac (99a) n.d.
c
 
13 Ac (83a) BQ DCE Ac (99a) trace 
14 Ac (83a) CsOAc DCE Ac (99a) n.d.
c
 
15 Ac (83a) AgOAc DCE Ac (99a) trace 
16 Ac (83a) CuI DCE Ac (99a) trace 
17 Piv (83b) Cu(OAc)2 DCE Piv (99b) n.d.
c
 
18 CO-2Py (83c) Cu(OAc)2 DCE CO-2Py (99c) n.d.
c
 
19 CONEt2 (83d) Cu(OAc)2 DCE CONEt2 (99d) 53 
20 SO2-2Py (83e) Cu(OAc)2 DCE SO2-2Py (99e) n.d.
c
 
a
 Reaction conditions: 83 (0.2 mmol), 84a (1.0 mmol), [RuCl2(p-cymene)]2 (10 mol %), 
AgSbF6 (40 mol %), oxidant (2.5 equiv), 0.2 M at 120 
o
C (the internal temperature of vial was 
105 
o
C) in a 12 mL screw-capped tube. 
b 
Isolated yield.
 c 
The formation of product was not 
detected. BQ = 1,4-benzoquinone. 
 
After a series of exploration with [RuCl2(p-cymene)]2, the catalyst was changed to 
[Cp*Rh(III)Cl2]2 to further examine this transformation. Impressively, initial attempt 
with styrene 84a and N,N-diethylcarbamoyl protected indoline 83d in DCE delivered 
the desired product 99d in 96% yield after 36 h (Table 3.2, entry 1). Subsequently, 
reactions were performed in different solvents (Table 3.2, entries 2–5). It was found 
that 1,4-dioxane or toluene did not improve the yield of the desired product (Table 3.2, 
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entries 2 and 3). The use of DMF as a solvent, only trace amounts of the desired 
product was detected (Table 3.2, entry 5). Delightedly, the desired product was 
obtained in 90% yield using t-AmOH as solvent after 8 h (Table 3.2, entry 4). 
Compared to DCE, the reaction proceeded more efficiently in t-AmOH (Table 3.2, 
entries 1 and 4). Screening of oxidants in t-AmOH did not further improve the yield 
of the desired product. Moderate yields were obtained when Ag2CO3 or Ag2O were 
used as oxidants. Nevertheless, PhI(OAc)2 or NFSI (N-fluorobenzenesulfonimide) 
provided desired products with trace amounts (Table 3.2, entries 6–9). Using acetyl 
protected indoline 83a as substrate, the desired product was gained with an almost 
quantitative yield in DCE after 36 h (Table 3.2, entry 10). 
 
Table 3.2 Optimization of conditions for the Rh(III)-catalyzed alkenylation of 
indolines at the C7-position.
a
 
 
Entry Indoline (DG) Oxidant Solvent Product (DG) Yield (%)
b
 
1 CONEt2 (83d) Cu(OAc)2 DCE 
CONEt2 
(99d) 
96 
2 CONEt2 (83d) Cu(OAc)2 1,4-dioxane CONEt2 (99d) 51 
3 CONEt2 (83d) Cu(OAc)2 toluene CONEt2 (99d) 31 
4 CONEt2 (83d) Cu(OAc)2 t-AmOH CONEt2 (99d) 90 
5 CONEt2 (83d) Cu(OAc)2 DMF CONEt2 (99d) trace 
6 CONEt2 (83d) Ag2CO3 t-AmOH CONEt2 (99d) 45 
7 CONEt2 (83d) Ag2O t-AmOH CONEt2 (99d) 28 
8 CONEt2 (83d) PIDA t-AmOH CONEt2 (99d) <5 
9 CONEt2 (83d) NFSI t-AmOH CONEt2 (99d) trace 
10 Ac (83a) Cu(OAc)2 DCE Ac (99a) 99 
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a
 Reaction conditions: 83 (0.1 mmol), 84a (0.5 mmol), [Cp*Rh(III)Cl2]2 (5 mol %), AgSbF6 
(20 mol %), oxidant (2.5 equiv), 0.1M at 120 
o
C, 36 h (16 h for entry 2, 48 h for entries 3 and 
5, 8 h for entry 4, 20 h for entry 6). 
b
 Isolated yield. 
 
After the alkenylation condition of indolines was established, it was wonder if this 
condition could be directly used for the alkenylation of indoles, and the 
transformations with different indoles were tested (Scheme 3.2). Firstly, styrene 84a 
and N,N-diethylcarbamoyl protected indole 100 were subjected to this coupling 
reaction. After 1.5 h, starting materials got consumed. However, the desired product 
was detected with trace amounts, and the reaction was messy. N,N-Diethylcarbamoyl 
protected 2-methylindole 101 and 2,3,4,9-tetrahydro-1H-carbazole 102 were also 
examined in the presence of styrene 84a under the same reaction conditions. 
Unfortunately, almost no reactions occurred in both cases. 
 
 
 
Scheme 3.2 Exploration of alkenylation with indoles. 
 
Next, the condition for a one-pot reaction via the coupling and oxidation to 
regioselectively synthesize 7-functionalized indoles was explored. Initially, acetyl 
protected indoline 83a was used as a substrate. The regioselective olefination step 
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completed after 36 h. The followed oxidation step did not afford the desired product 
85a with a good yield, although different oxidants were tested (Table 3.3, entries 
1–3).[83] Intriguingly, replacing the protecting group of acetyl by 
N,N-diethylcarbamoyl, the yield of the product 85d was dramatically improved under 
the oxidation of MnO2 (Table 3.3, entries 4 and 5). The reaction time of the oxidation 
step became shorter, when the reaction was performed in t-AmOH. It afforded the 
product 85d in 80% yield. Notably, the reaction could be easily scaled up to 10 folds 
under this reaction condition, and the product was obtained in 86% isolated yield. No 
improvement in the yield was observed when DDQ, Mn(OAc)3·2H2O, TBHP 
(tert-butyl hydroperoxide) or chloranil were used as oxidants (Table 3.3, entries 6–9). 
 
Table 3.3 Optimization of conditions for the synthesis of 7-substituted indoles in a 
one-pot fashion.
a
 
 
Entry Indoline (DG) Oxidant (equiv) Time (h) Product (DG) Yield (%)
b
 
1
c
 Ac (83a) MnO2 (20) 24 Ac (85a) 38 
2
c
 Ac (83a) DDQ (3) 24 Ac (85a) 11 
3
c,d
 Ac (83a) TBHP (4) 24 Ac (85a) trace 
4
c
 CONEt2 (83d) MnO2 (20) 24 CONEt2 (85d) 76 
5 CONEt2 (83d) MnO2 (20) 8 CONEt2 (85d) 80 
6 CONEt2 (83d) DDQ (3) 4 CONEt2 (85d) 57 
7 CONEt2 (83d) 
Mn(OAc)3 ·2H2O 
(1.5) 
24 CONEt2 (85d) 22 
8
d
 CONEt2 (83d) TBHP (4) 24 CONEt2 (85d) trace 
9 CONEt2 (83d) chloranil (3) 24 CONEt2 (85d) 36 
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a 
Reaction conditions: 83 (0.1 mmol), 84a (0.5 mmol), [Cp*Rh(III)Cl2]2 (5 mol %), AgSbF6 
(20 mol %), anhydrous Cu(OAc)2 (2.5 equiv), solvent (0.1 M, entries 1–4 are DCE, entries 
5–9 are t-AmOH) at 120 oC (the internal temperature of vial is 105 oC), after 99 completely 
disappeared (8 h), oxidant was added to the reaction system, continued stirring at 120 
o
C. The 
reaction time in table is oxidation step time. 
b 
Isolated yield. 
c 
After 36 h, 83 completely 
disappeared.
 d 
TBHP 5.5 M in decane. 
 
3.1.1.3 Substrate Scope Evaluation for the Synthesis of 7-Alkenylated Indoles 
After the establishment of the optimal condition, the substrate scope of this reaction 
was evaluated. Initially, reactions with different alkenes 84 were explored. 
Delightedly, the reaction of methyl acrylate 84b afforded the desired product 85e in 
54% yield after 9 h (Table 3.4, entry 1). Subsequently, styrenes with diverse 
substituents at different positions were subjected to this transformation. It was found 
that halogen substituted styrene 84c–84g afforded corresponding products 85f–85j in 
moderate to good yields (Table 3.4, entries 2–6). Styrene with a methoxyl group 84h 
gave the desired product 85k in moderate yield (Table 3.4, entry 7). Ortho-methyl 
substituted styrene 84i offered the desired product 85l in 74% isolated yield (Table 3.4, 
entry 8). Coupling with phenyl-1,3-butadiene derivatives 84j, 84k provided 
corresponding products 85m, 85n with good regioselectivity and yields (Table 3.4, 
entries 9 and 10). 2-Vinyl naphthalene 84l and 1-vinyl naphthalene 84m were also 
examined under this reaction condition. Reactions of both substrates proceeded 
smoothly and provided desired products in good yields (Table 3.4, entries 11 and 12). 
 
Table 3.4 Synthesis of 7-alkenylated indoles with different substituted alkenes.
a
 
 
Entry Alkene Time (h) Product Yield (%)
b
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1
c
 
R = CO2Me 
(84b) 
9 R = CO2Me (85e) 54 
 
 
 
 
 
2 R = 4-F (84c) 26 R = 4-F (85f) 66 
3 R = 3-F (84d) 16 R = 3-F (85g) 57 
4 R = 2-F (84e) 26 R = 2-F (85h) 64 
5 R = 4-Br (84f) 16 R = 4-Br (85i) 83 
6
c
 
R = 3-Br, 4-F 
(84g) 
16 R = 3-Br, 4-F (85j) 65 
7
d
 R = 4-OMe (84h) 16 R = 4-OMe (85k) 50 
8 R = 2-Me (84i) 26 R = 2-Me (85l) 74 
 
 
 
 
 
9 R = 4-NO2 (84j) 16 R = 4-NO2 (85m) 58 
10 R = H (84k) 26 R = H (85n) 59 
11
d
 
 
(84l) 
26 
 
(85o) 
68 
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12
c
 
 
(84m) 
26 
(85p) 
96 
a 
Reaction conditions: 83d (0.1 mmol), 84 (0.5 mmol), [Cp*Rh(III)Cl2]2 (5 mol %), AgSbF6 
(20 mol %), anhydrous Cu(OAc)2 (2.5 equiv) with t-AmOH (0.1M) at 120 
o
C (the internal 
temperature of vial is 105 
o
C), after indolines completely disappeared, MnO2 was added (30 
equiv) to reaction system, continue stirring at 120 
o
C for 8 hours. The reaction time in table is 
the whole reaction time. 
b 
Isolated yield. 
c 
Use 40 equiv MnO2. 
d 
Use 20 equiv MnO2. 
 
Subsequently, we explored the generality of this transformation with different 
indolines 83 (compounds 83f–83m were prepared by Prof. Dr. Rajashi Samanta). It 
was found that reactions of indolines, which have diverse electron-rich or -poor 
substituents proceeded successfully (Table 3.5, entries 1–5). Substrates possessing 
halogen groups 83f–83h were compatible with this newly developed reaction 
condition, and the related 7-substituted indoles 85q–85s were obtained with moderate 
to good yields (Table 3.5, entries 1–3). Reactions of 5-methoxyl indoline 83i and 
2-methyl indoline 83j gave desired products 85t, 85u with moderate yields after 16 h 
(Table 3.5, entries 4 and 5). Indolines with substituents at the C6-position was also 
examined. However, when 6-chloroindoline 83k was used as a substrate, only trace 
amounts of the desired product 85v was formed (Table 3.5, entry 6). It was assumed 
that the chlorine at the C6-position hampered the reaction of the indoline at the 
C7-position due to the steric effect or electronic effect. 3-Substituted indoline 83l was 
also employed. Most of the starting materials were remained, and only trace amounts 
of the desired product 85w were detected after 26 h (Table 3.5, entry 7). The reaction 
of tetrahydrocarbazole 83m gave a messy reaction system. According to the proton 
NMR and GC-MS of products, except the desired product 85x, the fully oxidized 85x, 
the partially oxidized 83m and the fully oxidized 83m were all produced (Table 3.5, 
entry 8). 
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Table 3.5 Synthesis of 7-alkenylated indoles with different substituted indolines.
a
 
 
Entry Indoline Time (h) Product Yield (%)
b
 
1
c
 R = 4-Br (83f) 26 R = 4-Br (85q) 55 
2
d
 R = 5-F (83g) 26 R = 5-F (85r) 77 
3
c
 R = 5-Br (83h) 16 R = 5-Br (85s) 64 
4
c
 R = 5-OMe (83i) 16 R = 5-OMe (85t) 50 
5 R = 2-Me (83j) 16 R = 2-Me (85u) 54 
6 R = 6-Cl (83k) 26 R = 6-Cl (85v) <5 
7 
 
(83l) 
26 
 
(85w) 
<5 
8 
 
(83m) 
26 
 
(85x) 
<5 
a 
Reaction conditions: indolines 83 (0.1 mmol), alkene 84a (0.5 mmol), [Cp*Rh(III)Cl2]2 (5 
mol %), AgSbF6 (20 mol %), anhydrous Cu(OAc)2 (2.5 equiv) with t-AmOH (0.1M) at 120 
o
C (the internal temperature of vial is 105 
o
C), after indolines completely disappeared (for 
entries 6–8, indolines did not completely disappeared). MnO2 was added (30 equiv) to the 
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reaction system, continued stirring at 120 
o
C for 8 hours. The reaction time in table is the 
whole reaction time. 
b 
Isolated yield. 
c 
Use 40 equiv MnO2. 
d 
Use 20 equiv MnO2. 
 
3.1.1.4 Proposed Mechanism for the Synthesis of 7-Alkenylated Indoles 
The mechanism for the preparation of 7-substituted indoles through regioselective 
alkenylation and followed oxidation was proposed (see Scheme 3.3).
[21−30]
 Initially, 
the reaction of [Rh(III)Cp*Cl2]2 and AgSbF6 delivers the species A, in which except 
the pentamethylcyclopentadienyl (Cp*) ligand, acetate
[84]
 or solvent also can be 
incorporated as ligands. Coordination between the rhodium species and the carbonyl 
oxygen of the diethyl carbamoyl group, followed by concerted 
metalation/deprotonation of C(sp
2
)–H bond leads to a six membered rhodacycle B. 
Subsequently, the attack of olefin to the carbon-rhodium bond of B delivers an eight 
membered rhodacycle C. The intermediate C undergoes β-H elimination, offering the 
7-substituted indoline 99d and a rhodium (I) species D. The oxidation of 99d by 
MnO2 provides the desired product 85d. The catalyst is regenerated under the 
transformation of Rh(I) species to Rh(III) species by Cu(OAc)2. 
 
Scheme 3.3 Plausible mechanistic pathway for the synthesis of 7-substituted 
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indoles.
[21−30]
 
3.1.1.5 Transformation of 7-Alkenylated Indoles 
To demonstrate the utility of 7-substituted indoles in synthetic chemistry, we explored 
the transformation of these compounds (Scheme 3.4). Further alkenylation at the 
C2-position of 7-substituted indole 85d was tried according to the reported method 
(Scheme 3.4).
[85]
 Using [Ru(p-cymene)Cl2]2 as catalyst, the desired product 85y was 
obtained in 63% yield after 3 h. This transformation provided an efficient way to 
synthesize 2- and 7-alkenylated indole derivatives. Additionally, the directing group 
of the product could be easily removed in ethanol with NaOH (25% aq.) under 
refluxing, and 7-substituted indole 85z was obtained in an excellent yield after 12 h. 
7-Alkenylated indoles 85d also could be readily transformed to 7-alkylated indole 
85aa by hydrogenation over palladium/charcoal at ambient temperature. The desired 
product 85aa was obtained in 72% isolated yield. This transformation offered a novel 
approach for the preparation of 7-alkylated indoles. 
 
 
Scheme 3.4 Transformation of synthesized 7-substituted indoles.
[85]
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3.1.1.6 Biological Results of 7-Alkenylated Indoles 
All synthesized 7-amino indoles 88 were submitted to COMAS (Compound 
Management and Screening Center) in Dortmund to investigate whether they exhibit 
biological activities against a number of targeted biological pathways in cell-based 
assays. Among the different assays in which the compounds were screened, it was 
revealed that one compound 85z inhibited the hedgehog signaling pathway in the low 
micromolar range (Table 3.6). 
Compared to the other submitted 7-substituted indoles, 85z is the only compound 
without N,N-diethylcarbamoyl group on the nitrogen of the indole. We then decided 
to remove the N,N-diethylcarbamoyl group of the other compounds and subjected 
these compounds to different cell-based assays again. Delightedly, several compounds 
showed inhibitions of the hedgehog signaling pathway in the low micromolar range 
(Table 3.6). These results indicated that the N,N-diethylcarbamoyl group has big 
influence for inhibitory activity in hedgehog signaling pathway. 
The details of the hedgehog cell-based assay are as follows: mouse embryonic 
mesoderm fibroblast C3H10T1/2 cells were used for assaying the modulation of 
hedgehog signaling pathway. These multipotent mesenchymal progenitor cells can 
differentiate into osteoblasts upon treatment with the SMO agonist purmorphamine. 
During differentiation, osteoblast specific genes such as alkaline phosphatase, which 
play a crucial role in bone formation, are strongly expressed. The activity of alkaline 
phosphatase can be directly monitored by following substrate hydrolysis, yielding a 
highly luminescent product. Inhibition of the hedgehog pathway results in a reduction 
in luminescence. Hits showed reduction in the luminescent signal without altering the 
cell viability. Dose-response analysis was performed for hit compounds. 
 
Table 3.6 Representative results of hedgehog-pathway inhibition. 
Entry Product IC50 [µM] Viability
a
 [µM] 
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1 R
1
 = H, R
2
 = H (85z) 2.19 ± 0.12 inactive 
2 R
1
 = H, R
2
 = 2-Me (85ab) 2.67 ± 0.22 inactive 
3 R
1
 = 5-F, R
2
 = H (85ac) 2.07 ± 0.06 inactive 
4 R
1
 = H, R
2
 = 3-Br, 4-F (85ad) 2.03 ± 0.35 inactive 
5 R
1
 = H, R
2
 = 4-F (85ae) 4.27 ± 0.37 inactive 
6 R
1
 = H, R
2
 = 2-F (85af) 2.91 ± 0.12 inactive 
a
 Compounds referred to as “inactive” showed more than 80% cell viability at 10 µM. 
 
 
 
 
 
3.1.2 Synthesis of 7-Substituted Indoles by Iridium(III)-Catalyzed Regioselective 
Sulfonamidation 
 
 
 
 
 
3.1.2.1 Introduction for the Direct C7-Functionalization of Indoles and Synthesis 
of 7-Amino Indoles 
 
The following chapter is related to: 
Iridium(III)-catalyzed regioselective C7-sulfonamidation of indoles 
Zengqiang Song, Andrey P. Antonchick 
Org. Biomol. Chem., 2016, 14, 4804–4808 
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7-Substituted indoles are frequently prepared by the functionalization of 
2-substituted indoles
[86]
 or indolines,
[87]
 methods for the synthesis of them by 
direct functionalization at the C7-position of indoles are rare. The first method 
for direct regioselective functionalization of indoles at the C7-position was 
reported by Hartwig and co-workers in 2010. They successfully synthesized 
7-borylated indoles with good regioselectivity when diethylsilyl was used as a 
directing group.
[88]
 Very recently, Ma’s group and Shi’s group reported 
Rh(III)-catalyzed olefination
[89]
 and Pd(II)-catalyzed arylation
[90]
 of indoles at 
the C7-position, respectively (Scheme 3.5). Undoubtedly, new approaches for 
direct functionalization of indoles at the C7-position are highly desirable. 
 
 
 
Scheme 3.5 Reported methods for direct functionalization of indoles at the 
C7-position.
[88−90]
 
 
7-Amino indole derivatives as important compounds are abundantly present in 
natural products and bioactive compounds (Figure 3.2).
[91]
 However, so far 
there is no report about the direct formation of C–N bond by C–H bond 
functionalization of indoles at the C7-position.
[92]
 Hence, methods for the direct 
formation of C–N bond at the C7-position of indoles are in high demand. 
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Figure 3.2 Representative bioactive compounds containing 7-amino indole 
structural motif.
[91] 
 
In 2014, the first example of the C7-amidation of indolines was reported by 
Zhu et al. with Ru(II) catalysis (Scheme 3.6).
[93]
 Later, using Ir(III) catalysts, 
the same reaction was accomplished by Chang’s group[49c] and Li’s group.[49d] 
These 7-substituted indolines were transformed to 7-substituted indoles when 
MnO2 was used as an external oxidant (Scheme 3.6). However, as far as we 
know, there are no reports about direct regioselective C–H bond amidation at 
the C7-position of indoles.
[92]
 The main challenge of this methodology is 
regioselective functionalization of indoles at the C7-position among the C2-, 
C3- and C7-positions. 
 
 
 
Scheme 3.6 Reported methods for the synthesis of 7-amino indoles from 
indolines.
[49c,49d,93]
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3.1.2.2 Optimization Studies for the Synthesis of 7-Amino Indoles 
In the initial studies, the reaction of indole 86 and tosyl azide 87a was 
examined using [Cp*IrCl2]2 as catalyst, AgNTf2 and AgOAc as additives in 
DCE at 120°C.
[45,94]
 Unfortunately, no desired product was detected after 24 h 
(Table 3.7, entry 1). Subsequently, indoles with various directing groups were 
tested (Table 3.7, entries 2–8). It was found that a mixture of regioisomers at 
the C7- and C2-positions of indoles was formed when benzoyl was used as a 
directing group (Table 3.7, entry 2). Acetyl protected indole 86e provided a 
complex regioisomers mixture (Table 3.7, entry 5). Intriguingly, changing the 
directing group from acetyl to pivaloyl led to the regioselective formation of 
C7-functionalized product 88f in 58% yield (Table 3.7, entry 6). The use of 
other directing groups, no desired product was formed (Table 3.7, entries 3, 4, 7 
and 8). Reactions with different transition-metal catalysts, like the Rh(III) 
complex, the Ru(II) complex and the Pd(II) complex were also tested. 
Unfortunately, almost no desired product was formed in all cases (Table 3.7, 
entries 9–11). Delightedly, the desired product was obtained in 93% yield after 
1 h when the amount of tosyl azide was increased to 2.2 equiv (Table 3.7, entry 
12). 
 
Table 3.7 Exploration of reactions with different directing groups and 
catalysts.
a
 
 
Entry Indole (DG) Catalyst Product (DG) Yield (%)
b
 
1 H (86a) [Cp*IrCl2]2 H (88a) n.d. 
2 Benzoyl (86b) [Cp*IrCl2]2 Benzoyl (88b) 29
c
 
3 Picolinyl (86c) [Cp*IrCl2]2 Picolinyl (88c) n.d. 
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4 Tosyl (86d) [Cp*IrCl2]2 Tosyl (88d) n.d. 
5 Acetyl (86e) [Cp*IrCl2]2 Acetyl (88e) n.d.
d
 
6 Pivaloyl (86f) [Cp*IrCl2]2 Pivaloyl (88f) 58 
7 
Dimethyl 
Carbamoyl (86g) 
[Cp*IrCl2]2 
Dimethyl 
Carbamoyl (88g) 
n.d. 
8 Boc (86h) [Cp*IrCl2]2 Boc (88h) n.d. 
9 Pivaloyl (86f) [RhCp*Cl2]2 Pivaloyl (88f) <5 
10 Pivaloyl (86f) [Ru(p-cymene)Cl2]2 Pivaloyl (88f) n.d. 
11 Pivaloyl (86f) Pd(OAc)2 Pivaloyl (88f) n.d. 
12 Pivaloyl (86f) [Cp*IrCl2]2 Pivaloyl (88f) 93 
a 
Reaction conditions: 86 (0.1 mmol), 87a (0.11 mmol for entries 1–11) or 87a (0.22 mmol; 
for entry 12), catalyst (4 mol%), AgNTf2 (16 mol%), AgOAc (10 mol%), DCE (0.1 M), 120 
o
C, 24 h (2 h for entry 7; 1 h for entry 12) in a 12 mL screw-capped tube. 
b 
Yield refers to 
isolated products after column chromatography. 
c 
C2 isomer in 12% yield and C7-isomer in 
17% yield. 
d
 Complex regioisomer mixture. n.d. = the desired product was not detected. 
 
After the development of method to synthesize 7-amino indoles, we did 
reaction condition studies of this transformation. Screening of solvents did not 
improve the yield of the desired product (Table 3.8, entries 1–7). Reducing the 
amounts of tosyl azide from 2.2 equiv to 1.6 equiv, the yield of the product 
dropped from 93% to 86% (Table 3.6, entry 8). Different additives were also 
tested for this transformation (Table 3.6, entries 9–13). Without the additive, 
the desired product was obtained only in 18% isolated yield after 24 h (Table 
3.6, entry 9). Intriguingly, when LiOAc was used as an additive, the reaction 
provided the desired product in 98% yield after 1 h (Table 3.6, entry 12). It was 
also found that decreasing the amounts of the catalyst or lowering reaction 
temperature led to a decrease in the yield of the desired product (Table 3.6, 
entries 14 and 15). 
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Table 3.8 Optimization of conditions for the sulfonamidation of indoles at the 
C7-position.
a
 
 
Entry Additive Solvent Time (h) Yield (%)
b
 
1 AgOAc Chloroform 1 69 
2 AgOAc 1,4-Dioxane 24 12 
3 AgOAc Toluene 24 n.d. 
4 AgOAc Chlorobenzene 4 79 
5 AgOAc tert-Amyl alcohol 24 n.d. 
6 AgOAc DMF 24 n.r. 
7 AgOAc DMSO 24 n.r. 
8
c
 AgOAc DCE 1 86 
9 — DCE 24 18 
10
d
 Cu(OAc)2 DCE 1 61 
11
d
 NaOAc DCE 24 21 
12
d
 LiOAc DCE 1 98 
13
d
 PivOH DCE 24 34 
14
d,e
 LiOAc DCE 24 56 
15
d,f
 LiOAc DCE 1 84 
a 
Reaction conditions: 86f (0.1 mmol), 87a (0.22 mmol), [Cp*IrCl2]2 (4 mol%), AgNTf2 (16 
mol%), additive (10 mol%), solvent (0.1 M), 120 
o
C in a 12 mL screw-capped tube. 
b 
Yield 
refers to isolated products after column chromatography. 
c 
1.6 equiv 87a was used. 
d 
40 mol% 
additive was used. 
e 
2 mol% [Cp*IrCl2]2, 8 mol% AgNTf2 were used. 
f 
The reaction was 
performed at 80
°
C. n.d. = the desired product was not detected. n.r. = no reaction occured. 
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The structure of the desired product 88f was confirmed by X-ray crystal 
structural analysis (Figure 3.3). 
 
 
Figure 3.3 Crystal structure of product 88f. X-Ray structure analysis was performed 
by Christopher Golz (TU Dortmund). 
 
3.1.2.3 Substrate Scope Evaluation for the Synthesis of 7-Amino Indoles 
With the optimal condition in hand, the scope of this novel transformation was 
explored. Initially, the generality of the indole part was examined. Indoles with 
diverse substituents at different positions were tested with tosyl azides. It was 
found that reactions of indoles with electron-donating or -withdrawing groups 
at the C4- or C5-positions proceeded well. The corresponding products 88i–88q 
were rapidly provided with good yields (Table 3.9, entries 1–9). Notably, 
halogens and formyl groups were tolerated under this reaction condition. 
Surprisingly, indole with a 6-methoxy group gave the desired product 88r in 78% 
yield after 1 h (Table 3.9, entry 10). In most cases, substituents at the 
C6-position of indoles will hamper the C–H bond functionalization of indoles 
at the C7-position because of steric effect, and the related product is very 
difficult to be formed. Using 6-chloro indole 86s as substrate, the desired 
product 88s was obtained in 34% isolated yield after 12 h (Table 3.9, entry 11). 
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These results indicated that under this newly developed reaction condition, 
electronic effect is more important than steric effect to control the formation of 
7-substituted indoles from 6-substituted indoles. Investigations on 3-substituted 
indoles gave corresponding products in good to excellent yields (Table 3.9, 
entries 12–15). Delightedly, reactions with tryptamine derivative 86v and 
tryptophan derivative 86w proceeded smoothly, and the corresponding products 
88v and 88w were provided in 90% and 80% yields (Table 3.9, entries 14 and 
15). 2-Substituted indoles were also examined. However, when 2-methylindole 
86x was used as a substrate, no desired product 88x was detected after 12 h 
(Table 3.9, entry 16). It was assumed that a possible interaction between 
2-methyl group and pivaloyl group led to an unfavored coordination between 
the metal catalyst and the substrate. Hence, no desired product was formed in 
this case (Scheme 3.7). 
 
 
 
Scheme 3.7 Interaction between catalyst and indoles. 
 
The same result was obtained using tetrahydrocarbazole as substrate (Table 3.9, 
entry 17). 
 
Table 3.9 Synthesis of 7-amino indoles with various substituted indoles.
a
 
 
Entry Indole Time (h) Product Yield (%)
b
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1 R = 4-Ph (86i) 1 R = 4-Ph (88i) 87 
2 R = 4-Br (86j) 2 R = 4-Br (88j) 69 
3 R = 4-Cl (86k) 1 R = 4-Cl (88k) 76 
4 R = 4-CHO (86l) 1 R = 4-CHO (88l) 92 
5 R = 5-OMe (86m) 2 R = 5-OMe (88m) 72 
6 R = 5-Ph (86n) 1 R = 5-Ph (88n) 88 
7 R = 5-F (86o) 2 R = 5-F (88o) 73 
8 R = 5-Cl (86p) 2 R = 5-Cl (88p) 66 
9 R = 5-Br (86q) 2 R = 5-Br (88q) 80 
10 R = 6-OMe (86r) 1 R = 6-OMe (88r) 78 
11 R = 6-Cl (86s) 12 R = 6-Cl (88s) 34 
12 R = 3-Me (86t) 2 R = 3-Me (88t) 79 
13 
 
(86u) 
1 
 
(88u) 
75 
14 
 
(86v) 
1 
 
(88v) 
90 
15 
(86w) 
2 
(88w) 
80 
16 R = 2-Me (86x) 12 R = 2-Me (88x) n.d. 
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17 
 
(86y) 
12 
 
(88y) 
n.d. 
a 
Reaction conditions: 86 (0.1 mmol), 87a (0.22 mmol), [Cp*IrCl2]2 (4 mol%), AgNTf2 (16 
mol%), LiOAc (40 mol%) in DCE (0.1 M) at 120 °C. 
b 
Yield refers to isolated products after 
column chromatography. 
 
The scope of the reaction with different azides was also explored. Firstly, 
reactions with various sulfonyl azides were examined. It was found that aryl 
sulfonyl azides with diverse groups at different positions of phenyl ring 
provided related products 88z–88ad in moderate to excellent yields (Table 
3.10, entries 1–5). The reactions of alkyl azides, such as methyl azide 87g, 
heptyl azide 87h, proceeded smoothly and provided corresponding products 
88ae and 88af in 94% and 80% yields (Table 3.10, entries 6 and 7). 
Interestingly, using thiophene-2-sulfonyl azide 87i as substrate, the desired 
product 88ah was obtained in 83% yield after 1 h (Table 3.10, entry 8). 
 
Table 3.10 Synthesis of 7-amino indoles with various substituted tosyl azides.
a
 
 
Entry Tosyl azide Time (h) Product Yield (%)
b
 
 
 
 
 
 
1 R' = H (87b) 1 R' = H (88z) 86 
2 R' = 4-Ac (87c) 1 R' = 4-Ac (88aa) 77 
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3 R' = 3-F (87d) 1 R' = 3-F (88ab) 88 
4 R' = 3-CN (87e) 12 R' = 3-CN (88ac) 52 
5 R' = 2-NO2 (87f) 1 R' = 2-NO2 (88ad) 93 
 
 
 
 
 
6 R = CH3 (87g) 1 R = CH3 (88ae) 94 
7 R = C7H15 (87h) 3 R = C7H15 (88af) 80 
8  
(87i) 
1 
 
(88ah) 
83 
a 
Reaction conditions: 86f (0.1 mmol), 87 (0.22 mmol), [Cp*IrCl2]2 (4 mol%), AgNTf2 (16 
mol%), LiOAc (40 mol%) in DCE (0.1 M) at 120°C. 
b 
Yield refers to isolated products after 
column chromatography. 
 
The reactions of other azides 112, like benzyl azide 112a, TMS (trimethylsilyl) 
azide 112b, diphenylphosphoryl azide 112c and 4-carboxybenzenesulfonazide 
112d were also tested. However, none of them produced desired products. 
Reactions with benzoyl azide 112e were performed at different temperatures (at 
25 
o
C, 60 
o
C, 120 
o
C), but no desired product was observed. Using amines 
instead of azides as nitrogen source, the reactions of 4-(trifluoromethyl)aniline 
112f, which was often used as a substrate in similar reactions,
[53]
 were 
examined. Unfortunately, no desired product appeared using neither LiOAc nor 
AgOAc as oxidants (Scheme 3.8). 
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Scheme 3.8 Synthesis of C7-amino indoles with different nitrogen sources. 
 
Gratifyingly, this newly developed method could be efficiently used to 
synthesize bioactive compounds. The reaction of azide 87p and indole 86f 
afforded the desired product 88ai in 96% yield after 1 h under the standard 
reaction condition. Deprotection of 88ai in methanol with Et3N provided the 
bioactive compound 88ak (ER-67836) with an excellent yield (Scheme 3.9).
[95] 
It was reported that the proliferation of HeLa cell was inhibited by ER-67836 
with half-maximal inhibitory concentrations ranging from 6 to 17 µM. The 
other bioactive compound 88al (ER-68394) was also readily prepared by the 
same procedures (Scheme 3.9).
[95b,96]
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Scheme 3.9 Synthesis of bioactive 7-amino indoles.
[95,96]
 
 
3.1.2.4 Mechanistic Studies for the Synthesis of 7-Amino Indoles 
To gain the evidence into the mechanism and regioselectivity of this novel 
transformation, deuterium labelling experiments were carried out. Initially, the 
reaction of 86f with 2 equiv of D2O was tested under the standard reaction 
condition. After 1 h, the reaction was stopped, and 86z was obtained in 92% 
isolated yield. The proton NMR revealed that 86z contained 36% D at the 
C7-position (Scheme 3.10). 
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Scheme 3.10 Deuterium labelling experiment with N-pivaloyl indole. 
 
Subsequently, the same reaction in the presence of 2.2 equiv of 87a was 
performed. 88am was obtained in 76% yield after 1h. In the proton NMR of 
88am, no deuterium on the indole ring was observed (Scheme 3.11). This result 
indicated that C–H bond activation exclusively occurred at the C7-position of 
the indole under the described reaction condition. 
 
 
 
Scheme 3.11 Deuterium labelling experiment with N-pivaloyl indole and tosyl azide. 
 
Based on the experimental results and literature reports,
[40,44a,97,98]
 a mechanism 
for the sulfonamidation of indoles at the C7-position using Ir(III) catalysis was 
proposed (Scheme 3.12). Initially, the reaction of [Cp*IrCl2]2 with AgNTf2 and 
acetate anion delivers an active cationic species A.
[46a] 
The coordination of the 
species A to the oxygen of the pivaloyl group and subsequent C(sp
2
)–H bond 
activation provides a metallocycle B. The attack of TsN3 to the iridium species 
B leads to the intermediate C, which give the intermediate D and releases N2 by 
sulfonyl amido group migratory insertion. A stepwise nitrenoid pathway also 
will be possible for this sulfonyl amido group transfer process.
[40]
 Finally, a 
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proto-demetalation of D delivers the desired product 88a with the regeneration 
of the iridium complex A. 
 
 
 
Scheme 3.12 Proposed mechanism for the amidation of indoles at the 
C7-position.
[40,44a,46a,97,98]
 
 
3.1.2.5 Biological Results of 7-Amino Indoles 
 
All synthesized 7-amino indoles 88 were submitted to COMAS (Compound 
Management and Screening Center) in Dortmund to investigate whether they exhibit 
biological activities against a number of targeted biological pathways in cell-based 
assays. Among the different assays in which the compounds were screened, it was 
revealed that three compounds 88k, 88p and 88q showed inhibition of the autophagy 
signaling pathway (Figure 3.4), and one compound 88aj showed inhibition of the Wnt 
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signaling pathway (Figure 3.5). 
 
 
 
Figure 3.4 Results of autophagy-pathway inhibition. 
 
The details of the autophagy cell-based assay are as follows: MCF7-LC3 (4000 
cells/well) cells were seeded in 384 well plates (Greiner). The next day cells were 
washed three times with 1x PBS using plate washer ELX405 (Biotek). After that, 10 
µM of compound was added using Echo dispenser (Labcyte) along with EBSS 
(starvation medium) and Chloroquine (50 µM) or Rapamycin (100 nM) and 
Chloroquine (50 µM). Three hours after incubation at 37°C cells were fixed by 
addition of 25 µl formaldehyde in 1 x PBS (4.6% final concentration) and 
simultaneously staining the nucleus with 1:500 Hoechst (Stock 1 mg/ml) for 20 min at 
ambient temperature. Fixed cells were washed thrice with 1x PBS using plate washer 
ELX405 (Biotek). For visualization 4 pictures/well were acquired using ImageXpress 
Micro XL (Molecular Devices) at 20x and analysed with the granularity algorithm of 
MetaXpress Software (Molecular Devices). 
Dose-response analysis was carried out starting from 10 µM using a three-fold 
dilution curve over eight steps. IC50 calculations were done using Quattro Workflow 
software (Quattro Research GmbH). 
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Figure 3.5 Result of Wnt-pathway inhibition. Compounds referred to as “inactive” 
showed no inhibition of luciferase activity at 30 µM. 
 
The details of the Wnt cell-based assay is as follows: compounds were screened at a 
concentration of 30 µM in a cell-based reporter gene assay using HEK293 cell line 
stably transfected with SuperTopFlash (STF) reporter plasmid. In addition, the cells 
were also stably transfected with multiple copies of Frizzled receptor (the binding 
partner of Wnt3a ligands to activate the pathway) to increase the sensitivity of the 
pathway activity for stimulation by Wnt3a proteins (approx. 10–20 fold higher 
induction of wnt-driven luciferase reporter compared with wild type HEK293 cells). 
Only the compounds that displayed cell viability above 80% were subjected to this 
assay. Furthermore, the compounds were also tested parallelly in HEK293 cells 
constitutively expressing renilla luiferase reporter plasmid to rule out false positives 
arising due to general transcription, translation and luciferase protein inhibition itself. 
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3.2 Synthesis of Nitrogen-Containing Heterocycles by Direct Functionalization of 
C(sp
3
)–H Bond at a-Position of Tertiary Amines 
 
3.2.1 Cyclization Between Tertiary Alkylanilines and Alkenes by Peroxide and 
Iodide 
 
 
 
 
 
 
 
3.2.1.1 Introduction for the Synthesis of Nitrogen-Containing Heterocycles via 
α-Aminoalkyl Radicals 
The development of new approaches to construct nitrogen-containing heterocycles 
attracts intensive attention in synthetic chemistry. Reactions involving α-aminoalkyl 
radicals, which are formed by direct functionalization of C(sp
3
)–H bond at a-position 
of tertiary amines, are one of the efficient tool to synthesize these compounds. In 
recent years, abundant of these reactions have been developed by different research 
groups under visible light photoredox catalysis, and diverse compounds were 
prepared through the addition or coupling of α-aminoalkyl radicals with electron 
deficient alkenes, arenes or allylic esters (Scheme 3.13).
[62,65,99]
 
 
The following chapter is related to: 
Catching a-aminoalkyl radicals: cyclization between tertiaryalkylanilines 
and alkenes 
Zengqiang Song, Andrey P. Antonchick 
Tetrahedron, 2016, DOI:10.1016/j.tet.2016.04.052 
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Scheme 3.13 Reactions with α-aminoalkyl radicals by photoredox catalysis.[62,65,99] 
 
Compared to the addition reactions, annulation reactions involving α-aminoalkyl 
radical intermediates for the preparation of nitrogen-containing heterocycles were less 
studied.
[65,100]
 In 1969, using benzoyl peroxide as catalyst, Swan and Roy discovered a 
cyclization reaction of tertiary anilines 90 with N-phenyl maleimides 89 via 
α-aminoalkyl radicals at low temperature (Scheme 3.14).[101] Later, the same reaction 
was accomplished by Miura and co-workers. They used Mn(NO3)2
[102]
 or CuCl2
[103]
 as 
oxidants to transfer single electron (Scheme 3.14). Bian’s group completed this 
reaction under visible light when iridium or ruthenium complexes were used as 
catalysts (Scheme 3.14).
[104]
 Very recently, Shen’s group[105] and Zhang’s group[59] 
reported the same transformation using nickel(II) oxide surface-modified titanium 
dioxide and Eosin Y as photoredox catalysts, respectively (Scheme 3.14). Although 
methods regarding this transformation were reported, the reactions still suffer from 
the limited substrate scope. Especially, in the case of strong electron-deficient tertiary 
alkylamines, for which the nitrogen has weak electron donating capability, are 
difficult to be oxidized to α-aminoalkyl radicals. Therefore, it is still an unsolved 
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challenge to broadly use this kind of reactions in the synthesis of nitrogen-containing 
heterocycles. 
 
Scheme 3.14 Annulation reactions via α-aminoalkyl radicals.[59,102–105] 
 
Pyrrolo[3,4-c]quinolone scaffolds are widely present in natural products and bioactive 
compounds (Figure 3.6).
[106]
 The development of efficient methods to prepare this 
kind of compounds is highly interesting. During our studies on reactions involving 
α-aminoalkyl radical intermediates, it was found that KI and TBHP (tert-butyl 
hydroperoxide) were able to produce α-aminoalkyl radicals of tertiary alkyl amines. 
Mostly, in the presence of peroxides and iodides, tertiary alkyl amines are initially 
transformed to α-aminoalkyl radicals by hydrogen abstraction or radical cations 
through single electron transfer, either α-aminoalkyl radicals or radical cations can be 
easily converted to iminium ions by one electron oxidation or deprotonation under 
this condition.
[107]
 Therefore, this discovery was of interest, and it was wonder if this 
new approach could be applied in the radical reactions. To demonstrate the utility of 
this novel way in synthetic chemistry, an annulation reaction between tertiary alkyl 
amines and electron-deficient alkenes via α-aminoalkyl radicals was explored with 
peroxides and iodides. 
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Figure 3.6 Representative natural product and bioactive compounds containing 
pyrrolo[3,4-c]quinolone scaffold.
[106]
 
 
3.2.1.2 Optimization Studies for the Annulation by Peroxide and Iodide 
Initially, the reaction of N-phenyl maleimide 89a and N,N-dimethyl aniline 90a was 
examined using KI (20 mol%) as catalyst and TBHP (70% in H2O, 4 equiv) as oxidant 
at 70 °C in MeCN (Table 3.11, entry 1). Delightedly, the desired product was obtained 
in 62% isolated yield after 1 h. Next, different reaction conditions were employed to 
improve the yield of the desired product 91a. Firstly, several iodide reagents were 
tested (Table 3.11, entries 1–4). It was found that KI and TBAI (tetrabutylammonium 
iodide) were the most efficient catalysts for this transformation. Using I2 or NIS 
(N-Iodosuccinimide) as catalysts, the desired product was rapidly formed, but the 
yield was dropped. Further screening was conducted with different solvents (Table 
3.11, entries 5–11). DCE was found the best solvent, and it provided the desired 
product in 90% yield after 2 h (Table 3.11, entry 10). When methanol was used as a 
solvent, the reaction completed after 0.5 h, but it gave a messy system (Table 3.11, 
entry 7). Other solvent did not improve the yield of the desired product, although in 
some solvents, like dioxane and EtOAc, reactions accomplished fast (Table 3.11, 
entries 5, 6, 8, 9 and 11). When the amounts of TBHP were decreased to 2 equiv, the 
desired product was obtained with a decreased yield after 8 h (Table 3.11, entry 12). 
Changing the loading amounts of KI from 20 mol% to 5 mol%, the yield of the 
desired product remained, but the reaction time was prolonged (Table 3.11, entries 10, 
13 and 14). Gratifyingly, when TBAI was used as a catalyst, the desired product was 
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obtained with an excellent yield (Table 3.11, entry 15). In the absence of the iodide, 
the reaction provided the desired product in 72% yield after 12 h (Table 3.11, entry 
16). This result further demonstrated that the peroxide is crucial for this 
transformation. 
 
Table 3.11 Optimization of conditions for the annulation between N-phenyl 
maleimides and N,N-dimethyl anilines.
a
 
 
Entry Solvent Catalyst (mol%) Time (h) Yield (%)
b
 
1 MeCN KI (20) 1 62 
2 MeCN TBAI (20) 1 59 
3 MeCN I2 (20) 1 56 
4 MeCN NIS (20) 1 50 
5 THF KI (20) 12 52 
6 Dioxane KI (20) 0.5 67 
7 MeOH KI (20) 0.5 messy 
8 CHCl3 KI (20) 12 80 
9 Toluene KI (20) 12 63 
10 DCE KI (20) 2 90 
11 EtOAc KI (20) 0.5 69 
12
c
 DCE KI (20) 8 84 
13 DCE KI (10) 2 89 
14 DCE KI (5) 3 87 
15 DCE TBAI (10) 2 91 
16 DCE — 12 72 
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a 
Reaction conditions: 89a (0.1 mmol), 90a (0.2 mmol), TBHP (70 % in H2O, 4 equiv), 
catalyst (mol%) in solvent (0.1 M) at 70°C.
 b 
Yield refers to isolated products after column 
chromatography.
 c 
TBHP (70%, in H2O) 2 equiv was used. 
3.2.1.3 Substrate Scope Evaluation for the Annulation by Peroxide and Iodide 
Having the optimized condition in hand, the substrate scope and generality of this 
transformation were explored. Initially, N,N-dimethyl anilines with different 
electron-rich and electron-poor substituents were tested. To our delight, all of them 
provided related products through radical annulations (Table 3.12, entries 1–13). 
Halogens at the para-position of N,N-dimethylaniline were tolerated, and the formed 
products could be readily transformed to other compounds by coupling reactions 
(Table 3.12, entries 3–5). Reactions of 3-methoxy or 3-acetyl substituted 
N,N-dimethylanilines afforded a mixture of regioisomers, in both cases the congested 
regioisomers A were favored. This result indicated that radicals at the ortho-position 
of substituents are more stable in these reactions (Table 3.12, entries 7 and 8). The 
desired products regarding ortho-substituted N,N-dimethylanilines were afforded with 
moderate to good yields, only 2 equiv of TBHP were used for the reaction of benzyl  
substituted N,N-dimethylaniline 89j (Table 3.12, entries 9–11). Using trimethoxy 
substituted N,N-dimethylaniline 89m as substrate, the desired product 91m was 
obtained in 93% yield after 6 h (Table 3.12, entry 12). Intriguingly, 
N,N-dimethylaniline even with a strong electron-withdrawing group, such as a 
ditrifluoromethyl group, still offered the desired product 91n in an acceptable yield 
(Table 3.12, entry 13). This indicated that under our newly developed reaction 
condition, strong electron-deficient N,N-dimethylanilines can be oxidized to the 
corresponding α-aminoalkyl radicals and provide the desired products. In most cases, 
iminium ions will be generated, and no desired products will be formed under this 
reaction condition. 
The nitrogen of anilines with various aromatic as well as aliphatic substituents were 
also subjected to this reaction (Table 3.12, entries 14–19). Delightedly, the reaction of 
N-methyl-N-phenyl aniline 89o proceeded smoothly and furnished the desired product 
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91o in 67% after 12 h (Table 3.12, entry 14). Impressively, only 91p was obtained 
when N-benzyl-N-methyl aniline 89p was used as a substrate. The product was 
formed by the reaction with the methyl group of 89p, and the benzyl group of 89p 
was tolerated in this transformation (Table 3.12, entry 15). The reaction of 
N-butyl-N-methylaniline 89q gave the same selectivity with the reaction of 89p 
(Table 3.12, entry 16). It was assumed that this result was because of the steric effect. 
Although the benzyl and butyl radicals are more stable than the methyl radicals for 
these compounds, the methyl is less steric hindered than the benzyl and butyl. Thus 
the methyl radical was selectively formed by TBHP/TBAI in this novel 
transformation. Additionally, anilines, such as N-diethylaniline 89r, 
1-phenylpyrrolidine 89s and 1-phenylpiperidine 89t, which have two same aliphatic 
groups on nitrogen, offered desired products in good to excellent yields. Nevertheless, 
all of them consisted of two diastereomers, and it seemed the stereoselectivity of these 
reactions were random (Table 3.12, entries 17–19). 
Table 3.12 Annulation with different tertiary amines.
a
 
 
Entry Tertiary Amine Time (h) Product Yield (%)
b
 
 
 
 
 
 
1 R
3
 = 4-Me (89b) 2 R
3
 = 4-Me (91b) 94 
2 R
3
 = 4-Et (89c) 1 R
3
 = 4-Et (91c) 79 
3 R
3
 = 4-F (89d) 3 R
3
 = 4-F (91d) 81 
4 R
3
 = 4-Br (89e) 6 R
3
 = 4-Br (91e) 86 
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5 R
3
 = 4-I (89f) 6 R
3
 = 4-I (91f) 77 
6 
R
3
 = 4-CO2Me 
(89g) 
6 R
3
 = 4-CO2Me (91g) 45 
7 
R
3
 = 3-OMe 
(89h) 
6 
 
(91h) 
91 (8:5) 
8 
R
3
 = 3-COCH3 
(89i) 
6 
91i 
76 (9:5) 
9
c
 R
3
 = 2-Bn (89j) 10 R
3
 = 2-Bn (91j) 51 
10 R
3
 = 2-Ph (89k) 4 R
3
 = 2-Ph (91k) 63 
11 R
3
 = 2-Bz (89l) 12 R
3
 = 2-Bz (91l) 45 
12 
(89m) 
6 93 
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(91m) 
13 
(89n) 
24 
 
(91n) 
40 
14 
 
(89o) 
12 
 
(91o) 
67 
15
c
 
 
(89p) 
12 
 
(91p) 
46 
16 
(89q) 
24 
(91q) 
65 
17 
 
(89r) 
1 
 
(91r) 
63 (3:7) 
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18 
 
(89s) 
3 
 
(91s) 
78 (1:2) 
19 
 
(89t) 
12 
 
(91t) 
73 (5:3) 
a 
Reaction conditions: 89a (0.1 mmol), 90 (0.2 mmol), TBAI (10 mol%), TBHP (70 % in 
H2O, 4 equiv) in DCE (0.1 M) at 70°C.
 b 
Yield refers to isolated products after column 
chromatography. 
c 
TBHP (70 %, in H2O, 2 equiv) used. 
 
Reactions with various electron-deficient alkenes were also explored. Initially, 
maleimides with different substituents were examined (Table 3.13, entries 1–5). 
Aliphatic as well as aromatic groups on the nitrogen of maleimides were compatible 
with this transformation, and corresponding products were rapidly obtained with good 
yields (Table 3.13, entries 1–4). Using 3-methyl-N-phenylmaleimide 89f as substrate, 
the desired product 91y was formed in an acceptable yield with 1 : 3 ratio of 
regioisomers (Table 3.13, entry 5). This result indicated that the formed radical 
preferably attacked to the small steric hindrance part of maleimide in the reaction. 
Interestingly, the reaction of maleimide without substituent on nitrogen proceeded 
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successfully. The desired product 91z was obtained in 78% isolated yield after 30 min 
(Table 3.13, entry 6). This suggested that substituents on the nitrogen of maleimides 
had less effect on this reaction. Maleic anhydride 89h was also examined and the 
reaction completed after 1.5 h (Table 3.13, entry 7). Unfortunately, only trace 
amounts of the desired product 91aa was detected in this case. It was assumed that the 
weak stability of formed intermediates leading to this result. Gratifyingly, 
tetrahydroquinoline 91ab was diastereoselectively formed when diethyl fumarate 89i 
was used as a substrate (Table 3.13, entry 8). The reaction of dimethyl maleate 89j 
was also tested. However, the desired product 91ac was obtained with trace amounts 
after 12 h (Table 3.13, entry 9). This result indicated that the trans configuration of 
acyclic alkenes is favored for this transformation. 
 
Table 3.13 Annulation with different alkenes.
a
 
 
Entry Alkene Time (h) Product Yield (%)
b
 
 
 
 
 
 
1 R = Me (89b) 0.5 R = Me (91u) 62 
2 R = Propyl (89c) 0.5 R = propyl (91v) 66 
3 
R = cyclohexyl 
(89d) 
0.5 R = cyclohexyl (91w) 87 
4 
R = 4-bromophenyl 
(89e) 
2.5 R = 4-bromophenyl (91x) 68 
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5 
 
(89f) 
2.5 
 
(91y) 
45 (1:3) 
6 R = H (89g) 0.5 
 
(91z) 
78 
7 
 
(89h) 
1.5 
 
(91aa) 
trace 
8 
 
(89i) 
12 
 
(91ab) 
60 
9 
(89j) 
12 
 
(91ac) 
trace 
a 
Reaction conditions: 89 (0.1 mmol), 90a (0.2 mmol), TBAI (10 mol%), TBHP (70 % in 
H2O, 4 equiv) in DCE (0.1 M) at 70°C. 
b 
Yield refers to isolated products after column 
chromatography. 
 
 
71                                                Results and Discussion 
 
3.2.1.4 Identification of Diastereomers 
Product 91r consisted of two diastereomers A and B. To identify them, NOE 
experiments were conducted regarding both of isomers (spectra see: Figures 7.2 and 
7.3 in part 7.6). 
According to the NOE spectra of 91r (A), there was no correlation between methyl 4 
and proton 1. This indicated that methyl 4 and proton 1 were in trans configuration 
with each other (Figure 3.7). 
According to the NOE spectra of 91r (B), there was a correlation between methyl 4 
and proton 1. This indicated that methyl 4 and proton 1 were in cis configuration with 
each other (Figure 3.7). 
 
 
 
Figure 3.7 Identification of diastereomers of 91r by NOE experiments. 
 
The diastereomers of 91s and 91t were also identified according to the above 
procedures (spectra see: Figures 7.4–7.7 in part 7.6). 
 
3.2.1.5 Proposed Mechanism for the Annulation by Peroxide and Iodide 
Based on the experimental results and literature reports, a plausible mechanism for 
this radical annulation reaction between N,N-dimethylanilines and alkenes was 
proposed (Scheme 3.15).
[59,101-105,108]
 Initially, reaction between tert-butyl 
hydroperoxide and iodide ion provides tert-butoxyl radical, iodine and hydroxyl anion. 
The reaction of formed iodine and tert-butyl peroxide produces tert-butylperoxyl 
radical, water and regenerated the iodide ion. One electron oxidation of 
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N,N-dimethylaniline 89a by tert-butoxyl or tert-butylperoxyl radicals and subsequent 
deprotonation offers a α-aminoalkyl radical I. The nucleophilic attack of I to alkene 
90a affords a radical intermediate II, which provides the intermediate III by 
following intra-molecular cyclization. Hydrogen abstraction of the intermediate III by 
tert-butoxyl or tert-butylperoxyl radicals leads to the desired product 91a. 
 
 
 
Scheme 3.15 Proposed mechanism of the annulation by TBHP/KI.
[59,101–105,108]
 
 
3.2.1.6 Biological Results of pyrrolo[3,4-c]quinolone derivatives 
 
All synthesized polycyclic compounds 91 were submitted to COMAS (Compound 
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Management and Screening Center) in Dortmund to investigate whether they exhibit 
biological activities against a number of targeted biological pathways in cell-based 
assays. Among the different assays in which the compounds were screened, it was 
revealed that one compound 91k, showed inhibition of the autophagy signaling 
pathway (Figure 3.8). The details of the autophagy cell-based assay are as follows: 
MCF7-LC3 (4000 cells/ well) cells were seeded in 384 well plates (Greiner). The next 
day cells were washed three times with 1x PBS using plate washer ELX405 (Biotek). 
After that, 10 µM of compound was added using Echo dispenser (Labcyte) along with 
EBSS (starvation medium) and Chloroquine (50 µM) or Rapamycin (100 nM) and 
Chloroquine (50 µM). Three hours after incubation at 37°C cells were fixed by 
addition of 25 µl formaldehyde in 1 x PBS (4.6% final concentration) and 
simultaneously staining the nucleus with 1:500 Hoechst (Stock 1 mg/ml) for 20 min at 
RT. Fixed cells were washed thrice with 1x PBS using plate washer ELX405 (Biotek). 
For visualization 4 pictures/well were acquired using ImageXpress Micro XL 
(Molecular Devices) at 20x and analysed with the granularity algorithm of 
MetaXpress Software (Molecular Devices).  
Dose-response analysis was carried out starting from 10 µM using a three-fold 
dilution curve over eight steps. IC50 calculations were done using Quattro Workflow 
software (Quattro Research GmbH). 
 
 
 
Figure 3.8 Result of autophagy-pathway inhibition. 
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Compared to the other synthesized polycyclic compounds, 91k is the only compound 
with phenyl group on N,N-dimethylaniline part. We then synthesized the analogues of 
91k (figure 3.9) and subjected these compounds to different cell-based assays again. 
Unfortunately, none of them has potential inhibition of various signaling pathways. 
 
 
 
Figure 3.9 Synthesized analogues of 91k. 
 
 
 
 
3.2.2 Synthesis of Imidazo[4,5-b]pyridine Derivatives by C(sp
3
)–H Bond 
Amination 
 
3.2.2.1 Introduction for the Synthesis of Imidazo[4,5-b]pyridine Derivatives 
Imidazo[4,5-b]pyridine derivatives as a key core extensively exist in natural products 
and bioactive compounds (Figure 3.10).
[109]
 Traditional methods were frequently used 
to synthesize these compounds.
[110]
 However, the disadvantages of these methods, 
such as long reaction sequences, harsh reaction conditions, low yields and limited 
substrate scope, diminish the synthetic efficiency of imidazo[4,5-b]pyridine 
derivatives. 
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Figure 3.10 Representative natural product and bioactive compounds based on 
imidazo[4,5-b]pyridines.
[109]
 
 
In recent years, several new approaches to access these compounds have been 
developed by different research groups (Scheme 3.16).
[111]
 Ma et al. reported a novel 
method to synthesize 1,2-disubstituted benzimidazoles by a copper catalyst with two 
steps, and four imidazo[4,5-b]pyridine derivatives 121 were prepared by this newly 
developed method (Scheme 3.16).
[111a]
 Using palladium as a catalyst, a new approach 
for the construction of N-aryl benzimidazoles was discovered by Buchwald and 
co-workers, it provided imidazo[4,5-b]pyridine 122 by the reaction of 119 and 120 
(Scheme 3.16).
[111b]
 In 2009, a rapid way to synthesize imidazo[4,5-b]pyridine 
derivatives 124 was developed by Schmitt and co-workers (Scheme 3.16).
[111c]
 This 
method contained two steps, and second step was performed by µ-waves at 180 
o
C. 
Unfortunately, harsh reaction conditions and expensive transition metals are still 
required in these novel methods, and some of them have long reaction sequences. 
Therefore, efficient methods for the synthesis of imidazo[4,5-b]pyridine derivatives 
are in high demand. 
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Scheme 3.16 Newly developed approaches to access imidazo[4,5-b]pyridine 
derivatives.
[111]
 
 
3.2.2.2 Preliminary Exploration and Results of Imidazo[4,5-b]pyridine 
Derivatives Synthesis 
Inspired by the applications of direct functionalization of C(sp
3
)–H bond at a-position 
of tertiary amines in the construction of nitrogen-containing compounds,
[56d,67-70,71h]
 a 
new route to synthesize imidazo[4,5-b]pyridine derivatives via iminium ion 
intermediates was designed. To check the possibility of it, starting material 92a was 
prepared according to the literature report.
[112]
 However, after 72 h refluxing in 
piperidine, the desired product 92a was obtained with only around 30% yield.
 
Delightedly, when the reaction was performed in microwave, it completed after 35 
min and provided the desired product 92a in 75% isolated yield (Scheme 3.17). 
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Scheme 3.17 Synthesis of starting materials by using microwave. 
 
With synthesized starting materials 92a in hand, we started to explore this novel 
approach under different reaction conditions. Initially, reactions were tested using 
metals as catalysts and peroxides as oxidants (Table 3.12, entries 1–12).[71] Iminium 
ions will be formed under this reaction condition, and subsequent intra-molecular 
cyclization with amino groups will afford the desired products. Unfortunately, when 
TBHP was used as an oxidant, no desired product was detected using neither CuBr 
nor Cu(OAc)2 as catalysts at 120 
o
C in DCE (Table 3.12, entries 1 and 2). Reactions 
with different iron salts like FeCl3 and FeCl2 were examined (Table 3.12, entries 3–6). 
It was found that the desired product with trace amounts was observed when DTBP 
(di-tert-butyl peroxide) was used as an oxidant, other oxidants like TBHP, TBPB 
(tert-butyl peroxybenzoate) did not afford any desired product. Then, different 
catalysts, such as CuF2·H2O, CuO and Cu2O, and different oxidants, such as DCP 
(dicumyl peroxide), TBHP, DTBP (di-tert-butyl peroxide) and TBPB, were employed 
in this transformation (Table 3.12, entries 7–12). However, almost no desired product 
was formed in all cases. Starting materials completely disappeared in all reactions 
with metal catalysts and peroxides, but none of them produced the desired product 
(Table 3.12, entries 1–12). This result suggested that 92a was difficult to be oxidized 
to the iminium ion under these conditions, and the formation of byproducts consumed 
the starting materials. Reactions with DDQ 
(2,3-dichloro-5,6-dicyano-1,4-benzoquinone), PIDA [(diacetoxyiodo)benzene ] and 
NaN3, which are used to generate radicals, were also tried (Table 3.12, entries 13 and 
14).
[71h]
 Starting materials were completed, but no desired product was formed in both 
cases. To our delight, when T
+
BF4
-
 (2,2,6,6-tetramethylpiperidine-1-oxoammonium 
tetrafluoro borate) salt
[72,74,113]
 was used as an oxidant, the desired product was 
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obtained in 70% yield after 15 min at rt (Table 3.12, entry 15). Commercial available 
4-NHAcT
+
BF4
-
 (4-acetamido-2,2,6,6-tetramethylpiperidine-1-oxoammonium 
tetrafluoro borate) salt,
[72,74] 
which has similar reactivity with T
+
BF4
-
, was also 
examined. The reaction completed after 15 min; however, the isolation of the desired 
product was difficult, since it has similar polarity with reduced 4-NHAcT
+
BF4
-
 salt. 
 
Table 3.12 Optimization of conditions for the synthesis of imidazo[4,5-b]pyridine 
derivatives via iminium ions.
a
 
 
Entry Reagent Solvent T (
o
C) Yield (%)
b
 
1 
CuBr (10 mol%), TBHP (1.2 equiv, 
70 wt% in water) 
DCE 120 n.d. 
2 
Cu(OAc)2·H2O (10 mol%), TBHP 
(1.2 equiv, 70 wt% in water) 
DCE 120 n.d. 
3 
FeCl3 (10 mol%), TBHP (1.2 equiv, 
70 wt% in water) 
DCE 120 n.d. 
4 FeCl3 (3 mol%), TBPB (4.0 equiv) DCE 120 n.d. 
5 FeCl3 (3 mol%), DTBP (4.0 equiv) DCE 120 trace 
6 FeCl2 (20 mol%), TBPB (4.0 equiv) DCE 120 n.d. 
7 FeCl2 (20 mol%), DTBP (4.0 equiv) DCE 120 trace 
8 
CuF2·H2O (5 mol%), DCP (3.0 
equiv) 
DCE 120 n.d. 
9 
CuF2·H2O (10 mol%), TBHP (4.0 
equiv, 70 wt% in H2O) 
DCE 120 n.d. 
10 CuO (20 mol%), DTBP (4.0 equiv) DCE 120 trace 
11 Cu2O (5 mol%), DCP (3.0 equiv) DCE 120 n.d. 
12 Cu2O (5 mol%), TBPB (2.0 equiv) benzene 120 trace 
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13 DDQ (1.2 equiv) DCE 120 n.d. 
14 PIDA (4 equiv), NaN3 (4 equiv) DCE 25 n.d. 
15
c
 T
+
BF4
-
 (3 equiv) DCE 25 70 
a 
Reaction conditions: 92a (0.2 mmol) with reagents in solvent (0.2 M). 
b 
Yield refers to 
isolated products after column chromatography. 
c 
30 min. n.d. = the desired product was not 
detected. 
Based on the literature reports and experimental results,
[72,74,113]
 a mechanism for the 
synthesis of imidazo[4,5-b]pyridine 93a by T
+
BF4
-
 100 was proposed (Scheme 3.18). 
Initially, single electron transfer from the nitrogen of tertiary amine 92a to T
+
BF4
-
 127 
and subsequent hydrogen abstraction affords the iminium ion I. Amination of I, 
followed by deprotonation leads to the intermediate III, which provides the 
intermediate IV through one electron oxidation and hydrogen abstraction by 127. 
Deprotonation of the intermediate IV delivers the desired product 93a. 
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Scheme 3.18 Proposed mechanism for the synthesis of imidazo[4,5-b]pyridine 
derivatives via iminium ions.
[72,74,113]
 
 
In this newly developed method, T
+
BF4
-
 (Fw: 243) were used as an oxidant with 3 
equiv amounts. It was wonder if the amounts of T
+
BF4
-
 could be reduced to further 
improve the efficiency of this transformation. We then checked literatures. Only a few 
reactions were achieved using T
+
BF4
-
 as oxidant, and all of them used stoichiometric 
amounts of this oxidant.
[72,74,113]
 According to the plausible mechanism (Scheme 3.18), 
T
+
BF4
-
 was firstly reduced to TEMPO 
(2,2,6,6-tetramethyl-1-piperidinyloxy)-hydroxylamine 128, then 128 was oxidized to 
TEMPO 129. Therefore, if T
+
BF4
-
 can be regenerated by oxidizing the formed 
TEMPO 129, the amounts of T
+
BF4
-
 will be reduced. In principle, there are two 
pathways to transform TEMPO to TEMPO oxoammonium salts.
[114,115]
 One way is 
oxidation, the other way is disproportionation under acidic conditions (Scheme 3.19). 
 
 
 
Scheme 3.19 Transformation of TEMPO to TEMPO oxoammonium salt.
[114,115]
 
 
Based on the above strategies, reactions were tested under different reaction 
conditions. Initially, various oxidants, such as PIDA, H2O2, Br2 and NaOCl, were 
used in the reactions.
[114]
 Unfortunately, no desired product was obtained in all cases 
(Table 1.3, entries 1–4). Reactions were also examined under acidic conditions with 
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various acids (Table 1.3, entries 5–7).[115] However, only trace amounts of the desired 
product were observed when the reaction was performed with DIAD (diisopropyl 
azodicarboxylate) and AcOH (Table 1.3, entry 7). In other cases, no desired products 
were yielded (Table 1.3, entries 5 and 6). These results indicated that the use of extra 
oxidants or acids to reduce the amounts of TEMPO oxoammonium salt did not work 
in this reaction. Subsequently, the scope and generality of this reaction were examined 
using 3 equiv of T
+
BF4
-
. 
 
Table 3.13 Optimization of conditions for the synthesis of imidazo[4,5-b]pyridine 
using catalytic amounts of T
+
BF4
-
.
a
 
 
Entry Reagent Solvent T (
o
C) Yield (%)
b
 
1 PIDA (1.2 equiv) DCE 25 n.d. 
2 H2O2 (1.1 equiv) DCE 80 n.d. 
3 Br2 (1.5 equiv) chloroform 25 n.d. 
4 
NaOCl (0.6 equiv, 11 %), KBr(5 
mol %) 
DCE : NaHCO3 
(aq. 0.4 M) (1 : 1) 
80 n.d. 
5 
NaNO2 (6.5 mol%), HCl (13 
mol%, 37%) 
MeCN 80 n.d. 
6 
HNO3 (10 mol%, 68%), HBr (10 
mol%, 48%) 
MeCN : H2O 
(20 :1) 
80 n.d. 
7 
DIAD (1.2 equiv), AcOH (1.0 
equiv) 
DCE 80 trace 
a 
Reaction conditions: 92a (0.2 mmol), T
+
BF4
- 
(5 mol%) with reagents in solvent (0.2 M). 
b 
Yield refers to isolated products after column chromatography. n.d. = the desired product was 
not detected. 
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3.2.2.3 Further Exploration and Results of Imidazo[4,5-b]pyridine Derivatives 
Synthesis 
Initially, 3-amino pyridines with different tertiary and secondary amino groups at the 
C2-position were prepared from 3-amino-2-chloro-pyridines. Unfortunately, using the 
same microwave condition with the synthesis of 92a, only trace or even no desired 
products were obtained for these substrates. Finally, the desired 3-amino pyridine 
derivatives 92 were prepared by nucleophilic substitution of amines 126 to 
3-nitro-2-chloro-pyridines 130 and followed reduction of the nitro groups (Scheme 
3.20).
[116]
 
 
 
Scheme 3.20 Preparation of starting materials.
[116] 
 
After the preparation of the starting materials, reactions of 3-amino pyridines with 
different tertiary or secondary amino groups at the C2-position were examined (Table 
3.14). To our delight, the reaction of 92b afforded the desired product 93b in a 
moderate yield after 30 min (Table 3.14, entry 1). When 92c was used as a substrate, 
the reaction completed after 30 min at 25 
o
C, but no desired product 93c was detected 
(Table 3.14, entry 2). Reducing the reaction temperature to -40 
o
C did not change the 
result of the reaction even after 1h (Table 3.14, entry 3). No desired product 93d was 
provided from the reaction of 92d, although starting materials disappeared after 30 
min (Table 3.14, entry 4). Using 92e or 92f as substrates, the same result was obtained 
with the reaction of 92d (Table 3.14, entries 4–6). These results suggested that this 
method can only be used for the reactions of 3-aminopyridines with dialkyl amino 
groups at the C2-position. 3-Aminopyridines with benzyl alkyl amino groups or alkyl 
amino groups at the C2-position did not provide desired products. It was assumed that 
this was due to the electron density difference of the nitrogen which connected to the 
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C2-position of the 3-amino pyridines. Only 3-amino pyridines with dialkyl amino 
groups were suitable for this transformation under this reaction condition. In this case, 
iminium ion intermediates were formed and led to the desired products. For others, 
side reactions happened and no desired products were yielded. 
 
Table 3.14 Evaluation of substrate scope.
a
 
 
 
Entry Pyridine T (
o
C) T (min) Product Yield (%)
b
 
1 
R
1
 = Ethyl, R
2
 = 
Methyl (92b) 
25 30 
R
1
 = Ethyl, R
2
 = 
Methyl (93b) 
57 
2 
R
1
 = H, R
2
 = Phenyl 
(92c) 
25 30 
R
1
 = H, R
2
 = 
Phenyl (93c) 
n.d. 
3 
R
1
 = H, R
2
 = Phenyl 
(92c) 
-40 60 
R
1
 = H, R
2
 = 
Phenyl (93c) 
n.d. 
4 
R
1
 = Methyl, R
2
 = 
phenyl (92d) 
25 30 
R
1
 = Methyl, R
2
 = 
phenyl (93d) 
n.d. 
5 
R
1
 = H, R
2
 = Ethyl 
(92e) 
25 30 
R
1
 = H, R
2
 = 
Ethyl (93e) 
n.d. 
6 
R
1
 = H, R
2
 = Pentyl 
(92f) 
25 30 
R
1
 = H, R
2
 
=Pentyl (93f) 
n.d. 
a 
Reaction conditions: 92 (0.2 mmol), T
+
BF4
- 
(3 equiv) in solvent (0.2 M). 
b 
Yield refers to 
isolated products after column chromatography. n.d. = the desired product was not detected. 
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IV Summary 
In summary, four novel methods to prepare heterocyclic compounds have been 
developed. Two methods are used to synthesize 7-substituted indoles with 
transition-metal catalysis. The other two methods deal with the construction of 
nitrogen-containing compounds via direct functionalization of C(sp
3
)–H bond at 
a-position of tertiary amines. 
I started my study from the synthesis of 7-substituted indoles. A new and convenient 
methodology for the synthesis of 7-substituted indoles was developed in a one-pot 
fashion. This transformation involves rhodium(III)-catalyzed regioselective 
alkenylation of indolines and subsequent oxidation of MnO2 (Scheme 4.1). It features 
high regioselectivity and broad substrate scope. A series of 7-substituted indoles with 
good to excellent yields were efficiently prepared under this strategy. Additionally, the 
synthesized 7-substituted indoles can be further transformed to the other compounds. 
 
 
 
Scheme 4.1 Rhodium(III)-catalyzed direct regioselective synthesis of 7-substituted 
indoles. 
 
Subsequently, a novel method for the selective sulfonamidation of indole derivatives 
at the C7-position was established using iridium(III) catalysis (Scheme 4.2). 
Substrates with diverse functional groups were tolerated in this reaction. Various 
7-substituted indoles with good to excellent yields were readily synthesized by this 
new approach. Furthermore, this method provided an efficient way to prepare 
biologically active compounds. The results of the mechanistic studies explained the 
regioselectivity of this transformation. 
85                                                           Summary 
 
 
 
Scheme 4.2 Iridium(III)-catalyzed regioselective C7-sulfonamidation of indoles. 
 
Based on the strategy of direct functionalization of C(sp
3
)–H bond at a-position of 
tertiary amines, a robust and environmentally benign method to construct polycyclic 
heterocycles was developed. In this transformation, α-aminoalkyl radicals as reaction 
intermediates were generated using TBAI and TBHP. The cyclization between 
electron-deficient alkenes and tertiary alkylanilines proceeded smoothly and provided 
different tricyclic products in good to excellent yields (Scheme 4.3). Notably, strong 
electron-deficient tertiary arylamines could be transformed to corresponding 
α-aminoalkyl radicals and provided the desired products. 
 
 
 
Scheme 4.3 Cyclization between tertiary alkylanilines and alkenes via α-aminoalkyl 
radicals. 
 
Using T
+
BF4
-
 as oxidant, a new route to construct imidazo[4,5-b]pyridines via 
iminium ions was discovered (Scheme 4.4). In this transformation, iminium ions as 
reaction intermediates were formed by the oxidation of electron-deficient amines. 
Reactions of 3-aminopyridines with dialkyl amino groups at the C2-position 
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proceeded smoothly under this metal-free condition at ambient temperature. The 
corresponding products were efficiently prepared with moderate to good yields. 
Unfortunately, no desired products were obtained when 3-aminopyridines with alkyl 
benzyl amino groups or alkyl amino groups at the C2-position were used as 
substrates. 
 
 
 
Scheme 4.4 Synthesis of imidazo[4,5-b]pyridines via iminium ions. 
 
All synthesized compounds were subjected to various cell-based assays to investigate 
potential modulation of important biological pathways. The results of biological 
studies revealed the potential inhibitors of Wnt, hedgehog and autophagy signaling 
pathways. 
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V Experimental Part 
 
5.1 General Information 
 
5.1.1 Materials 
Unless otherwise noted, chemicals were obtained from Sigma-Aldrich, Alfa Aesar, 
Acros Organics and TCl were used without further purification. Solvents for 
chromatography were technical grade. Petroleum ether 40-60 °C was used for column 
chromatography and thin layer chromatography. Dry dichloromethane was purified by 
the Solvent Purification System M-BRAUN Glovebox Technology SPS-800. Dry 
tetrahydrofuran, methanol, toluene, benzene, tert-amyl alcohol, 1,2-dichloroethane, 
1,4-dioxane, diethyl ether, ethyl acetate, acetonitrile, chloroform, dimethylformamide, 
dimethyl sulfoxide were purchased from Sigma-Aldrich, Alfa Aesar, Acros Organics. 
Analytical thin-layer chromatography (TLC) was performed on Merck silica gel 
aluminium plates with F-254 indicator, visualized by irradiation with UV light. 
Column chromatography was performed using silica gel Merck 60 (particle size 
0.040-0.063 mm). Solvent mixtures are understood as volume/volume.  
 
5.1.2 Instrumentation 
Proton and carbon nuclear magnetic resonance spectra (
1
H-NMR, 
13
C-NMR, 
19
F-NMR) spectra were recorded on Varian Mercury 200 (200 MHz), Bruker Avance 
DPX-300 (300 MHz), Varian Mercury 400 (400 MHz), Bruker Avance DRX 500 (500 
MHz), INOVA500 (500 MHz) and Bruker AV600 (600 MHz) spectrometer in CDCl3 
(δ = 7.26 ppm for 1H, δ = 77.16 ppm for 13C), CD2Cl2 (δ = 5.32 ppm for 
1H, δ = 54.00 
ppm for 
13
C) and CD3CN (δ = 1.940 ppm for 
1H, δ = 1.320, 118.260 ppm for 13C). 
Data are reported in the following order: chemical shift (δ) in ppm; multiplicities are 
indicated s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet); coupling 
constants (J) are given in Hertz (Hz). 
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High resolution mass spectra (HRMS) were recorded on a LTQ Orbitrap mass 
spectrometer coupled to an Accela HPLC-System (HPLC column: Hypersyl GOLD, 
50 mm × 1 mm × 1.9 μm). Mass spectra (MS-EI, 70 eV) were collected using a 
GC-MS (GC system 7890A equipped with 5975C detector) produced by Agilent 
Technologies (column: HP-5MS, 30 m × 0.250 mm × 0.25μm). 
Fourier transform infrared spectroscopy (FT-IR) spectra were obtained with a 
Bruker Tensor 27 spectrometer (ATR, neat) and are reported in terms of frequency of 
absorption (cm
-1
). Chemical yields refer to pure isolated substances. 
Optical rotations ( ][
RT
D
) were measured in a Schmidt + Haensch Polartronic HH8 
polarimeter in cuvettes with a path length of 10 cm at ambient temperature. The 
concentration is given as g/100 mL. 
 
5.2 Experimental Part for 3.1.1 
 
5.2.1 Synthesis of N-Protected Indolines 83a–83e 
General Procedure A for the Synthesis of N-Protected Indolines 83a, 83b, 83d:
[117]
 
To a solution of indoline (10 mmol) in 8 mL THF was added to a suspension of NaH 
(60% in mineral oil, 1.2 equiv, 12 mmol) in 6 mL THF at 0 °C. The mixture was 
stirred for 1 h at room temperature. After recooling to 0 °C, acyl chloride (1.1 equiv, 
11 mmol) was added and the mixture was stirred overnight at room temperature. Then 
a saturated solution of NH4Cl was carefully added and the resulting mixture was 
extracted three times with Et2O. The combined organic layers were washed with water 
and brine, dried over anhydrous MgSO4 and concentrated. The product was purified 
by normal silica gel column with petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compounds 83a, 83b, 83d: 
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1-(Indolin-1-yl)ethan-1-one (83a):
[117]
 
The product was prepared according to the general procedure A. Yield: 85%; Light 
brown amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR 
(500 MHz, CDCl3) δ 8.21 (d, J = 8.0 Hz, 1H), 7.20 – 7.16 (m, 2H), 7.00 (td, J = 7.5, 
0.8 Hz, 1H), 4.04 (t, J = 8.5 Hz, 2H), 3.19 (t, J = 8.5 Hz, 2H), 2.22 (s, 3H); 
13
C NMR 
(126 MHz, CDCl3) δ 168.83, 142.94, 131.19, 127.60, 124.62, 123.66, 117.00, 48.83, 
28.05, 24.36. 
 
 
1-(Indolin-1-yl)-2,2-dimethylpropan-1-one (83b):
[118]
 
The product was prepared according to the general procedure A. Yield: 91%; Light 
brown amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR 
(500 MHz, CDCl3) δ 8.24 – 8.22 (m, 1H), 7.20 – 7.17 (m, 2H), 7.03 – 7.00 (m, 1H), 
4.23 (t, J = 8.2 Hz, 2H), 3.14 (t, J = 8.2 Hz, 2H), 1.38 (s, 9H); 
13
C NMR (126 MHz, 
CDCl3) δ 176.66, 144.89, 130.90, 127.49, 124.36, 123.72, 118.54, 49.59, 40.34, 29.48, 
27.88. 
 
 
N,N-diethylindoline-1-carboxamide (83d):
[86a]
 
The product was prepared according to the general procedure A. Yield: 91%; Brown 
liquid; TLC (10% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 MHz, CDCl3) 
δ 7.16 (dd, J = 7.4, 0.6 Hz, 1H), 7.11 (ddd, J = 8.0, 1.2, 0.6 Hz, 1H), 6.96 (d, J = 8.0 Hz, 
1H), 6.86 (td, J = 7.4, 1.2 Hz, 1H), 3.89 (t, J = 8.3 Hz, 2H), 3.35 (q, J = 7.1 Hz, 4H), 
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3.02 (t, J = 8.3 Hz, 2H), 1.18 (t, J = 7.1 Hz, 6H); 
13
C NMR (126 MHz, CDCl3) δ 
159.74, 144.88, 131.49, 127.11, 124.93, 121.34, 112.98, 50.50, 42.03, 28.25, 13.71. 
 
Procedure for the Synthesis of N-Protected Indolines 83c:
[117]
 
The indoline (3 mmol) were added to pyridine-2-carboxylic acid (2.7 mmol), 
triethylamine (0.48 mL) and TBTU (29.1 mmol) in THF(20 mL). The reaction 
mixture was stirred for 3 h at room temperature, diluted with EtOAc and washed with 
15% potassium carbonate solution, saturated sodium chloride solution and 1 M 
hydrochloric acid. The organic phase was dried over MgSO4 and concentrated under 
vacuum. The product was purified by normal silica gel column with petroleum ether 
(40-60°C)/EtOAc mixture. 
 
Characterization of Compounds 83c: 
 
 
Indolin-1-yl(pyridin-2-yl)methanone (83c):
[117]
 
Yield: 53%; Light brown amorphous solid; TLC (20% EtOAc in petroleum ether): Rf 
= 0.2; 
1
H NMR (400 MHz, CDCl3) δ 8.63 (d, J = 4.5 Hz, 1H), 8.31 (d, J = 7.9 Hz, 
1H), 7.88 – 7.86 (m, 2H), 7.41 (m, 1H), 7.28 – 7.22 (m, 2H), 7.08 (t, J = 7.2 Hz, 1H), 
4.35 (t, J = 8.3 Hz, 2H), 3.15 (t, J = 8.3 Hz, 2H); 
13
C NMR (126 MHz, CDCl3) δ 
166.15, 154.58, 148.07, 143.30, 137.25, 132.27, 127.49, 125.12, 124.71, 124.49, 
124.27, 118.03, 50.62, 28.75. 
 
Procedure for the Synthesis of N-Protected Indoline 83e:
[117]
 
First step: 
To a solution of 2-mercaptopyridine (3.6 mmol) in conc. H2SO4 (10 mL) was added 
dropwise a commercially available bleach solution (roughly 5% NaOCl, 40 mL). The 
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resulting mixture was stirred at 0 ºC for 15 min before extracting two times with 
dichloromethane. The combined organic phase was dried over Na2SO4 and 
concentrated to afford the 2-pyridylsulfonyl chloride as colorless oil. 
Second step: 
To a solution of indoline (2.4 mmol) and pyridine (3.6 mmol) in THF (25 mL), was 
slowly added 2-pyridylsulfonyl chloride (3.6 mmol) under argon at 0 
o
C. The 
resulting solution was stirred at room temperature overnight. The mixture was 
quenched with saturated NH4Cl solution (10 mL) and extracted three times with 
EtOAc. The combined organic phase was dried over anhydrous MgSO4 and 
concentrated under vacuum. The product was purified by normal silica gel column 
with petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compounds 83e: 
 
 
1-(Pyridin-2-ylsulfonyl)indoline (83e):
[117]
 
Yield: 65%; Brown amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 
0.25; 
1
H NMR (400 MHz, CDCl3) δ 8.61 (d, J = 4.6 Hz, 1H), 7.97 (d, J = 7.8 Hz, 
1H), 7.83 (td, J = 7.8, 1.6 Hz, 1H), 7.47 – 7.41 (m, 2H), 7.12 – 7.09 (m, 2H), 6.93 (t, J 
= 7.4 Hz, 1H), 4.34 (t, J = 8.5 Hz, 2H), 3.06 (t, J = 8.5 Hz, 2H); 
13
C NMR (126 MHz, 
CDCl3) δ 156.41, 150.27, 141.63, 137.83, 132.04, 127.61, 127.04, 125.22, 123.77, 
123.15, 114.59, 51.47, 28.18. 
 
5.2.2 Synthesis of Substituted Styrenes 84 
General Procedure B for the Synthesis of Substituted Styrenes 84c, 84g, 84i–84m:[119] 
To a suspension of phosphonium salt (10 mmol) in 25 mL dry diethyl ether was added 
92                                                   Experimental Part 
potassium tert-butoxide (1.8 equiv, 9 mmol) under argon at 0 
o
C. After stirring 15 min, 
it turned yellow. The solution was kept for 10 min without stirring to precipitate all 
the solids and get a supernatant. In another flask, aldehyde (2 equiv, 5 mmol) was 
dissolved in 10 mL dry ether and the solution was kept at 0 
o
C. The supernatant was 
added to the aldehyde solution and the mixture was stirred for 30 min at room 
temperature. The mixture was quenched with saturated NH4Cl solution, extracted 
three times with ether, washed with water, brine and dried over anhydrous Na2SO4. 
The product was purified by normal silica gel column with petroleum ether 
(40-60°C)/EtOAc mixture. 
 
Characterization of Compounds 84c, 84g, 84i–84m: 
 
 
1-Fluoro-4-vinylbenzene (84c):
[119]
 
The product was prepared according to the general procedure B. Yield: 40%; 
Colourless liquid; TLC (in petroleum ether): Rf = 0.6; 
1
H NMR (500 MHz, CDCl3) δ 
7.40 – 7.37 (m, 2H), 7.05 – 7.00 (m, 2H), 6.69 (dd, J = 17.6, 10.9 Hz, 1H), 5.68 (d, J 
= 17.6 Hz, 1H), 5.23 (d, J = 10.9 Hz, 1H); 
13
C NMR (126 MHz, CDCl3) δ 162.57 (d, 
J = 246.7 Hz), 135.80, 133.82 (d, J = 3.3 Hz), 127.86 (d, J = 8.0 Hz), 115.53 (d, J = 
21.6 Hz), 113.65 (d, J = 2.2 Hz). 
 
 
2-Bromo-1-fluoro-4-vinylbenzene (84g):
[120]
 
The product was prepared according to the general procedure B. Yield: 41%; 
Colourless liquid; TLC (in petroleum ether): Rf = 0.6; 
1
H NMR (500 MHz, CDCl3) δ 
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7.59 (dd, J = 6.6, 2.2 Hz, 1H), 7.30 (ddd, J = 8.5, 4.7, 2.2 Hz, 1H), 7.08 – 7.05 (m, 
1H), 6.61 (dd, J = 17.6, 10.9 Hz, 1H), 5.68 (d, J = 17.6 Hz, 1H), 5.27 (d, J = 10.9 Hz, 
1H); 
13
C NMR (126 MHz, CDCl3) δ 158.73 (d, J = 248.0 Hz), 135.42 (d, J = 3.8 Hz), 
134.66, 131.20, 126.82 (d, J = 7.2 Hz), 116.57 (d, J = 22.7 Hz), 115.12 (d, J = 2.3 Hz), 
109.34 (d, J = 21.3 Hz). 
 
 
1-Methyl-2-vinylbenzene (84i):
[119]
 
The product was prepared according to the general procedure B. Yield: 43%; 
Colourless liquid; TLC (in petroleum ether): Rf = 0.3; 
1
H NMR (500 MHz, CDCl3) δ 
7.52 – 7.50 (m, 1H), 7.23 – 7.16 (m, 3H), 6.98 (dd, J = 17.4, 11.0 Hz, 1H), 5.67 (dd, J 
= 17.4, 1.4 Hz, 1H), 5.32 (dd, J = 11.0, 1.4 Hz, 1H), 2.38 (s, 3H); 
13
C NMR (126 
MHz, CDCl3) δ 136.98, 135.53, 135.00, 130.36, 127.79, 126.21, 125.50, 115.26, 
19.83. 
 
 
(E)-1-(Buta-1,3-dien-1-yl)-4-nitrobenzene (84j):
[120]
 
The product was prepared according to the general procedure B. Yield: 75%; Yellow 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (500 MHz, 
CDCl3) δ 8.17 (d, J = 8.8 Hz, 2H), 7.53 – 7.50 (m, 2H), 6.95 – 6.90 (m, 1H), 6.62 – 
6.50 (m, 2H), 5.48 (dd, J = 16.9, 0.5 Hz, 1H), 5.34 (dd, J = 10.0, 0.5 Hz, 1H); 
13
C 
NMR (126 MHz, CDCl3) δ 146.94, 143.78, 136.53, 134.12, 130.52, 126.92, 124.19, 
121.03. 
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(E)-Buta-1,3-dien-1-ylbenzene (84k):
[120]
 
The product was prepared according to the general procedure B. Yield: 47%; 
Colourless liquid; TLC (1% EtOAc in petroleum ether): Rf = 0.5; 
1
H NMR (500 MHz, 
CDCl3) δ 7.43 – 7.41 (m, 2H), 7.35 – 7.31 (m, 2H), 7.26 – 7.22 (m, 1H), 6.83 – 6.78 
(m, 1H), 6.60 – 6.49 (m, 2H), 5.37 – 5.33 (m, 1H), 5.20 – 5.18 (m, 1H); 13C NMR 
(126 MHz, CDCl3) δ 137.31, 137.27, 132.99, 129.76, 128.74, 127.76, 126.58, 117.74. 
 
 
2-Vinylnaphthalene (84l):
[121]
 
The product was prepared according to the general procedure B. Yield: 49%; 
Colourless liquid; TLC (in petroleum ether): Rf = 0.1; 
1
H NMR (500 MHz, CDCl3) δ 
7.84 – 7.81 (m, 3H), 7.77 (s, 1H), 7.66 (dd, J = 8.5, 1.7 Hz, 1H), 7.50 – 7.44 (m, 2H), 
6.91 (dd, J = 17.6, 10.9 Hz, 1H), 5.90 (d, J = 17.6 Hz, 1H), 5.36 (d, J = 10.9 Hz, 1H); 
13
C NMR (126 MHz, CDCl3) δ 137.08, 135.16, 133.71, 133.30, 128.29, 128.18, 
127.80, 126.50, 126.37, 126.05, 123.32, 114.31. 
 
 
1-Vinylnaphthalene (84m):
[121]
 
The product was prepared according to the general procedure B. Yield: 43%; 
Colourless liquid; TLC (in petroleum ether): Rf = 0.1; 
1
H NMR (500 MHz, CDCl3) δ 
8.15 (d, J = 8.1 Hz, 1H), 7.88 (d, J = 7.4 Hz, 1H), 7.82 (d, J = 8.2 Hz, 1H), 7.65 (d, J 
= 7.1 Hz, 1H), 7.56 – 7.47 (m, 4H), 5.82 (dd, J = 17.3, 1.4 Hz, 1H), 5.51 (dd, J = 11.0, 
1.4 Hz, 1H); 
13
C NMR (126 MHz, CDCl3) δ 135.75, 134.52, 133.73, 131.25, 128.64, 
128.22, 126.18, 125.88, 125.76, 123.90, 123.76, 117.23. 
 
5.2.3 Synthesis of 7-Alkenylated Indolines 99 
General Procedure C for the Synthesis of 7-Substituted Indolines 99a, 99d: 
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Protected indoline (0.1 mmol) was dissolved in a 12 mL screw-capped tube with 1 mL 
of anhydrous t-AmOH. Then styrene (0.5 mmol) followed by [(RhCp*Cl2)2] (5 
mol %), AgSbF6 (20 mol %) and anhydrous Cu(OAc)2 (0.25 mmol) were added to the 
reaction mixture at room temperature. The reaction mixture was allowed to warm up 
to 120 °C and stirred for 1-16 h. After the reaction finished, the reaction mixture was 
directly loaded in silica gel column and purified with petroleum ether 
(40-60°C)/EtOAc mixture. 
 
Characterization of Compounds 99a, 99d: 
 
 
(E)-1-(7-Styrylindolin-1-yl)ethanone (99a): 
The compound was prepared according to the general procedure C. Yield: 99%; Beige 
amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (400 
MHz, CDCl3) δ 7.52 – 7.50 (m, 3H), 7.35 (t, J = 7.5 Hz, 2H), 7.28 – 7.24 (m, 1H), 
7.17 – 7.11 (m, 3H), 7.07 (br s, 1H), 4.21 (br s, 2H), 3.01 (t, J = 7.1 Hz, 2H), 2.21 (br 
s, 3H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 128.81 (br s), 128.28, 126.69, 125.56, 
124.87, 123.80 (br s), 51.41, 29.57 ppm; FT-IR: ṽ = 3063.54, 3019.64, 2921.25, 
1943.79, 1736.43, 1583.56, 1387.37, 1328.92, 1015.38 cm
-1
; HRMS: calc. for 
[M+H]
+ 
 C18H18ON2: 264.13829 found: 264.13851. 
 
 
(E)-N,N-Diethyl-7-styrylindoline-1-carboxamide (99d): 
The compound was prepared according to the general procedure C. Yield: 96%; 
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Yellow liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (400 MHz, 
CDCl3) δ 7.44 (d, J = 7.5 Hz, 3H), 7.30 (t, J = 7.6 Hz, 2H), 7.21 (t, J = 7.3 Hz, 1H), 
7.10 (d, J = 7.2 Hz, 1H), 7.02 – 6.98 (m, 3H), 3.93 (t, J = 8.0 Hz, 2H), 3.42 (q, J = 7.1 
Hz, 4H), 3.12 (t, J = 7.9 Hz, 2H), 1.23 (t, J = 7.1 Hz, 6H) ppm; 
13
C NMR (101 MHz, 
CDCl3) δ 161.49, 143.82, 138.01, 133.97, 128.60, 128.35, 127.35, 126.65, 126.57, 
125.98, 124.56, 123.68, 123.59, 53.19, 41.53, 30.46, 13.50 ppm; FT-IR: ṽ = 2970.15, 
2932.55, 2360.60, 2341.66, 1600.16, 1450.89, 1412.63, 1290.89, 1263.37,1153.97, 
1028.18; HRMS: calc. for [M+H]
+ 
 C21H25ON2: 321.19614 found: 321.19650. 
 
5.2.4 Synthesis of 7-Alkenylated Indoles 85 
General Procedure D for the Synthesis of 7-substituted Indoles 85a: 
N,N-Diethylcarbamoyl protected indoline (0.1 mmol) was dissolved in a 12 mL 
screw-capped tube with 1 mL of anhydrous t-AmOH. Then styrene (0.5 mmol) 
followed by [(RhCp*Cl2)2] (5 mol %), AgSbF6 (20mol %) and anhydrous Cu(OAc)2 
(0.25 mmol) were added to the reaction mixture at room temperature. The reaction 
mixture was allowed to warm up to 120 °C and stirred for 1-16 h. After 
N,N-diethylcarbamoyl protected indoline disappeared, 20-40 mmol MnO2 was added 
to the reaction system at 120 
o
C and continued stirring for 8 h. After the reaction 
finished, the reaction mixture was directly loaded in silica gel column and purified 
with petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compounds 85a, 85d-85x: 
 
 
(E)-1-(7-Styryl-1H-indol-1-yl)ethanone (85a): 
The product was prepared according to the general procedure D. Yield: 38%; Beige 
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amorphous solid; TLC (5% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 
MHz, CDCl3) δ 7.80 (d, J = 16.0 Hz, 1H), 7.60 – 7.56 (m, 3H), 7.50 (d, J = 7.6 Hz, 
1H), 7.46 (d, J = 3.8 Hz, 1H), 7.36 (t, J = 7.6 Hz, 2H), 7.32 (t, J = 7.6 Hz, 1H), 7.26 – 
7.24 (m, 1H), 6.91 (d, J = 16.0 Hz, 1H), 6.67 (d, J = 3.8 Hz, 1H), 2.68 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 168.32, 138.19, 133.51, 132.53, 129.43, 128.78, 
128.74, 127.49, 127.36, 127.22,  126.79, 124.51, 124.49, 120.45, 109.33, 24.98 ppm; 
FT-IR: ṽ = 3058.06, 2929.01, 2360.61, 2341.37, 1598.03, 1494.34, 1448.15, 1409.43, 
1301.82, 1201.37; MS-EI: m/z (%) 262 (11) [M+H]
+
, 261 (57) [M]
+.
, 219 (81), 218 
(100), 204 (6), 189 (12). 
 
 
(E)-N,N-Diethyl-7-styryl-1H-indole-1-carboxamide (85d): 
The product was prepared according to the general procedure D. Yield: 80%; Yellow 
liquid;
 
TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (400 MHz, CDCl3) 
δ 7.62 (d, J = 7.5 Hz, 1H), 7.59 – 7.51 (m, 4H), 7.40 (t, J = 7.5 Hz, 2H), 7.33 – 7.28 
(m, 2H), 7.24 (d, J = 3.4 Hz, 1H), 7.08 (d, J = 15.9 Hz, 1H), 6.68 (d, J = 3.4 Hz, 1H), 
3.34 (br s, 4H), 1.14 (br s, 6H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 155.04, 137.62, 
133.24, 130.57, 129.78, 128.75, 127.70, 126.72, 126.61, 125.04, 123.96, 121.77, 
121.52, 120.78, 104.98, 42.62, 13.44 ppm; FT-IR: ṽ = 2974, 1683, 1541, 1457, 1418, 
1230, 1033 cm
-1
; HRMS: calc. for [M+H]
+ 
 C21H22N2O: 319.18049 found: 
319.18108. 
 
 
(E)-Methyl 3-(1-(diethylcarbamoyl)-1H-indol-7-yl)acrylate (85e): 
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The product was prepared according to the general procedure D. Yield: 54%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.45; 
1
H NMR (500 MHz, CDCl3) 
δ 8.05 (d, J = 15.7 Hz, 1H), 7.65 (dd, J = 7.8, 0.8 Hz, 1H), 7.47 (d, J = 7.5 Hz, 1H), 
7.21 – 7.18 (m, 2H), 6.63 (d, J = 3.4 Hz, 1H), 6.40 (d, J = 15.7 Hz, 1H), 3.79 (s, 3H), 
3.43 (br s, 4H), 1.26 (br s, 6H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 167.23, 154.56, 
141.12, 133.81, 130.43, 127.08, 123.31, 122.45, 121.82, 120.71, 118.88, 105.34, 
51.68, 42.80, 13.48 ppm; FT-IR: ṽ = 2974, 1716, 1685, 1635, 1419, 1310, 1273, 1167 
cm
-1
; HRMS: calc. for [M+H]
+ 
 C17H20N2O3: 301.15467 found: 301.15578. 
 
 
(E)-N,N-Diethyl-7-(4-fluorostyryl)-1H-indole-1-carboxamide (85f): 
The product was prepared according to the general procedure D. Yield: 66%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (400 MHz, CDCl3) 
δ 7.57 (d, J = 7.8 Hz, 1H), 7.48 – 7.41 (m, 4H), 7.22 – 7.18 (m, 2H), 7.06 – 6.96 (m, 
3H), 6.63 (d, J = 3.4 Hz, 1H), 3.27 (br s, 4H), 1.08 (br s, 6H) ppm; 
13
C NMR (101 
MHz, CDCl3) δ 162.43 (d, J = 247.2 Hz), 155.04, 133.88 (d, J = 3.3 Hz), 133.24, 
129.81, 129.32 , 128.18 (d, J = 7.9 Hz), 126.60, 124.99 (d, J = 2.3 Hz), 123.82, 
121.78, 121.49, (d, J = 29.3 Hz), 120.84, 115.69 (d, J = 21.7 Hz), 105.03, 42.56, 
13.62 ppm; FT-IR: ṽ = 2975, 1683, 1600, 1508, 1419, 1299, 1224 cm-1; HRMS: calc. 
for [M+H]
+
 C21H21FN2O: 337.17107found: 337.17162. 
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(E)-N,N-Diethyl-7-(3-fluorostyryl)-1H-indole-1-carboxamide (85g): 
The product was prepared according to the general procedure D. Yield: 57%; Yellow 
liquid;
 
TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (400 MHz, CDCl3) 
δ 7.58 (d, J = 7.8 Hz, 1H), 7.52 (d, J = 15.9 Hz, 1H), 7.46 (d, J = 7.4 Hz, 1H), 7.33 – 
7.25 (m, 2H), 7.23 – 7.18 (m, 3H), 7.00 – 6.93 (m, 2H), 6.63 (d, J = 3.3 Hz, 1H), 3.31 
(br s, 4H), 1.11 (br s, 6H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 164.51, 155.00, 
140.07 (d, J = 7.7 Hz), 133.31, 130.19 (d, J = 8.5 Hz), 129.93, 129.26 (d, J = 2.7 Hz), 
126.64 (d, J = 11.9 Hz), 123.48, 122.58 (d, J = 2.8 Hz), 121.73 (d, J = 19.4 Hz), 
121.15, 114.57, 114.36, 113.14, 112.93, 105.11, 42.73, 13.34 ppm; FT-IR: ṽ = 2974, 
1684, 1541, 1419, 1033 cm
-1
; HRMS: calc. for [M+H]
+
 C21H21FN2O: 337.17107 
found: 337.17172. 
 
 
(E)-N,N-Diethyl-7-(2-fluorostyryl)-1H-indole-1-carboxamide (85h): 
The product was prepared according to the general procedure D. Yield: 64%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (400 MHz, CDCl3) 
δ 7.62 – 7.54 (m, 3H), 7.50 (d, J = 7.4 Hz, 1H), 7.24 – 7.17 (m, 4H), 7.13 (t, J = 7.4 
Hz, 1H), 7.09 – 7.04 (m, 1H), 6.64 (d, J = 3.3 Hz, 1H), 3.30 (br s, 4H), 1.10 (br s, 6H) 
ppm; 
13
C NMR (101 MHz, CDCl3) δ 160.48 (d , J = 249.5 Hz), 154.97, 133.29, 
129.87, 128.89 (d, J = 8.3 Hz), 127.43, 127.42 (d, J = 9.2 Hz), 126.67, 125.49 (d, J = 
12.1 Hz), 124.31 (d, J = 3.5 Hz), 123.85, 122.66 (d, J = 3.6 Hz), 121.75 (d, J = 13.3 
Hz), 121.07, 115.85 (d, J = 22.1 Hz), 115.74, 105.06, 42.69, 13.42 ppm; FT-IR: ṽ = 
2974, 1684, 1541, 1488, 1456, 1418, 1299, 1230, 1033 cm
-1
; HRMS: calc. for 
[M+H]
+ 
 C21H21FN2O: 337.17107 found: 337.17171. 
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(E)-7-(4-Bromostyryl)-N,N-diethyl-1H-indole-1-carboxamide (85i): 
The product was prepared according to the general procedure D. Yield: 83%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.30; 
1
H NMR (400 MHz, CDCl3) 
δ 7.58 (d, J = 7.8 Hz, 1H), 7.53 – 7.44 (m, 4H), 7.37 – 7.35 (m, 2H), 7.22 – 7.17 (m, 
2H), 6.95 (d, J = 16.0 Hz, 1H), 6.63 (d, J = 3.3 Hz, 1H), 3.28 (br s, 4H), 1.09 (br s, 6H) 
ppm; 
13
C NMR (101 MHz, CDCl3) δ 155.00, 136.60, 133.20, 131.85, 129.85, 129.18, 
128.16, 126.63, 125.89, 123.58, 121.80, 121.54, 121.39, 121.05, 105.06, 42.65, 13.72 
ppm; FT-IR: ṽ = 2974, 1684, 1558, 1541, 1488, 1419, 1033, 1009 cm-1; HRMS: calc. 
for [M+H]
+ 
 C21H21
79
BrN2O: 397.09100 found: 397.09029; [M+H]
+ 
 C21H21
81
BrN2O: 
399.08896 found:399.08729. 
 
 
(E)-7-(3-Bromo-4-fluorostyryl)-N,N-diethyl-1H-indole-1-carboxamide (85j): 
The product was prepared according to the general procedure D. Yield: 65%; Yellow 
liquid;
 
TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (300 MHz, CDCl3) 
δ 7.90 (s, 2H), 7.74 – 7.61 (m, 3H), 7.50 (d, J = 7.3 Hz, 1H), 7.22 (d, J = 7.6 Hz, 1H), 
7.18 (d, J = 3.4 Hz, 1H), 7.07 (d, J = 16.0 Hz, 1H), 6.65 (d, J = 3.4 Hz, 1H), 3.41 (br s, 
4H), 1.17 (t, J = 6.6 Hz, 6H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 158.54 (d, J = 
248.3 Hz), 155.00, 135.53 (d, J = 3.9 Hz), 133.35, 131.33, 130.01, 127.80 (d, J = 1.3 
Hz), 127.08 (d, J = 7.1 Hz), 126.71, 126.49 (d, J = 2.5 Hz), 123.35, 121.86, 121.54, 
121.20, 116.72 (d, J = 22.6 Hz), 109.48 (d, J = 21.3 Hz), 105.20, 42.77, 13.52 ppm; 
Experimental Part                                                   101 
 
FT-IR: ṽ = 2974, 1684, 1558, 1541, 1494, 1457, 1418, 1312, 1046 cm-1; HRMS: calc. 
for [M+H]
+
 C21H20
79
BrFN2O: 415.08158 found: 415.08180; C21H20
81
BrFN2O: 
417.07953 found: 417.07820. 
 
 
(E)-N,N-Diethyl-7-(4-methoxystyryl)-1H-indole-1-carboxamide (85k): 
The product was prepared according to the general procedure D. Yield: 50%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (400 MHz, CDCl3) 
δ 7.54 (d, J = 7.8 Hz, 1H), 7.45 – 7.43 (m, 3H), 7.35 (d, J = 16.0 Hz, 1H), 7.21 – 7.17 
(m, 2H), 6.97 (d, J = 16.0 Hz, 1H), 6.90 – 6.88 (m, 2H), 6.62 (d, J = 3.3 Hz, 1H), 3.83 
(s, 3H), 3.28 (br s, 4H), 1.08 (br s, 6H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 159.26, 
130.13, 130.00, 129.60, 127.81, 126.42, 124.18, 122.80, 121.62, 121.19, 120.28, 
114.06, 113.77, 113.47, 104.78, 55.32, 42.52, 13.41 ppm; FT-IR: ṽ = 2930, 1683, 
1606, 1509, 1418, 1249, 1175, 1033 cm
-1
; HRMS: calc. for [M+H]
+ 
 C22H24N2O2: 
349.19105 found: 349.19158. 
 
 
(E)-N,N-Diethyl-7-(2-methylstyryl)-1H-indole-1-carboxamide (85l): 
The product was prepared according to the general procedure D. Yield: 74%; Yellow 
liquid;
 
TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (400 MHz, CDCl3) 
δ 7.59 – 7.55 (m, 2H), 7.47 (d, J = 7.4 Hz, 1H), 7.37 (d, J = 15.8 Hz, 1H), 7.26 – 7.15 
(m, 6H), 6.62 (d, J = 3.4 Hz, 1H), 3.26 (brs, 4H), 2.41 (s, 3H), 1.05 (brs, 6H) ppm; 
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13
C NMR (101 MHz, CDCl3) δ 154.97, 136.59, 135.74, 133.26, 130.42, 129.80, 
128.40, 127.63, 126.64, 126.30, 126.22, 125.72, 124.27, 121.74, 121.59, 120.75, 
104.97, 42.66, 20.09, 13.62 ppm; FT-IR: ṽ = 2973, 1683, 1541, 1457, 1418, 1298, 
1033 cm
-1
; HRMS: calc. for [M+H]
+
 C22H24N2O: 333.19614 found: 333.19681. 
 
 
N,N-Diethyl-7-((1E,3E)-4-(4-nitrophenyl)buta-1,3-dien-1-yl)-1H-indole-1-carbox
amide (85m): 
The product was prepared according to the general procedure D. Yield: 58%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.15;
 1
H NMR (400 MHz, CDCl3) 
δ 8.19 (d, J = 8.8 Hz, 2H), 7.58 (d, J = 7.8 Hz, 1H), 7.53 (d, J = 8.8 Hz, 2H), 7.45 (d, 
J = 7.4 Hz, 1H), 7.22 – 7.16 (m, 3H), 7.12 – 7.05 (m, 1H), 6.96 – 6.90 (m, 1H), 6.70 
(d, J = 15.4 Hz, 1H), 6.63 (d, J = 3.4 Hz, 1H), 3.35 (br s, 4H), 1.21 (br s, 6H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 154.93, 146.72, 144.03, 133.93, 132.10, 130.18, 
130.07, 129.70, 129.17, 126.76, 126.72, 124.32, 123.07, 121.83, 121.60, 121.47, 
105.18, 42.57, 13.27 ppm; FT-IR: ṽ = 2923, 1716, 1683, 1587, 1541, 1509, 1419, 
1337, 1107 cm
-1
; HRMS: calc. for [M+H]
+ 
C23H23N3O3: 390.18122 found: 
390.18294. 
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N,N-Diethyl-7-((1E,3E)-4-phenylbuta-1,3-dien-1-yl)-1H-indole-1-carboxamide 
(85n): 
The product was prepared according to the general procedure D. Yield: 59%; Yellow 
liquid;
 
TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, CDCl3) 
δ 7.55 (d, J = 7.8 Hz, 1H), 7.43 (d, J = 8.1 Hz, 3H), 7.34 (t, J = 7.6 Hz, 2H), 7.26 – 
7.23 (m, 1H), 7.20 – 7.17 (m, 2H), 7.03 (d, J = 14.5 Hz, 1H), 6.98 – 6.87 (m, 2H), 
6.67 (d, J = 14.7 Hz, 1H), 6.62 (d, J = 3.3 Hz, 1H), 3.33 (br s, 4H), 1.19 (br s, 6H) 
ppm; 
13
C NMR (126 MHz, CDCl3) δ 155.02, 137.49, 132.96, 132.93, 130.89, 129.86, 
129.45, 128.83, 128.75, 127.73, 126.63, 126.49, 123.76, 121.75, 121.22, 120.82, 
104.95, 42.73, 13.42 ppm; FT-IR: ṽ = 2973, 1717, 1698, 1684, 1558, 1541, 1522, 
1508, 1473, 1457, 1033 cm
-1
; HRMS: calc. for [M+H]
+
 C23H24N2O: 345.19614 found: 
345.19727. 
 
 
(E)-N,N-Diethyl-7-(2-(naphthalen-2-yl)vinyl)-1H-indole-1-carboxamide (85o): 
The product was prepared according to the general procedure D. Yield: 68%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 MHz, CDCl3) 
δ 7.85 – 7.81 (m, 4H), 7.75 – 7.74 (m, 1H), 7.66 (d, J = 15.9 Hz, 1H), 7.59 (d, J = 7.8 
Hz, 1H), 7.53 (d, J = 7.8 Hz, 1H), 7.50 – 7.44 (m, 2H), 7.25 – 7.18 (m, 3H), 6.65 (d, J 
= 3.3 Hz, 1H), 3.30 (br s, 4H), 1.10 (br s, 6H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 
155.11, 135.20, 133.84, 133.31, 133.17, 130.68, 129.86, 128.41, 128.13, 127.84, 
126.76, 126.65,  126.45, 126.01, 125.46, 124.05, 123.83, 121.83, 121.54, 120.87, 
105.02, 42.82, 13.48 ppm; FT-IR: ṽ = 2974, 1683, 1541, 1418, 1056, 1033 cm-1; 
HRMS: calc. for [M+H]
+ 
 C25H24N2O: 369.19614 found: 369.19795. 
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(E)-N,N-Diethyl-7-(2-(naphthalen-1-yl)vinyl)-1H-indole-1-carboxamide (85p): 
The product was prepared according to the general procedure D. Yield: 96%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 MHz, CDCl3) 
δ 8.23 (d, J = 8.6 Hz, 1H), 7.89 – 7.78 (m, 4H), 7.62 (t, J = 8.6 Hz, 2H), 7.56 – 7.48 
(m, 4H), 7.29 – 7.26 (m, 1H), 7.21 (d, J = 3.3 Hz, 1H), 6.66 (d, J = 3.3 Hz, 1H), 3.26 
(br s, 4H), 0.99 (t, J = 7.2 Hz, 6H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 154.96, 
135.15, 133.83, 133.31, 131.48, 129.89, 128.74, 128.14, 128.02, 127.60, 126.68, 
126.19, 125.88, 125.85, 124.20, 124.01, 123.81, 121.79, 121.72, 120.97, 104.99, 
42.66, 13.38 ppm; FT-IR: ṽ = 2973, 1683, 1418, 1306, 1033 cm-1; HRMS: calc. for 
[M+H]
+ 
 C25H24N2O: 369.19614 found: 369.19789. 
 
 
(E)-4-Bromo-N,N-diethyl-7-styryl-1H-indole-1-carboxamide (85q): 
The product was prepared according to the general procedure D. Yield: 55%; Yellow 
liquid;
 
TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (400 MHz, CDCl3) 
δ 7.49 (d, J = 7.5 Hz, 2H), 7.43 (d, J = 16.0 Hz, 1H), 7.38 – 7.25 (m, 5H), 7.23 (d, J = 
3.4 Hz, 1H), 7.01 (d, J = 16.0 Hz, 1H), 6.70 (d, J = 3.4 Hz, 1H), 3.24 (br s, 4H), 1.08 
(br s, 6H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 154.33, 137.39, 133.24, 131.28, 
130.16, 128.82, 127.96, 127.03, 126.78, 124.70, 124.11, 123.39, 122.37, 114.39, 
105.17, 42.39, 13.22 ppm; FT-IR: ṽ = 2974, 1685, 1558, 1541, 1473, 1421, 1385, 
1274, 1033 cm
-1
; HRMS: calc. for [M+H]
+
 C21H21
79
BrN2O: 397.09100 found: 
397.09001; C21H21
81
BrN2O: 399.08896 found: 399.08713. 
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(E)-N,N-Diethyl-5-fluoro-7-styryl-1H-indole-1-carboxamide (85r): 
The product was prepared according to the general procedure D. Yield: 77%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (400 MHz, CDCl3) 
δ 7.50 (d, J = 7.5 Hz, 2H), 7.45 (d, J = 16.0 Hz, 1H), 7.36 (t, J = 7.5 Hz, 2H), 7.29 – 
7.26 (m, 1H), 7.23 – 7.21 (m, 3H), 7.02 (d, J = 16.0 Hz, 1H), 6.59 (d, J = 3.3 Hz, 1H), 
3.31 (br s, 4H), 1.11 (br s, 6H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 158.90 (d, J = 
236.8 Hz), 154.71, 137.17, 131.69, 129.92, 128.82, 128.12 (d, J = 5.9 Hz), 126.85, 
124.99 (d, J = 9.3 Hz), 123.96 (d, J = 1.9 Hz), 109.19 (d, J = 26.4 Hz), 105.65 (d, J = 
23.7 Hz), 105.77, 105.53, 105.09 (d, J = 4.6 Hz), 42.86, 13.59 ppm; FT-IR: ṽ = 2974, 
1684, 1558, 1541, 1508, 1457, 1417, 1033 cm
-1
; HRMS: calc. for [M+H]
+
 
C21H21FN2O: 337.17107 found: 337.17168. 
 
 
(E)-5-Bromo-N,N-diethyl-7-styryl-1H-indole-1-carboxamide (85s): 
The product was prepared according to the general procedure D. Yield: 64%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (400 MHz, CDCl3) 
δ 7.68 (d, J = 1.7 Hz, 1H), 7.56 (d, J = 1.5 Hz, 1H), 7.49 (d, J = 7.4 Hz, 2H), 7.42 (d, 
J = 16.0 Hz, 1H), 7.36 (t, J = 7.5 Hz, 2H), 7.28 (d, J = 7.3 Hz, 1H), 7.18 (d, J = 3.3 
Hz, 1H), 7.02 (d, J = 16.0 Hz, 1H), 6.57 (d, J = 3.3 Hz, 1H), 3.28 (br s, 4H), 1.08 (br s, 
6H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 154.49, 137.12, 131.99, 131.94, 131.34, 
128.83, 128.13, 127.65, 126.86, 125.56, 124.00, 123.60, 122.99, 115.01, 104.45 , 
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42.75, 13.15 ppm; FT-IR: ṽ = 2974, 1684, 1541, 1423, 1033 cm-1; HRMS: calc. for 
[M+H]
+ 
 C21H21
79
BrN2O: 397.09100 found: 397.08993; C21H21
81
BrN2O: 399.08896 
found: 399.08711. 
 
 
(E)-N,N-Diethyl-5-methoxy-7-styryl-1H-indole-1-carboxamide (85t): 
The product was prepared according to the general procedure D. Yield: 50%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (400 MHz, CDCl3) 
δ 7.50 – 7.44  (m, 3H), 7.35 (t, J = 7.6 Hz, 2H), 7.27 – 7.24 (m, 1H), 7.16 (d, J = 3.2 
Hz, 1H), 7.12 (d, J = 2.2 Hz, 1H), 7.05 – 7.00, (m, 2H), 6.55 (d, J = 3.3 Hz, 1H), 3.89 
(s, 3H), 3.30 (br s, 4H), 1.09 (br s, 6H) ppm;
 13
C NMR (101 MHz, CDCl3) δ 155.38, 
155.07, 137.46, 130.95, 130.62, 128.76, 128.68, 127.82, 127.30, 126.78, 124.76, 
124.70, 110.69, 104.86, 102.92, 55.97, 42.77, 13.44 ppm; FT-IR: ṽ = 2973, 1683, 
1417, 1283, 1033 cm
-1
; HRMS: calc. for [M+H]
+ 
 C22H24N2O2: 349.19105 found: 
349.19155. 
 
 
(E)-N,N-Diethyl-2-methyl-7-styryl-1H-indole-1-carboxamide (85u): 
The product was prepared according to the general procedure D. Yield: 54%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.20; 
1
H NMR (400 MHz, CDCl3) 
δ 7.52 – 7.45 (m, 4H), 7.38 – 7.34 (m, 3H), 7.27 – 7.21 (m, 1H), 7.13 (t, J = 7.6 Hz, 
1H), 7.03 (d, J = 15.9 Hz, 1H), 6.33 (s, 1H), 3.74 – 3.61 (m, 1H), 3.37 – 3.28 (m, 1H), 
2.87 – 2.67 (m, 2H), 2.40 (s, 3H), 1.18 (t, J = 7.2 Hz, 3H), 0.86 (t, J = 7.2 Hz, 3H) 
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ppm; 
13
C NMR (101 MHz, CDCl3) δ 154.72, 137.60, 135.33, 133.41, 130.67, 129.17, 
128.78, 127.68, 126.68, 124.51, 122.74, 121.10, 120.15, 119.76, 102.64, 43.12, 42.04, 
13.52, 12.81, 12.63 ppm; FT-IR: ṽ = 2974, 1683, 1558, 1541, 1508, 1457, 1418, 1302, 
1033 cm
-1
; HRMS: calc. for [M+H]
+
 C22H24N2O: 333.19614 found: 333.19671. 
5.2.5 Synthesis of 7-Alkenylated Indole Derivatives 85y–85aa 
Procedure for the Synthesis of Compound 85y:
[85]
 
Compound 85d (0.08 mmol) was dissolved in 1 mL anhydrous DCE in a 12 mL 
screw-capped tube. Then methyl acrylate (0.12 mmol) followed by 
[Ru(p-cymene)Cl2]2 (5 mol %), AgSbF6 (20 mol %), Cu(OAc)2·2H2O (1.0 equiv) 
were added to the reaction mixture at room temperature. The reaction mixture was 
allowed to warm up to 100 °C and stirred for 3 h. Then the reaction mixture was 
cooled to room temperature, loaded in silica gel column and purified with petroleum 
ether (40-60°C)/EtOAc mixture. 
Characterization of Compound 85y: 
 
 
(E)-Methyl 3-(1-(diethylcarbamoyl)-7-((E)-styryl)-1H-indol-2-yl)acrylate (85y): 
Yield: 63%; Yellow liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H 
NMR (400 MHz, CDCl3) δ 7.61 (d, J = 16.0 Hz, 1H), 7.58 – 7.56 (m, 1H), 7.53 – 
7.46(m, 4H), 7.37 (t, J = 7.6 Hz, 2H), 7.29 – 7.26 (m, 1H), 7.20 (t, J = 7.7 Hz, 1H), 
7.04 – 7.00 (m, 2H), 6.47 (d, J = 16.0 Hz, 1H), 3.80 (s, 3H), 3.74 – 3.65 (m, 1H), 3.43 
– 3.34 (m, 1H), 2.81 – 2.65 (m, 2 H), 1.21 (t, J = 7.2 Hz, 3H), 0.84 (t, J = 7.2 Hz, 3H) 
ppm; 
13
C NMR (101 MHz, CDCl3) δ 167.24, 153.86, 137.34, 134.92, 133.51, 132.55, 
131.72, 128.84, 128.43, 127.96, 126.78, 124.02, 123.82, 123.23, 122.18, 121.27, 
118.44, 107.32, 51.94, 43.36, 42.30, 13.54, 12.53 ppm; FT-IR: ṽ = 2975, 1684, 1635, 
1558, 1541, 1507, 1434, 1350, 1277, 1172 cm
-1
; HRMS: calc. for [M+H]
+
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C25H26N2O3: 403.20162 found: 403.20019. 
Procedure for the Synthesis of Compound 85z:
[122]
 
A mixture of 85d (0.8 mmol), aqueous sodium hydroxide solution (25%, 2 mL) and 
ethanol (5 mL) was refluxed for 12 h in a 12 mL screw-capped tube. Then the mixture 
was evaporated and extracted with dichloromethane. The extract was dried over 
anhydrous MgSO4 and concentrated under vacuum. The product was purified by 
normal silica gel column with petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compound 85z: 
 
 
(E)-7-Styryl-1H-indole (85z): 
Yield: 88%; Yellow liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H 
NMR (500 MHz, CDCl3) δ 8.53 (br s, 1H), 7.66 (d, J = 7.9 Hz, 1H), 7.62 (d, J = 7.7 
Hz, 2H), 7.47 – 7.43 (m, 4H), 7.37 – 7.34 (m, 1H), 7.32 – 7.31 (m, 1H), 7.23 – 7.20 
(m, 2H), 6.68 – 6.67 (m, 1H) ppm; 13C NMR (126 MHz, CDCl3) δ 137.63, 133.91, 
129.92, 128.91, 128.67, 127.85, 126.54, 125.27, 124.40, 121.54, 120.65, 120.62, 
120.36, 103.43 ppm; FT-IR: ṽ = 3413, 1698, 1653, 1558, 1541, 1508, 1457 cm-1; 
HRMS: calc. for [M+H]
+
 C16H13N: 220.11208 found: 220.11239. 
 
Procedure for the Synthesis of Compound 85aa: 
A mixture of 4d (0.08 mmol) and 10% Pd/C (0.01 mmol) in MeOH (2.0mL) was 
vigorously stirred at room temperature under 1 atm hydrogen for 12 h. Then the 
reaction mixture was filtered and concentrated under vacuum. The product was 
purified by normal silica gel column with petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compound 85aa: 
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N,N-Diethyl-7-phenethyl-1H-indole-1-carboxamide (85aa): 
Yield: 72%; Yellow liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.20; 
1
H 
NMR (400 MHz, CDCl3) δ 7.52 (dd, J = 7.3, 1.0 Hz, 1H), 7.33 – 7.26 (m, 4H), 7.23 
–7.19 (m, 1H), 7.17– 7.12 (m, 3H), 6.65 (d, J = 3.4 Hz, 1H), 3.44 (br s, 4H), 3.15 (t, J 
= 7.9 Hz, 2H), 3.00 (t, J = 7.9 Hz, 2H), 1.19 (t, J = 7.0 Hz, 6H) ppm; 
13
C NMR (101 
MHz, CDCl3) δ 154.88, 142.22, 134.24, 130.13, 128.57, 128.41, 126.74, 126.46, 
125.99, 124.42, 121.80, 119.19, 105.42, 42.34, 36.35, 34.34, 13.32 ppm; FT-IR: ṽ = 
2974, 1683, 1653, 1558, 1541, 1473, 1457, 1418, 1310, 1033 cm
-1
; HRMS: calc. for 
[M+H]
+
 C21H24N2O: 321.19614 found: 321.19674. 
 
5.2.6 Synthesis of Deprotected 7-Alkenylated Indoles 85ab–85af 
General Procedure E for the Synthesis of Compound 85ab–85af:[122] 
A mixture of 85 (0.2 mmol), aqueous sodium hydroxide solution (25%, 1 mL) and 
ethanol (1.5 mL) was refluxed for 12 h in a 12 mL screw-capped tube. Then the 
mixture was evaporated and extracted with dichloromethane. The extract was dried 
over anhydrous MgSO4 and concentrated under vacuum. The product was purified by 
normal silica gel column with petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compound 85ab–85af: 
 
 
(E)-7-(2-Methylstyryl)-1H-indole (85ab): 
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The product was prepared according to the general procedure E. Yield: 75%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, CDCl3) 
δ 8.44 (brs, 1H), 7.65 (d, J = 7.4 Hz, 1H), 7.61 (d, J = 7.8 Hz, 1H), 7.43 – 7.38 (m, 
2H), 7.28 – 7.24 (m, 3H), 7.22 – 7.21 (m, 2H), 7.16 (t, J = 7.6 Hz, 1H), 6.62 (dd, J = 
3.1, 2.0 Hz, 1H), 2.45 (s, 3H). 
 
 
(E)-5-Fluoro-7-styryl-1H-indole (85ac): 
The product was prepared according to the general procedure E. Yield: 70%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, CDCl3) 
δ 8.43 (brs, 1H), 7.57 – 7.55 (m, 2H), 7.40 (t, J = 7.5 Hz, 2H), 7.33 – 7.29 (m, 2H), 7.24 
– 7.13 (m, 4H), 6.57 – 6.56 (m, 1H). 
 
 
(E)-7-(3-Bromo-4-fluorostyryl)-1H-indole (85ad): 
The product was prepared according to the general procedure E. Yield: 80%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, CDCl3) 
δ 8.45 (brs, 1H), 7.76 (dd, J = 6.5, 2.1 Hz, 1H), 7.62 (d, J = 7.8 Hz, 1H), 7.46 – 7.42 
(m, 1H), 7.36 – 7.27 (m, 3H), 7.17 – 7.06 (m, 4H), 6.62 (dd, J = 3.1, 1.9 Hz, 1H). 
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(E)-7-(4-Fluorostyryl)-1H-indole (85ae): 
The product was prepared according to the general procedure E. Yield: 80%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, CDCl3) 
δ 8.47 (brs, 1H), 7.60 (d, J = 7.9 Hz, 1H), 7.55 – 7.50 (m, 2H), 7.37 – 7.33 (m, 1H), 
7.29 – 7.26 (m, 1H), 7.18 – 7.15 (m, 2H), 7.13 – 7.05 (m, 3H), 6.62 – 6.61 (m, 1H). 
 
 
(E)-7-(2-fluorostyryl)-1H-indole (85af): 
The product was prepared according to the general procedure E. Yield: 80%; Yellow 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, CDCl3) 
δ 8.52 (brs, 1H), 7.68 – 7.60 (m, 2H), 7.50 – 7.35 (m, 3H), 7.29 – 7.26 (m, 1H), 7.20 – 
7.08 (m, 4H), 6.63 – 6.61 (m, 1H). 
 
5.3 Experimental Part for 3.1.2 
 
5.3.1 Synthesis of N-Protected Indoles 86a–86h 
General Procedure F for the Synthesis of Substituted Indolines 86b, 86f–86h:[123] 
To a solution of indole (5 mmol), DMAP (0.5 mmol, 0.1 equiv) and Et3N (7.5 mmol, 
1.5 equiv) in dry dichloromethane (3.5 mL), was dropwise added acyl chloride or 
anhydride (6 mmol, 1.2 equiv) at 0 °C. The resulting solution was allowed to warm to 
room temperature and stirred overnight. The reaction mixture was concentrated under 
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vacuum, the crude product was dissolved in Et2O and washed with saturated NH4Cl 
solution. The organic layer was separated and the aqueous phase was extracted three 
times with Et2O. The combined organic extracts were washed with brine, dried over 
anhydrous Na2SO4, filtered and concentrated under vacuum. The product was purified 
by normal silica gel column with petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compounds 86b, 86f–86h: 
 
 
(1H-Indol-1-yl)(phenyl)methanone (86b):
[123]
 
The product was prepared according to the general procedure F. Yield: 75%; White 
amorphous solid; TLC (1% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 MHz, 
CDCl3) δ 8.41 (dd, J = 8.2, 0.5 Hz, 1H), 7.76 – 7.74 (m, 2H), 7.63 – 7.59 (m, 2H), 7.55 
– 7.52 (m, 2H), 7.41 – 7.38 (m, 1H), 7.34 – 7.32 (m, 1H), 7.31 (d, J = 3.8 Hz, 1H), 6.62 
(d, J = 3.8 Hz, 1H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 168.70, 136.03, 134.62, 
131.87, 130.78, 129.15, 128.58, 127.58, 124.92, 123.94, 120.87, 116.40, 108.56 ppm. 
 
 
1-(1H-Indol-1-yl)-2,2-dimethylpropan-1-one (86f):
[123]
 
The product was prepared according to the general procedure F. Yield: 80%; 
Colourless amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.4; 
1
H NMR 
(500 MHz, CDCl3) δ 8.53 – 8.51 (m, 1H), 7.74 (d, J = 3.8 Hz, 1H), 7.56 (ddd, J = 7.6, 
1.1, 0.7 Hz, 1H), 7.37 – 7.33 (m, 1H), 7.29 – 7.25 (m, 1H), 6.62 (dd, J = 3.8, 0.7 Hz, 
1H), 1.53 (s, 9H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 177.22, 136.91, 129.52, 125.78, 
125.24, 123.67, 120.61, 117.47, 108.36, 41.39, 28.86 ppm. 
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N,N-Dimethyl-1H-indole-1-carboxamide (86g):
[76e]
 
The product was prepared according to the general procedure F. Yield: 80%; Yellow 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (500 
MHz, CDCl3) δ 7.65 (dd, J = 8.3, 0.7 Hz, 1H), 7.60 (d, J = 7.8 Hz, 1H), 7.32 (d, J = 3.5 
Hz, 1H), 7.31 – 7.27 (m, 1H), 7.21 – 7.18 (m, 1H), 6.60 (dd, J = 3.5, 0.6 Hz, 1H), 3.10 
(s, 6H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 155.47, 135.60, 129.56, 126.36, 123.65, 
121.88, 121.11, 113.58, 105.81, 38.60 ppm. 
 
 
tert-Butyl 1H-indole-1-carboxylate (86h):
[124]
 
The product was prepared according to the general procedure F. Yield: 73%; Yellow 
liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1;
1
H NMR (500 MHz, CDCl3) 
δ 8.17 (s, 1H), 7.63 (s, 1H), 7.60 (d, J = 7.8 Hz, 1H), 7.34 (t, J = 7.8 Hz, 1H), 7.29 – 7.24 
(m, 1H), 6.60 (d, J = 3.5 Hz, 1H), 1.71 (s, 9H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 
149.94, 135.25, 130.66, 126.01, 124.30, 122.74, 121.06, 115.26, 107.40, 83.77, 28.33 
ppm. 
 
Procedure for the Synthesis of N-Protected Indole 86c:
[125]
 
The mixture of compound 83c (2.27 mmol) and DDQ (2.95 mmol, 1.3 eq) in toluene 
(10 mL) was heated at 80 
o
C. After 12 hours, the mixture was cooled to room 
temperature, and ethyl acetate was added. Then the organic layer was washed with 
water, brine, dried over anhydrous Na2SO4, and concentrated under vacuum. The 
product was purified by normal silica gel column with petroleum ether 
(40-60°C)/EtOAc mixture. 
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Characterization of Compound 86c: 
 
 
(1H-Indol-1-yl)(pyridin-2-yl)methanone (86c):
[125]
 
Yield: 68%; Brown amorphous solid; TLC (10% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 MHz, CDCl3) δ 8.75 (ddd, J = 4.8, 1.5, 0.8 Hz, 1H), 8.54 (d, J = 8.2 Hz, 
1H), 8.09 (dt, J = 7.8, 1.0 Hz, 1H), 7.98 (d, J = 3.8 Hz, 1H), 7.95 (td, J = 7.7, 1.7 Hz, 
1H), 7.59 (d, J = 7.7 Hz, 1H), 7.52 (ddd, J = 7.6, 4.8, 1.2 Hz, 1H), 7.41 – 7.37 (m, 1H), 
7.32 (td, J = 7.5, 1.0 Hz, 1H), 6.66 – 6.62 (m, 1H) ppm; 13C NMR (126 MHz, CDCl3) 
δ 142.62, 129.31, 125.49, 114.37, 113.37, 107.68, 105.37, 103.09, 102.71, 101.90, 
101.14, 97.72, 93.86, 86.07 ppm. 
 
General Procedure G for the Synthesis of N-Protected Indoles 86d, 86e:
[117]
 
A solution of indole (20 mmol) in 10 mL THF was added to a suspension of NaH (60% 
in mineral oil, 1.1 equiv, 22 mmol) in 10 mL THF at 0 °C. The mixture was stirred for 
20 min at room temperature. Then acyl chloride (1.1 equiv, 22 mmol) was added, and 
the mixture was stirred overnight at room temperature. A saturated solution of NH4Cl 
was carefully added, and the resulting mixture was extracted three times with Et2O. 
The combined organic layers were washed with water and brine, dried over anhydrous 
MgSO4 and concentrated. The product was purified by normal silica gel column with 
petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compound 86d, 86e: 
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1-Tosyl-1H-indole (86d):
[123]
 
The product was prepared according to the general procedure G. Yield: 84%; Yellow 
amorphous solid; TLC (5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 MHz, 
CDCl3) δ 7.99 (dd, J = 8.3, 0.6 Hz, 1H), 7.77 – 7.75 (m, 2H), 7.56 (d, J = 3.7 Hz, 1H), 
7.52 (d, J = 7.8 Hz, 1H), 7.32 – 7.29 (m, 1H), 7.24 – 7.21 (m, 3H), 6.65 (dd, J = 3.6, 0.5 
Hz, 1H), 2.33 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 145.03, 135.51, 134.85, 
130.89, 130.00, 126.96, 126.48, 124.68, 123.39, 121.49, 113.69, 109.15, 21.69 ppm. 
 
 
1-(1H-Indol-1-yl)ethan-1-one (86e):
[124]
 
The product was prepared according to the general procedure G. Yield: 72%; White 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (600 MHz, 
CDCl3) δ 8.45 (d, J = 6.4 Hz, 1H), 7.57 (d, J = 7.8 Hz, 1H), 7.43 (d, J = 2.5 Hz, 1H), 
7.37 – 7.34 (m, 1H), 7.29 – 7.27 (m, 1H), 6.65 (dd, J = 3.8, 0.5 Hz, 1H), 2.65 (s, 3H) 
ppm; 13C NMR (151 MHz, CDCl3) δ 168.81, 135.68, 130.54, 125.36, 125.28, 123.81, 
120.98, 116.69, 109.33, 24.16 ppm. 
 
5.3.2 Synthesis of Substituted Indoles 86i–86y 
General Procedure H for the Synthesis of Substituted Indoles 86i, 86n: 
First step:
[126]
 
To a stirred solution of phenylboronic acid (0.86 mmol) in EtOH (5mL) was added 
indole (0.71 mmol), K2CO3 (1.78 mmol), Pd(PPh3)4 (10% mmol). The reaction was 
refluxed for 24 h under argon atmosphere before EtOH was removed by rotary 
evaporation. The remained mixture was extracted with EtOAc, and the combined 
organic layers were washed with H2O and brine, dried over anhydrous Na2SO4, 
evaporated under vacuum. The product was purified by normal silica gel column with 
petroleum ether (40-60°C)/EtOAc mixture. 
Second Step:
[123]
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To a solution of indole (0.47 mmol), DMAP (0.05 mmol) and Et3N (0.7 mmol) in dry 
dichloromethane (3.5 mL) at 0 °C was added pivaloyl chloride (0.56 mmol) dropwise. 
The resulting solution was allowed to warm to room temperature and stirred overnight. 
The reaction mixture was concentrated under vacuum, the crude product was 
dissolved in Et2O and washed with a saturated solution of NH4Cl. The organic layer 
was separated and the aqueous phase was extracted three times with Et2O. The 
combined organic extracts were washed with brine, dried over anhydrous Na2SO4, 
filtered and concentrated under vacuum. The product was purified by normal silica gel 
column with petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compounds 86i, 86n: 
 
 
2,2-Dimethyl-1-(4-phenyl-1H-indol-1-yl)propan-1-one (86i): 
The product was prepared according to the general procedure H. Yield: 43%; White 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 MHz, 
CDCl3) δ 8.55 (d, J = 8.4 Hz, 1H), 7.78 (d, J = 3.9 Hz, 1H), 7.61 – 7.60 (m, 2H), 7.50 (t, 
J = 7.6 Hz, 2H), 7.45 – 7.39 (m, 2H), 7.34 (d, J = 7.4 Hz, 1H), 6.78 (d, J = 3.9 Hz, 1H), 
1.54 (s, 9H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 177.28, 140.47, 137.23, 134.58, 
129.06, 128.72, 127.69, 127.34, 126.06, 125.53, 123.74, 116.43, 107.58, 41.47, 28.84 
ppm; FT‐IR: ṽ = 2360, 2341, 1686, 1538, 1472, 1305, 1203, 1169, 1094 cm-1; HRMS: 
calc. for [M+H]
+
 C19H20ON: 278.15394, found: 278.15417. 
 
 
Experimental Part                                                   117 
 
 
2,2-Dimethyl-1-(5-phenyl-1H-indol-1-yl)propan-1-one (86n): 
The product was prepared according to the general procedure H. Yield: 40%; White 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, 
CDCl3) δ 8.57 (d, J = 8.7 Hz, 1H), 7.78 (d, J = 3.7 Hz, 2H), 7.66 (dd, J = 8.2, 1.1 Hz, 
2H), 7.60 (dd, J = 8.7, 1.9 Hz, 1H), 7.47 – 7.44 (m, 2H), 7.36 – 7.33 (m, 1H), 6.68 (d, J 
= 3.8 Hz, 1H), 1.54 (s, 9H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 177.20, 141.65, 
137.00, 136.28, 130.04, 128.88, 127.49, 127.05, 126.40, 124.74, 119.02, 117.63, 
108.62, 41.37, 28.82 ppm; FT‐IR: ṽ = 2360, 2341, 1692, 1460, 1302, 1179, 1082 cm-1; 
HRMS: calc. for [M+H]
+
 C19H20ON: 278.15394, found: 278.15399. 
 
General Procedures I for the Synthesis of Substituted Indoles 86j, 86k, 86m, 86o–86t, 
86x:
[123]
 
To a solution of indole (1.5 mmol), DMAP (0.15 mmol) and Et3N (2.25 mmol) in dry 
dichloromethane (3.5 mL) at 0 °C, was added pivaloyl chloride (1.8 mmol) dropwise. 
The resulting solution was allowed to warm to room temperature and stirred overnight. 
The reaction mixture was concentrated under vacuum, the crude product was 
dissolved in Et2O and washed with a saturated solution of NH4Cl. The organic layer 
was separated, and the aqueous phase was extracted three times with Et2O. The 
combined organic extracts were washed with brine, dried over anhydrous Na2SO4, 
filtered and concentrated under vacuum. The product was purified by normal silica gel 
column with petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compounds 86j, 86k, 86m, 86o–86t, 86x: 
 
118                                                   Experimental Part 
 
1-(4-Bromo-1H-indol-1-yl)-2,2-dimethylpropan-1-one (86j):
[89]
 
The product was prepared according to the general procedure I. Yield: 75%; Colourless 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, 
CDCl3) δ 8.46 (d, J = 8.4 Hz, 1H), 7.79 (d, J = 3.9 Hz, 1H), 7.43 (d, J = 8.4 Hz, 1H), 
7.21 (t, J = 8.4 Hz, 1H), 6.70 (d, J = 3.9 Hz, 1H), 1.52 (s, 9H) ppm; 
13
C NMR (126 
MHz, CDCl3) δ 177.33, 137.23, 130.15, 126.57, 126.36, 126.21, 116.48, 114.56, 
108.14, 41.50, 28.76 ppm. 
 
 
1-(4-Chloro-1H-indol-1-yl)-2,2-dimethylpropan-1-one (86k):
[89]
 
The product was prepared according to the general procedure I. Yield: 80%; Colourless 
liquid; TLC (2% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, CDCl3) δ 
8.42 – 8.39 (m, 1H), 7.77 (d, J = 3.9 Hz, 1H), 7.26 – 7.25 (m, 2H), 6.74 (dd, J = 3.9, 0.5 
Hz, 1H), 1.51 (s, 9H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 177.28, 137.54, 128.27, 
126.35, 125.95, 125.93, 123.44, 115.95, 106.41, 41.47, 28.74 ppm. 
 
 
1-(5-Methoxy-1H-indol-1-yl)-2,2-dimethylpropan-1-one (86m):
[89]
 
The product was prepared according to the general procedure I. Yield: 72%; Brown 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, 
CDCl3) δ 8.41 (d, J = 9.1 Hz, 1H), 7.71 (d, J = 3.8 Hz, 1H), 7.02 (d, J = 2.5 Hz, 1H), 
6.95 (dd, J = 9.1, 2.5 Hz, 1H), 6.55 (d, J = 3.8 Hz, 1H), 3.86 (s, 3H), 1.51 (s, 9H) ppm; 
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13
C NMR (126 MHz, CDCl3) δ 176.87, 156.44, 131.54, 130.42, 126.41, 118.22, 
113.48, 108.24, 103.33, 55.77, 41.22, 28.88 ppm. 
 
 
1-(5-Fluoro-1H-indol-1-yl)-2,2-dimethylpropan-1-one (86o):
[89]
 
The product was prepared according to the general procedure I. Yield: 77%; Light 
yellow amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR 
(500 MHz, CDCl3) δ 8.47 (dd, J = 9.1, 4.8 Hz, 1H), 7.78 (d, J = 3.8 Hz, 1H), 7.20 (dd, 
J = 8.7, 2.5 Hz, 1H), 7.08 – 7.04 (m, 1H), 6.58 (d, J = 3.8 Hz, 1H), 1.52 (s, 9H) ppm; 13C 
NMR (126 MHz, CDCl3) δ 177.02, 159.69 (d, J = 239.9 Hz), 133.21, 130.45 (d, J = 
10.0 Hz), 127.24, 118.47 (d, J = 8.9 Hz), 112.82 (d, J = 24.5 Hz), 108.04 (d, J = 3.9 Hz), 
106.10 (d, J = 23.7 Hz), 41.33, 28.84 ppm. 
 
 
1-(5-Chloro-1H-indol-1-yl)-2,2-dimethylpropan-1-one (86p):
[89]
 
The product was prepared according to the general procedure I. Yield: 85%; White 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, 
CDCl3) δ 8.44 (d, J = 8.9 Hz, 1H), 7.76 (d, J = 3.8 Hz, 1H), 7.52 (d, J = 1.9 Hz, 1H), 
7.30 (dd, J = 8.9, 1.9 Hz, 1H), 6.56 (dd, J = 3.8 Hz , J = 0.4 Hz, 1H), 1.51 (s, 9H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 177.12, 135.22, 130.72, 129.15, 126.99, 125.31, 
120.19, 118.46, 107.65, 41.38, 28.78 ppm. 
 
 
1-(5-Bromo-1H-indol-1-yl)-2,2-dimethylpropan-1-one (86q):
[89]
 
120                                                   Experimental Part 
The product was prepared according to the general procedure I. Yield: 69%; White 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, 
CDCl3) δ 8.39 (d, J = 8.9 Hz, 1H), 7.74 (d, J = 3.8 Hz, 1H), 7.68 (d, J = 1.8 Hz, 1H), 
7.43 (dd, J = 8.9, 1.8 Hz, 1H), 6.56 (d, J = 3.8 Hz, 1H), 1.51 (s, 9H) ppm; 
13
C NMR 
(126 MHz, CDCl3) δ 177.14, 135.58, 131.24, 128.00, 126.86, 123.26, 118.85, 116.90, 
107.54, 41.41, 28.77 ppm. 
 
 
1-(6-Methoxy-1H-indol-1-yl)-2,2-dimethylpropan-1-one (86r):
[127]
 
The product was prepared according to the general procedure I. Yield: 78%; White 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, 
CDCl3) δ 8.15 (d, J = 2.3 Hz, 1H), 7.63 (d, J = 3.8 Hz, 1H), 7.41 (d, J = 8.5 Hz, 1H), 
6.91 (dd, J = 8.5, 2.3 Hz, 1H), 6.58 – 6.53 (m, 1H), 3.88 (s, 3H), 1.52 (s, 9H) ppm; 13C 
NMR (126 MHz, CDCl3) δ 177.60, 158.48, 137.81, 124.57, 123.14, 120.92, 113.38, 
108.32, 101.21, 55.77, 41.41, 28.79 ppm. 
 
 
1-(6-Chloro-1H-indol-1-yl)-2,2-dimethylpropan-1-one (86s):
[89]
 
The product was prepared according to the general procedure I. Yield: 66%; Brown 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, 
CDCl3) δ 8.58 (dd, J = 1.2, 0.5 Hz, 1H), 7.73 (d, J = 3.8 Hz, 1H), 7.46 (d, J = 8.3 Hz, 
1H), 7.27 – 7.22 (m, 1H), 6.61 – 6.57 (m, 1H), 1.51 (s, 9H) ppm; 13C NMR (126 MHz, 
CDCl3) δ 177.21, 137.15, 131.17, 127.92, 126.34, 124.21, 121.19, 117.74, 108.09, 
41.39, 28.71 ppm. 
 
Experimental Part                                                   121 
 
 
2,2-Dimethyl-1-(3-methyl-1H-indol-1-yl)propan-1-one (86t):
[89]
 
The product was prepared according to the general procedure I. Yield: 43%; Brown 
amorphous solid; TLC (5% EtOAc in petroleum ether): Rf = 0.5; 
1
H NMR (500 MHz, 
CDCl3) δ 8.51 (d, J = 8.2 Hz, 1H), 7.50 – 7.49 (m, 2H), 7.37 – 7.34 (m, 1H), 7.29 (td, J 
= 7.6, 0.9 Hz, 1H), 2.30 (d, J = 1.2 Hz, 3H), 1.51 (s, 9H) ppm; 
13
C NMR (126 MHz, 
CDCl3) δ 176.91, 137.23, 130.46, 125.33, 123.41, 122.73, 118.57, 117.54, 117.47, 
41.22, 28.80, 9.94 ppm. 
 
 
2,2-Dimethyl-1-(2-methyl-1H-indol-1-yl)propan-1-one (86x):
[89]
 
The product was prepared according to the general procedure I. Yield: 35%; Brown 
solid; TLC (5% EtOAc in petroleum ether): Rf = 0.5; 
1
H NMR (500 MHz, CDCl3) δ 
7.49 (dd, J = 7.1 Hz, , J = 0.7 Hz, 1H), 7.29 – 7.26 (m, 1H), 7.17 – 7.10 (m, 2H), 6.33 (s, 
1H), 2.39 (d, J = 0.7 Hz, 3H), 1.41 (s, 9H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 
186.57, 136.35, 136.08, 128.81, 121.88, 121.11, 120.13, 112.20, 104.61, 44.34, 28.39, 
14.13 ppm. 
 
General Procedure J for the Synthesis of Substituted Indoles 86l, 86u, 86y:
[117]
 
NaH (60% dispersion in mineral oil, 3 mmol) was added in portions at 0 °C to a stirred 
solution of indole (1.5 mmol) in dry THF (5 mL). After stirring for 30 min at 0 °C, 
pivaloyl chloride (1.8 mmol) was added, and the reaction was allowed to warm to room 
temperature and stirred overnight. Then the reaction mixture was poured into saturated 
solution of NH4Cl and extracted with dichloromethane. The organic phase was dried 
over anhydrous Na2SO4. After evaporation of the solvents under vacuum, the product 
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was purified by normal silica gel column with petroleum ether (40-60°C)/EtOAc 
mixture. 
Characterization of Compounds 86l, 86u, 86y: 
 
 
1-Pivaloyl-1H-indole-4-carbaldehyde (86l): 
The product was prepared according to the general procedure J. Yield: 72%; White 
amorphous solid; TLC (5% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (500 MHz, 
CDCl3) δ 10.24 (s, 1H), 8.79 (d, J = 8.4 Hz, 1H), 7.93 (d, J = 3.8 Hz, 1H), 7.75 (dd, J = 
7.4, 0.8 Hz, 1H), 7.51 (d, J = 8.4 Hz, 1H), 7.49 – 7.47 (m, 1H), 1.54 (s, 9H) ppm; 13C 
NMR (126 MHz, CDCl3) δ 192.93, 177.54, 137.51, 129.87, 128.81, 128.09, 127.85, 
124.89, 123.31, 107.69, 41.61, 28.78 ppm; FT‐IR: ṽ = 2979, 2360, 2341, 1685, 1584, 
1430, 1302, 1166, 1077 cm
-1
; HRMS: calc. for [M+H]
+
 C14H16O2N: 230.11756, found: 
230.11761. 
 
 
5-Methoxy-1-pivaloyl-1H-indole-3-carbaldehyde (86u): 
The product was prepared according to the general procedure J. Yield: 65%; White 
amorphous solid; TLC (5% EtOAc in petroleum ether): Rf = 0.35; 
1
H NMR (500 MHz, 
CDCl3) δ 10.11 (s, 1H), 8.34 (d, J = 9.2 Hz, 1H), 8.29 (s, 1H), 7.75 (d, J = 2.6 Hz, 1H), 
7.03 (dd, J = 9.2, 2.6 Hz, 1H), 3.90 (s, 3H), 1.56 (s, 9H) ppm; 
13
C NMR (126 MHz, 
CDCl3) δ 185.95, 176.99, 157.79, 136.07, 132.30, 126.20, 121.93, 118.13, 116.20, 
103.45, 55.86, 41.70, 28.91 ppm; FT‐IR: ṽ = 2360, 2341, 1666, 1554, 1480, 1210, 
1145, 1018 cm
-1
; HRMS: calc. for [M+H]
+
 C15H18O3N: 260.12812, found: 260.12826. 
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2,2-Dimethyl-1-(1,2,3,4-tetrahydro-9H-carbazol-9-yl)propan-1-one (86y):
[128]
 
The product was prepared according to the general procedure J. Yield: 32%; White 
amorphous solid; TLC (5% EtOAc in petroleum ether): Rf = 0.5; 
1
H NMR (500 MHz, 
CDCl3) δ 7.45 – 7.40 (m, 1H), 7.38 (d, J = 7.6 Hz, 1H), 7.19 – 7.12 (m, 2H), 2.72 – 2.68 
(m, 4H), 1.88 – 1.87 (m, 4H), 1.44 (s, 9H) ppm; 13C NMR (126 MHz, CDCl3) δ 
184.94, 135.97, 135.56, 129.05, 122.16, 121.01, 118.18, 114.64, 112.94, 43.60, 28.42, 
24.29, 23.50, 22.72, 21.10 ppm. 
 
Procedure for the Synthesis of Substituted Indole 86v: 
First Step:
[129]
 
A mixture of tryptamine (3 mmol) and phthalic anhydride (3 mmol) in toluene (5 mL) 
was held at reflux for 2 h and then cooled to room temperature. The solvent was 
removed under vacuum. The crude product was purified on a silica gel column 
chromatography to give the corresponding product. 
Second Step:
[130]
 
To a solution of indole (2.6 mmol) in dry dichloromethane (15 mL) were successively 
added tetrabutylammonium hydrogen sulfate (0.26 mmol) and freshly finely powdered 
sodium hydroxide (13 mmol). The resulting light yellow solution was stirred for 15 
minutes, and pivaloylchloride (7.8 mmol) was added in three portions over 15 minutes. 
The resulting slurry was vigorously stirred for 2-4 hours and quenched by addition of 
water. The organic layer was separated and the aqueous layer was extracted with 
dichloromethane. Combined organic layers were washed with brine, dried over 
anhydrous MgSO4, filtered and concentrated under vacuum. The residue was then 
purified by flash chromatography over silica gel. 
 
Characterization of Compound 86v: 
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2-(2-(1-Pivaloyl-1H-indol-3-yl)ethyl)isoindoline-1,3-dione (86v): 
Yield: 32%; White amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.2; 
1
H NMR (500 MHz, CDCl3) δ 8.49 (d, J = 8.2 Hz, 1H), 7.84 (dd, J = 5.4, 3.0 Hz, 2H), 
7.72 (dd, J = 5.4, 3.0 Hz, 2H), 7.67 – 7.65 (m, 1H), 7.61 (s, 1H), 7.36 – 7.29 (m, 2H), 
4.07 – 4.04 (m, 2H), 3.14 (t, J = 7.3 Hz, 2H), 1.47 (s, 9H) ppm; 13C NMR (126 MHz, 
CDCl3) δ 177.06, 168.46, 137.27, 134.21, 132.14, 129.36, 125.60, 123.67, 123.44, 
123.07, 118.61, 117.87, 117.62, 41.25, 37.46, 28.69, 24.27 ppm. 
 
Procedure for the Synthesis of Substituted Indole 86w: 
First Step: 
To a suspension of tryptamine (6.24 mmol) in 1, 4-dioxane (5 mL) was added Et3N 
(12.9 mmol). Then a solution of (Boc)2O (6.87 mmol) in 1,4-dioxane (5 mL) was added 
to the reaction mixture. This mixture was stirred for 1 h, and the yellow solution was 
concentrated under vacuum. The crude product was purified on a silica gel column 
chromatography to give the corresponding product. 
Second Step:
[130]
 
To a solution of indole (1.0 mmol) in dry dichloromethane (10 mL) were successively 
added tetrabutylammonium hydrogen sulfate (0.1 mmol) and freshly finely powdered 
sodium hydroxide (5.0 mmol). The resulting light yellow solution was stirred for 15 
minutes, and pivaloyl chloride (3.0 mmol) was added in three portions over 15 minutes. 
The resulting slurry was vigorously stirred for 2-4 hours and quenched by addition of 
water. The organic layer was separated, and the aqueous layer was extracted with 
dichloromethane. Combined organic layers were washed with brine, dried over 
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anhydrous MgSO4, filtered and concentrated under vacuum. The residue was then 
purified by flash chromatography over silica gel. 
 
Characterization of Compound 86w: 
 
 
Ethyl N
α
-(tert-butoxycarbonyl)-1-pivaloyl-D-tryptophanate (86w): 
Yield: 38%; Light yellow liquid; TLC (1.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H 
NMR (500 MHz, CDCl3) δ 8.49 (d, J = 8.3 Hz, 1H), 7.57 (s, 1H), 7.48 (d, J = 7.7 Hz, 
1H), 7.35 (t, J = 7.7 Hz, 1H), 7.29 – 7.26 (m, 1H), 5.14 (d, J = 7.8 Hz, 1H), 4.69 (dd, J 
= 13.6, 5.8 Hz, 1H), 4.19 – 4.07 (m, 2H), 3.24 (ddd, J = 46.6, 15.0, 5.7 Hz, 2H), 1.50 (s, 
9H), 1.43 (s, 9H), 1.21 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 176.86, 
171.94, 155.12, 136.92, 129.60, 125.46, 123.79, 123.47, 118.43, 117.42, 116.09, 80.06, 
61.67, 41.20, 28.66, 28.35, 27.76, 27.10, 14.10 ppm; FT‐IR: ṽ = 2979, 2360, 2341, 
1690, 1504, 1450, 1315, 1159 cm
-1
; HRMS: calc. for [M+H]
+
 C23H33O5N2: 417.23840, 
found: 417.23858. 
 
5.3.3 Synthesis of Azides 87 
General Procedure K for the Synthesis of Azides 87a–87i, 87o:[49c] 
To a solution of sodium azide (3 mmol) in water (3 mL) was added a solution of 
sulfonyl chloride (2 mmol) in acetone (3 mL) dropwise over 1 h at 0 °C. The reaction 
mixture was warmed up to room temperature and then stirred for 11 h. Acetone was 
removed under vacuum, and the residue was extracted with ethyl acetate for three 
times. The combined organic layers were washed with water and saturated Na2CO3 
solution, dried over anhydrous MgSO4, and then the solvent was removed under 
vacuum. Crude product was used without further purification. 
126                                                   Experimental Part 
 
Characterization of Compounds 87a-87i, 87o: 
 
 
4-Methylbenzenesulfonyl azide (87a):
[49c]
 
The product was prepared according to the general procedure K. Yield: 88%; 
Colourless liquid; TLC (2% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 
MHz, CDCl3) δ 7.84 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 8.4 Hz, 2H), 2.48 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 146.33, 135.68, 130.41, 127.67, 21.89 ppm. 
 
 
Benzenesulfonyl azide (87b):
[49c]
 
The product was prepared according to the general procedure K. Yield: 85%; 
Colourless liquid; TLC (2% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (400 
MHz, CDCl3) δ 7.99 – 7.96 (m, 2H), 7.76 – 7.72 (m, 1H), 7.65 – 7.61 (m, 2H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 138.68, 134.94, 129.84, 127.62 ppm. 
 
 
4-Acetylbenzenesulfonyl azide (87c):
[131]
 
The product was prepared according to the general procedure K. Yield: 87%; Yellow 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (400 MHz, 
CDCl3) δ 8.18 – 8.15 (m, 2H), 8.08 – 8.05 (m, 2H), 2.68 (s, 3H) ppm; 
13
C NMR (101 
MHz, CDCl3) δ 196.34, 142.14, 141.73, 129.52, 128.00, 27.07 ppm. 
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3-Fluorobenzenesulfonyl azide (87d):
[132]
 
The product was prepared according to the general procedure K. Yield: 75%; Yellow 
liquid; TLC (2% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (400 MHz, CDCl3) δ 
7.78 (ddd, J = 7.9, 1.7, 1.0 Hz, 1H), 7.68 – 7.60 (m, 2H), 7.47 – 7.42 (m, 1H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 162.65 (d, J = 253.7 Hz), 140.41, 131.74 (d, J = 7.8 
Hz), 123.45 (d, J = 3.5 Hz), 122.30 (d, J = 21.2 Hz), 115.09 (d, J = 25.1 Hz) ppm. 
 
 
3-Cyanobenzenesulfonyl azide (87e): 
The product was prepared according to the general procedure K. Yield: 76%; White 
amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (400 MHz, 
CDCl3) δ 8.25 – 8.25 (m, 1H), 8.20 – 8.17 (m, 1H), 8.02 – 7.99 (m, 1H), 7.79 (t, J = 
7.9 Hz, 1H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 140.33, 137.83, 131.39, 131.13, 
130.99, 116.56, 114.73 ppm; FT‐IR: ṽ = 2360, 2234, 2128, 1368, 1208, 1170, 1145, 
1086 cm
-1
. 
 
 
2-Nitrobenzenesulfonyl azide (87f):
[133]
 
The product was prepared according to the general procedure K. Yield: 85%; Light 
yellow solid; TLC (10% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (400 MHz, 
CDCl3) δ 8.21 – 8.19 (m, 1H), 7.93 – 7.80 (m, 3H) ppm; 
13
C NMR (101 MHz, 
CDCl3) δ 147.82, 135.82, 133.18, 132.86, 131.88, 125.52 ppm. 
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Methanesulfonyl azide (87g):
[134]
 
The product was prepared according to the general procedure K. Yield: 83%; Light 
yellow liquid; TLC (2% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (400 MHz, 
CDCl3) δ 3.26 (s, 3H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 42.95 ppm. 
 
 
Octane-1-sulfonyl azide (87h):
[135]
 
The product was prepared according to the general procedure K. Yield: 77%; Light 
yellow liquid; TLC (2% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (400 MHz, 
CDCl3) δ 3.32 – 3.28 (m, 2H), 1.95 – 1.87 (m, 2H), 1.56 – 1.42 (m, 2H), 1.33 – 1.28 
(m, 8H), 0.88 (t, J = 6.8 Hz, 3H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 56.13, 31.78, 
29.01, 28.98, 28.10, 23.49, 22.70, 14.16 ppm. 
 
 
Thiophene-2-sulfonyl azide (87i):
[132]
 
The product was prepared according to the general procedure K. Yield: 86%; Black 
liquid; TLC (15% EtOAc in petroleum ether): Rf = 0.2; 
1
H NMR (500 MHz, CDCl3) 
δ 7.83 – 7.80 (m, 2H), 7.22 – 7.21 (m, 1H) ppm; 13C NMR (126 MHz, CDCl3) δ 
138.18, 135.32, 134.91, 128.20 ppm. 
 
4-Methoxybenzenesulfonyl azide (87o):
[49c]
 
The product was prepared according to the general procedure K. Yield: 88%; Light 
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yellow liquid; TLC (2% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (400 MHz, 
CDCl3) δ 7.92 – 7.89 (m, 2H), 7.07 – 7.04 (m, 2H), 3.91 (s, 3H) ppm; 
13
C NMR (101 
MHz, CDCl3) δ 164.76, 130.06, 130.01, 114.97, 56.01 ppm. 
 
Procedures for the Synthesis of Azide 87j:
[135]
 
 
To a solution of benzyl chloride (4.0 mmol) in THF (10 mL) was added NaN3 (8.0 
mmol) in water (1.0 mL). The resulting solution was stirred at 80 
o
C for 3 h. The 
reaction mixture was diluted with EtOAc (20 mL) and washed with water (20 mL) 
and brine (20 mL). The organic layer was separated, dried over anhydrous MgSO4, 
and concentrated under vacuum to give the azide in quantitative yield. 
 
Characterization of Compound 87j: 
 
 
(Azidomethyl)benzene (87j):
[135]
 
Yield: 68%; Colourless liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.35; 
1
H 
NMR (500 MHz, CDCl3) δ 7.41 – 7.31 (m, 5H), 4.35 (s, 2H) ppm; 
13
C NMR (126 
MHz, CDCl3) δ 135.52, 128.98, 128.45, 128.36, 54.97 ppm. 
 
Procedure for the Synthesis of Azide 87n:
[45]
 
To a solution of sodium azide (15 mmol) in H2O (5 mL) was added dropwise a 
solution of benzoyl chloride (22.5 mmol) in acetone (10 mL) at 0 
o
C. The reaction 
mixture was allowed to stir overnight at room temperature. Water (40 mL) was added, 
and the reaction mixture was extracted three times with EtOAc. The combined 
organic layers were dried over anhydrous MgSO4 and concentrated under vacuum. 
The product was purified by normal silica gel column with petroleum ether 
(40-60°C)/EtOAc mixture. 
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Characterization of Compound 87n: 
 
 
Benzoyl azide (87n):
[45]
 
Yield: 83%; Colourless liquid; TLC (5% EtOAc in petroleum ether): Rf = 0.25; 
1
H 
NMR (500 MHz, CDCl3) δ 8.03 (dd, J = 8.4, 1.2 Hz, 2H), 7.64 – 7.61 (m, 1H), 7.48 
– 7.45 (m, 2H) ppm; 13C NMR (126 MHz, CDCl3) δ 172.70, 134.50, 130.75, 129.60, 
128.81 ppm. 
 
5.3.4 Synthesis of 7-Amino Indoles 88 
General Procedure L for the Synthesis of Compounds 88: 
N-Pivaloyl indole (0.1 mmol) was dissolved in a 12 mL screw-capped tube with 1 mL 
DCE. Then sulfonyl azide (0.22 mmol) followed by [(IrCp*Cl2)2] (4 mol %), AgNTf2 
(16 mol %) and LiOAc (40 mol%) were added to the reaction mixture at room 
temperature. The reaction mixture was allowed to warm up to 120 °C and stirred for 
1-12 h. After the reaction finished, the reaction mixture was directly loaded in silica 
gel column and purified with petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compounds 88: 
 
 
4-Methyl-N-(1-pivaloyl-1H-indol-7-yl)benzenesulfonamide (88f): 
The product was prepared according to the general procedure L. Yield: 98%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.32 (brs, 1H), 7.56 (d, J = 3.9 Hz, 1H), 7.51 (dd, J = 7.8, 1.2 Hz, 
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1H), 7.40 (dd, J = 7.8, 1.2 Hz, 1H), 7.36 – 7.35 (m, 2H), 7.31 (t, J = 7.7 Hz, 1H), 7.11 
– 7.09 (m, 2H), 6.61 (d, J = 3.9 Hz, 1H), 2.29 (s, 3H), 1.38 (s, 9H) ppm; 13C NMR 
(126 MHz, CD2Cl2) δ 180.22, 144.11, 137.82, 133.01, 129.96, 129.80, 127.46, 
127.21, 125.78, 125.63, 122.84, 119.29, 109.76, 42.21, 29.32, 21.66 ppm; FT‐IR: ṽ = 
3854, 3734, 3629, 3286, 3136, 2985, 2360, 2342, 1541, 1117 cm
-1
; HRMS: calc. for 
[M+H]
+ 
 C20H23N2O3S: 371.14239, found: 371.14304. 
 
 
4-Methyl-N-(4-phenyl-1-pivaloyl-1H-indol-7-yl)benzenesulfonamide (88i): 
The product was prepared according to the general procedure L. Yield: 87%; Brown 
liquid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, 
CD2Cl2) δ 9.20 (brs, 1H), 7.59 – 7.54 (m, 4H), 7.49 (t, J = 7.6 Hz, 2H), 7.42 – 7.36 
(m, 4H), 7.13 (d, J = 8.1 Hz, 2H), 6.74 (d, J = 4.0 Hz, 1H), 2.31 (s, 3H), 1.38 (s, 9H) 
ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 180.35, 144.16, 139.86, 137.83, 133.29, 
130.91, 130.10, 130.01, 129.44, 129.18, 127.98, 127.63, 127.17, 125.67, 124.77, 
123.16, 108.81, 42.25, 29.25, 21.65 ppm; FT‐IR: ṽ = 2975, 2360, 2342, 1672, 1481, 
1377, 1361, 1233, 1218 cm
-1
; HRMS: calc. for [M+H]
+ 
 C26H27N2O3S: 447.17369, 
found: 447.17411. 
 
 
N-(4-Bromo-1-pivaloyl-1H-indol-7-yl)-4-methylbenzenesulfonamide (88j): 
The product was prepared according to the general procedure L. Yield: 69%; Brown 
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1
H NMR (500 
MHz, CD2Cl2) δ 9.12 (brs, 1H), 7.62 (d, J = 4.0 Hz, 1H), 7.48 (d, J = 8.4 Hz, 1H), 
7.39 (d, J = 8.4 Hz, 1H), 7.36 (d, J = 8.2 Hz, 2H), 7.12 (d, J = 8.2 Hz, 2H), 6.69 (d, J 
= 4.0 Hz, 1H), 2.30 (s, 3H), 1.36 (s, 9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 
180.45, 144.34, 137.46, 133.01, 130.11, 130.07, 128.38, 128.04, 127.13, 125.07, 
123.92, 112.52, 109.42, 42.30, 29.16, 21.65 ppm; FT‐IR: ṽ = 3187, 2975, 2360, 2342, 
1678, 1327, 1237 cm
-1
; HRMS: calc. for [M+H]
+ 
 C20H22
79
BrN2O3S: 449.05290, 
found: 449.05352; HRMS: calc. for [M+H]
+ 
 C20H22
81
BrN2O3S: 451.05086, found: 
451.05125. 
 
 
N-(4-Chloro-1-pivaloyl-1H-indol-7-yl)-4-methylbenzenesulfonamide (88k): 
The product was prepared according to the general procedure L. Yield: 76%; Brown 
amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.10 (brs, 1H), 7.60 (d, J = 4.0 Hz, 1H), 7.45 (d, J = 8.4 Hz, 1H), 
7.35 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.4 Hz, 1H), 7.12 (d, J = 8.3 Hz, 2H), 6.73 (d, J 
= 4.0 Hz, 1H), 2.30 (s, 3H), 1.36 (s, 9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 
180.37, 144.32, 137.46, 131.17, 130.43, 130.05, 128.05, 127.13, 125.19, 124.44, 
124.22, 123.79, 107.58, 42.27, 29.15, 21.64 ppm; FT‐IR: ṽ = 2360, 2342, 1673, 1480, 
1322, 1181, 1162, 1085 cm
-1
; HRMS: calc. for [M+H]
+ 
 C20H22
35
ClN2O3S: 
405.10342, found: 405.10461; HRMS: calc. for [M+H]
+ 
 C20H22
37
ClN2O3S: 
407.10047, found: 407.10146. 
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N-(4-Formyl-1-pivaloyl-1H-indol-7-yl)-4-methylbenzenesulfonamide (88l): 
The product was prepared according to the general procedure L. Yield: 92%; Yellow 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (500 
MHz, CD2Cl2) δ 10.33 (s, 1H), 9.81 (brs, 1H), 8.80 (dd, J = 8.5, 0.8 Hz, 1H), 8.08 (m, 
1H), 7.72 (dd, J = 8.5, 0.8 Hz, 1H), 7.63 (d, J = 8.3 Hz, 2H), 7.49 – 7.43 (m, 1H), 7.15 
(d, J = 8.3 Hz, 2H), 2.28 (s, 3H), 1.52 (s, 9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 
196.69, 177.56, 144.52, 136.57, 136.48, 134.68, 130.01, 128.83, 127.59, 125.67, 
124.92, 122.11, 120.42, 118.00, 42.00, 28.76, 21.69 ppm; FT‐IR: ṽ = 2360, 2342, 
1706, 1668, 1561, 1217, 1154 cm
-1
; HRMS: calc. for [M+H]
+ 
 C21H23N2O4S: 
399.13730, found: 399.13721. 
 
 
N-(5-Methoxy-1-pivaloyl-1H-indol-7-yl)-4-methylbenzenesulfonamide (88m): 
The product was prepared according to the general procedure L. Yield: 72%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.75 (brs, 1H), 7.54 (d, J = 3.9 Hz, 1H), 7.41 (d, J = 8.3 Hz, 2H), 
7.13 (s, 1H), 7.11 – 7.10 (m, 2H), 6.84 (d, J = 2.5 Hz, 1H), 6.52 (d, J = 3.9 Hz, 1H), 
3.84 (s, 3H), 2.30 (s, 3H), 1.37 (s, 9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 179.68, 
157.90, 144.15, 137.57, 133.82, 129.94, 128.21, 127.21, 126.57, 123.97, 109.89, 
109.67, 101.86, 56.16, 42.02, 29.30, 21.65 ppm; FT‐IR: ṽ = 2934, 2360, 2342, 1658, 
1616, 1378, 1230, 1128, 1042 cm
-1
; HRMS: calc. for [M+H]
+ 
 C21H25N2O4S: 
401.15295, found: 401.15347. 
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4-Methyl-N-(5-phenyl-1-pivaloyl-1H-indol-7-yl)benzenesulfonamide (88n): 
The product was prepared according to the general procedure L. Yield: 88%; Brown 
liquid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 MHz, 
CD2Cl2) δ 9.49 (brs, 1H), 7.79 (d, J = 1.7 Hz, 1H), 7.68 (d, J = 8.3 Hz, 2H), 7.63 (d, J 
= 1.7 Hz, 1H), 7.59 (d, J = 3.9 Hz, 1H), 7.48 (t, J = 7.7 Hz, 2H), 7.41 – 7.37 (m, 3H), 
7.12 (d, J = 8.3 Hz, 2H), 6.66 (d, J = 3.9 Hz, 1H), 2.30 (s, 3H), 1.38 (s, 9H) ppm; 
13
C 
NMR (126 MHz, CD2Cl2) δ 180.02, 144.18, 140.47, 138.70, 137.63, 133.54, 129.97, 
129.41, 128.98, 128.04, 128.00, 127.63, 127.22, 125.83, 121.85, 117.30, 110.02, 
42.12, 29.22, 21.64 ppm; FT‐IR: ṽ = 3151, 2974, 2930, 2360, 2342, 1670, 1332, 
1220 cm
-1
; HRMS: calc. for [M+H]
+ 
 C26H27N2O3S: 447.17369, found: 447.17420. 
 
 
N-(5-Fluoro-1-pivaloyl-1H-indol-7-yl)-4-methylbenzenesulfonamide (88o): 
The product was prepared according to the general procedure L. Yield: 73%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.69 (brs, 1H), 7.62 (d, J = 3.9 Hz, 1H), 7.44 (d, J = 8.3 Hz, 2H), 
7.29 (dd, J = 10.7, 2.5 Hz, 1H), 7.14 (d, J = 8.3 Hz, 2H), 7.04 (dd, J = 10.7, 2.5 Hz, 
1H), 6.57 (d, J = 3.9 Hz, 1H), 2.30 (s, 3H), 1.38 (s, 9H) ppm; 
13
C NMR (126 MHz, 
CD2Cl2) δ 180.18, 160.50 (d, J = 241.2 Hz), 144.43, 137.34, 133.73 (d, J = 11.2 Hz), 
130.07, 129.08, 127.19, 127.00 (d, J = 12.0 Hz), 125.76 (d, J = 1.8 Hz), 109.71 (d, J = 
4.1 Hz), 109.25 (d, J = 28.5 Hz), 104.25 (d, J = 23.6 Hz), 42.22, 29.27, 21.67 ppm; 
19
F NMR (377 MHz, CD2Cl2) δ -117.81 (dd, J = 10.6, 7.7 Hz) ppm; FT‐IR: ṽ = 3198, 
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2975, 1661, 1600, 1473, 1334, 1184, 1160 cm
-1
; HRMS: calc. for [M+H]
+ 
 
C20H22FN2O3S: 389.13297, found: 389.13290. 
 
 
N-(5-Chloro-1-pivaloyl-1H-indol-7-yl)-4-methylbenzenesulfonamide (88p): 
The product was prepared according to the general procedure L. Yield: 66%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.48 (brs, 1H), 7.59 (d, J = 3.9 Hz, 1H), 7.51 (d, J = 2.0 Hz, 1H), 
7.40 (d, J = 8.2 Hz, 2H), 7.36 (d, J = 2.0 Hz, 1H), 7.13 (d, J = 8.2 Hz, 2H), 6.55 (d, J 
= 3.9 Hz, 1H), 2.30 (s, 3H), 1.36 (s, 9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 
180.20, 144.42, 137.36, 133.91, 130.80, 130.07, 128.78, 128.11, 127.16, 126.63, 
121.95, 118.48, 109.18, 42.22, 29.20, 21.66 ppm; FT‐IR: ṽ = 2975, 2360, 2342, 1663, 
1583, 1454, 1376, 1158, 1091 cm
-1
; HRMS: calc. for [M+H]
+
 C20H22
35
ClN2O3S: 
405.10342, found: 405.10339; HRMS: calc. for [M+H]
+
 C20H22
37
ClN2O3S: 
407.10047, found: 407.10022. 
 
 
N-(5-Bromo-1-pivaloyl-1H-indol-7-yl)-4-methylbenzenesulfonamide (88q): 
The product was prepared according to the general procedure L. Yield: 80%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.43 (brs, 1H), 7.64 (d, J = 1.9 Hz, 1H), 7.57 (d, J = 3.9 Hz, 1H), 
7.52 (d, J = 1.9 Hz, 1H), 7.40 (d, J = 8.3 Hz, 2H), 7.13 (d, J = 8.3 Hz, 2H), 6.55 (d, J 
= 3.9 Hz, 1H), 2.30 (s, 3H), 1.36 (s, 9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 
180.21, 144.42, 137.36, 134.31, 130.07, 128.64, 128.58, 127.15, 126.78, 124.75, 
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121.61, 118.27, 109.03, 42.22, 29.18, 21.66 ppm; FT‐IR: ṽ = 2975, 2361, 2342, 1670, 
1448, 1330, 1295, 1122, 1092 cm
-1
; HRMS: calc. for [M+H]
+
 C20H22
79
BrN2O3S: 
449.05290, found: 449.05215; HRMS: calc. for [M+H]
+
 C20H22
81
BrN2O3S: 
451.05086; found: 451.05115. 
 
 
N-(6-Methoxy-1-pivaloyl-1H-indol-7-yl)-4-methylbenzenesulfonamide (88r): 
The product was prepared according to the general procedure L. Yield: 78%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.2; 
1
H NMR (500 
MHz, CD2Cl2) δ 7.55 (d, J = 3.8 Hz, 1H), 7.49 (d, J = 8.2 Hz, 2H), 7.45 – 7.43 (m, 
2H), 7.21 (d, J = 8.2 Hz, 2H), 6.91 (d, J = 8.5 Hz, 1H), 6.57 (d, J = 3.8 Hz, 1H), 3.50 
(s, 3H), 2.38 (s, 3H), 1.47 (s, 9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 179.64, 
154.34, 143.73, 138.54, 133.99, 129.53, 127.57, 126.69, 126.38, 120.41, 114.00, 
109.95, 108.05, 56.69, 42.13, 29.12, 21.70 ppm; FT‐IR: ṽ = 2972, 2360, 2342, 1715, 
1671, 1492, 1403, 1303, 1156 cm
-1
; HRMS: calc. for [M+H]
+ 
C21H25N2O4S: 
401.15295, found: 401.15308. 
 
 
N-(6-Chloro-1-pivaloyl-1H-indol-7-yl)-4-methylbenzenesulfonamide (88s): 
The product was prepared according to the general procedure L. Yield: 34%; Brown 
amorphous solid; TLC (6% EtOAc in petroleum ether): Rf = 0.2; 
1
H NMR (500 MHz, 
CD2Cl2) δ 7.70 (brs, 1H), 7.65 (d, J = 3.8 Hz, 1H), 7.55 (d, J = 8.2 Hz, 2H), 7.49 (d, J 
= 8.3 Hz, 1H), 7.39 (d, J = 8.3 Hz, 1H), 7.24 (d, J = 8.2 Hz, 2H), 6.65 (d, J = 3.8 Hz, 
1H), 2.40 (s, 3H), 1.46 (s, 9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 179.98, 144.57, 
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137.91, 134.53, 131.94, 131.80, 129.99, 128.23, 127.82, 126.64, 121.98, 121.38, 
108.29, 42.22, 29.09, 21.80 ppm; FT‐IR: ṽ = 3238, 2975, 2360, 2342, 1715, 1464, 
1333, 1296, 1165 cm
-1
; HRMS: calc. for [M+H]
+
 C20H22
35
ClN2O3S: 405.10342, 
found: 405.10345; HRMS: calc. for [M+H]
+
 C20H22
37
ClN2O3S: 407.10047, found: 
407.10040. 
 
 
4-Methyl-N-(3-methyl-1-pivaloyl-1H-indol-7-yl)benzenesulfonamide (88t): 
The product was prepared according to the general procedure L. Yield: 79%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (600 
MHz, CD2Cl2) δ 9.56 (brs, 1H), 7.52 – 7.50 (m, 1H), 7.36 – 7.31 (m, 5H), 7.10 (d, J 
= 8.0 Hz, 2H), 2.29 (s, 3H), 2.21 (d, J = 1.2 Hz, 3H), 1.36 (s, 9H) ppm; 
13
C NMR 
(151 MHz, CD2Cl2) δ 179.70, 144.03, 137.79, 133.99, 129.97, 129.93, 127.17, 
125.77, 125.36, 124.23, 122.66, 118.75, 117.04, 41.99, 29.23, 21.65, 9.93 ppm; 
FT‐IR: ṽ = 2976, 2919, 2360, 2342, 1662, 1321, 1258, 1119 cm-1; HRMS: calc. for 
[M+H]
+
 C21H25N2O3S: 385.15804, found: 385.15888. 
 
 
N-(3-Formyl-5-methoxy-1-pivaloyl-1H-indol-7-yl)-4-methylbenzenesulfonamide 
(88u): 
The product was prepared according to the general procedure L. Yield: 75%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.2; 
1
H NMR (500 
MHz, CD2Cl2) δ 10.00 (s, 1H), 9.02 (brs, 1H), 8.38 (s, 1H), 8.25 (d, J = 9.2 Hz, 1H), 
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7.58 (d, J = 8.3 Hz, 2H), 7.23 (d, J = 8.3 Hz, 2H), 6.98 (d, J = 9.2 Hz, 1H), 3.45 (s, 
3H), 2.39 (s, 3H), 1.53 (s, 9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 187.17, 177.46, 
151.23, 143.70, 138.54, 138.15, 133.62, 129.36, 127.58, 122.79, 122.12, 119.67, 
115.88, 112.43, 56.38, 42.19, 28.90, 21.75 ppm; FT‐IR: ṽ = 3166, 2927, 2360, 2342, 
1702, 1654, 1538, 1499, 1266 cm
-1
; HRMS: calc. for [M+H]
+
 C22H25N2O5S: 
429.14787, found: 429.14907. 
 
 
N-(3-(2-(1,3-Dioxoisoindolin-2-yl)ethyl)-1-pivaloyl-1H-indol-7-yl)-4-methylbenze
nesulfonamide (88v): 
The product was prepared according to the general procedure L. Yield: 90%; Brown 
liquid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 MHz, 
CD2Cl2) δ 9.40 (brs, 1H), 7.81 – 7.80 (m, 2H), 7.73 – 7.72 (m, 2H), 7.49 (td, J = 7.9, 
0.9 Hz, 2H), 7.40 (s, 1H), 7.36 – 7.32 (m, 3H), 7.09 (d, J = 8.0 Hz, 2H), 3.98 (t, J = 
7.2 Hz, 2H), 3.06 (t, J = 7.2 Hz, 2H), 2.27 (s, 3H), 1.29 (s, 9H) ppm; 
13
C NMR (126 
MHz, CD2Cl2) δ 179.85, 168.62, 144.01, 137.72, 134.62, 132.87, 132.46, 130.03, 
129.93, 127.09, 125.77, 125.49, 124.52, 123.60, 123.01, 119.33, 117.04, 41.96, 37.41, 
29.06, 24.29, 21.63 ppm; FT‐IR: ṽ = 3727, 2918, 2850, 2360, 2342, 1709, 1669, 
1346, 1163 cm
-1
; HRMS: calc. for [M+H]
+
 C30H30N3O5S: 544.19007, found: 
544.19064. 
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Ethyl(R)-2-((tert-butoxycarbonyl)amino)-3-(7-((4-methylphenyl)sulfonamido)-1-
pivaloyl-1H-indol-3-yl)propanoate (88w): 
The product was prepared according to the general procedure L. Yield: 80%; Brown 
amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.39 (brs, 1H), 7.51 (dd, J = 6.4, 2.4 Hz, 1H), 7.38 (s, 1H), 7.36 – 
7.31 (m, 4H), 7.11 (d, J = 8.1 Hz, 2H), 5.11 – 5.09 (brs, 1H), 4.62 – 4.58 (m, 1H), 
4.16 – 4.06 (m, 2H), 3.22 (dd, J = 13.0, 5.9 Hz, 1H), 3.08 (dd, J = 13.0, 5.9 Hz, 1H), 
2.30 (s, 3H), 1.40 (s, 9H), 1.35 (s, 9H), 1.23 – 1.20 (m, 3H) ppm; 13C NMR (126 
MHz, CD2Cl2) δ 179.78, 172.05, 155.42, 144.11, 137.61, 133.16, 129.96, 129.83, 
127.11, 125.81, 125.46, 125.35, 122.97, 117.68, 117.03, 80.37, 62.21, 42.06, 29.57, 
29.22, 28.55, 27.88, 21.65, 14.43 ppm; FT‐IR: ṽ = 2977, 2360, 2342, 1711, 1670, 
1601, 1495, 1347, 1160 cm
-1
; HRMS: calc. for [M+H]
+
 C30H40N3O7S: 586.25815, 
found: 586.25979; ][
RT
D  = 29.8 (CHCl3, c = 1). 
 
 
N-(1-pivaloyl-1H-indol-7-yl)benzenesulfonamide (88z): 
The product was prepared according to the general procedure L. Yield: 86%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (400 
MHz, CD2Cl2) δ 9.38 (brs, 1H), 7.55 (d, J = 4.0 Hz, 1H), 7.52 (dd, J = 7.8, 1.2 Hz, 
1H), 7.49 – 7.44 (m, 3H), 7.43 – 7.40 (m, 1H), 7.34 – 7.28 (m, 3H), 6.60 (d, J = 4.0 
Hz, 1H), 1.38 (s, 9H) ppm; 
13
C NMR (101 MHz, CD2Cl2) δ 180.26, 140.72, 133.13, 
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133.04, 129.83, 129.38, 127.48, 127.17, 125.67, 125.62, 122.84, 119.41, 109.79, 
42.23, 29.37 ppm; FT‐IR: ṽ = 3118, 2360, 2342, 1663, 1580, 1363, 1326, 1174, 1163 
cm
-1
; HRMS: calc. for [M+H]
+
 C19H21N2O3S: 357.12674, found: 357.12782. 
 
 
4-Acetyl-N-(1-pivaloyl-1H-indol-7-yl)benzenesulfonamide (88aa): 
The product was prepared according to the general procedure L. Yield: 77%; Brown 
amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.58 (brs, 1H), 7.84 (d, J = 8.2 Hz, 2H), 7.58 (d, J = 8.2 Hz, 2H), 
7.55 (d, J = 3.7 Hz, 1H), 7.51 (d, J = 7.8 Hz, 1H), 7.42 (d, J = 7.8 Hz, 1H), 7.33 (t, J = 
7.7 Hz, 1H), 6.61 (d, J = 3.7 Hz, 1H), 2.52 (s, 3H), 1.36 (s, 9H) ppm; 
13
C NMR (126 
MHz, CD2Cl2) δ 197.03, 180.24, 144.26, 140.43, 133.06, 129.61, 129.06, 127.52, 
127.50, 125.76, 125.11, 122.54, 119.59, 109.91, 42.17, 29.27, 27.20 ppm; FT‐IR: ṽ = 
2925, 2360, 2342, 1686, 1667, 1321, 1230, 1180, 1164 cm
-1
; HRMS: calc. for 
[M+H]
+
 C21H23N2O4S: 399.13730, found: 399.13777. 
 
 
3-Fluoro-N-(1-pivaloyl-1H-indol-7-yl)benzenesulfonamide (88ab): 
The product was prepared according to the general procedure L. Yield: 88%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (400 
MHz, CD2Cl2) δ 9.53 (brs, 1H), 7.58 (d, J = 4.0 Hz, 1H), 7.52 (dd, J = 7.8, 1.2 Hz, 
1H), 7.43 (dd, J = 7.8, 1.2 Hz, 1H), 7.35 – 7.22 (m, 4H), 7.17 – 7.13 (m, 1H), 6.62 (d, 
J = 4.0 Hz, 1H), 1.40 (s, 9H) ppm; 
13
C NMR (101 MHz, CD2Cl2) δ 180.33, 162.69 (d, 
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J = 250.7 Hz), 142.66 (d, J = 6.8 Hz), 133.13, 131.23 (d, J = 7.8 Hz), 129.83, 127.57, 
125.80, 125.24, 123.15 (d, J = 3.3 Hz), 122.83, 120.28 (d, J = 21.2 Hz), 119.69, 
114.53 (d, J = 24.4 Hz), 109.94, 42.26, 29.35 ppm ; 
19
F NMR (377 MHz, CD2Cl2) δ 
-110.71 (td, J = 8.3, 5.0 Hz) ppm; FT‐IR: ṽ = 2980, 2360, 2342, 1656, 1364, 1328, 
1163, 1081 cm
-1
; HRMS: calc. for [M+H]
+
 C19H20FN2O3S: 375.11732, found: 
375.11799. 
 
 
3-Cyano-N-(1-pivaloyl-1H-indol-7-yl)benzenesulfonamide (88ac): 
The product was prepared according to the general procedure L. Yield: 52%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.71 (brs, 1H), 7.78 (s, 1H), 7.73 – 7.70 (m, 2H), 7.59 (d, J = 3.9 Hz, 
1H), 7.50 – 7.44 (m, 3H), 7.34 (t, J = 7.8 Hz, 1H), 6.64 (d, J = 3.9 Hz, 1H), 1.40 (s, 
9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 180.31, 141.95, 136.31, 133.17, 131.18, 
130.83, 130.45, 129.61, 127.63, 125.94, 124.80, 122.45, 119.86, 117.44, 113.85, 
110.09, 42.24, 29.34 ppm; FT‐IR: ṽ = 2976, 2360, 2342, 2234, 1666, 1587, 1333, 
1302, 1179, 1158 cm
-1
; HRMS: calc. for [M+H]
+
 C20H20N3O3S: 382.12199, found: 
382.12259.  
 
 
2-Nitro-N-(1-pivaloyl-1H-indol-7-yl)benzenesulfonamide (88ad): 
The product was prepared according to the general procedure L. Yield: 93%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (400 
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MHz, CD2Cl2) δ 9.49 (brs, 1H), 7.77 – 7.75 (m, 1H), 7.68 (d, J = 3.9 Hz, 1H), 7.67 – 
7.56 (m, 3H), 7.52 – 7.47 (m, 1H), 7.39 (dd, J = 7.7, 1.2 Hz, 1H), 7.30 (t, J = 7.8 Hz, 
1H), 6.62 (d, J = 3.9 Hz, 1H), 1.50 (s, 9H) ppm; 
13
C NMR (151 MHz, CD2Cl2) δ 
180.39, 148.39, 134.37, 133.28, 133.26, 132.52, 131.86, 129.20, 127.91, 125.62, 
125.08, 125.04, 120.15, 119.15, 109.65, 42.25, 29.27 ppm; FT‐IR: ṽ = 3101, 2987, 
2360, 2342, 1685, 1672, 1588, 1365, 1127 cm
-1
; HRMS: calc. for [M+H]
+
 
C19H20N3O5S: 402.11182, found: 402.11254. 
 
 
N-(1-Pivaloyl-1H-indol-7-yl)methanesulfonamide (88ae): 
The product was prepared according to the general procedure L. Yield: 94%; Brown 
liquid; TLC (20% EtOAc in petroleum ether): Rf = 0.2; 
1
H NMR (500 MHz, CD2Cl2) 
δ 9.13 (brs, 1H), 7.79 (d, J = 3.9 Hz, 1H), 7.49 – 7.44 (m, 2H), 7.34 (t, J = 7.8 Hz, 
1H), 6.73 (d, J = 3.9 Hz, 1H), 2.87 (s, 3H), 1.55 (s, 9H) ppm; 
13
C NMR (126 MHz, 
CD2Cl2) δ 180.72, 133.37, 129.23, 127.77, 126.10, 125.77, 120.71, 119.00, 109.89, 
42.53, 40.10, 29.46 ppm; FT‐IR: ṽ = 3188, 2977, 2935, 2360, 2341, 1669, 1590, 
1316, 1230, 1179, 1152 cm
-1
; HRMS: calc. for [M+H]
+
 C14H19N2O3S: 295.11109, 
found: 295.11191. 
 
 
N-(1-Pivaloyl-1H-indol-7-yl)octane-1-sulfonamide (88af): 
The product was prepared according to the general procedure L. Yield: 80%; Brown 
liquid; TLC (12% EtOAc in petroleum ether): Rf = 0.2; 
1
H NMR (500 MHz, CD2Cl2) 
Experimental Part                                                   143 
 
δ 9.05 (brs, 1H), 7.78 (d, J = 3.9 Hz, 1H), 7.50 (d, J = 7.8 Hz, 1H), 7.42 (d, J = 7.8 Hz, 
1H), 7.32 (t, J = 7.8 Hz, 1H), 6.71 (d, J = 3.9 Hz, 1H), 2.97 – 2.94 (m, 2H), 1.73 – 
1.67 (m, 2H), 1.56 (s, 9H), 1.33 – 1.17 (m, 10H), 0.85 (t, J = 7.1 Hz, 3H) ppm; 13C 
NMR (126 MHz, CD2Cl2) δ 180.79, 133.39, 129.06, 127.71, 126.43, 125.81, 119.92, 
118.63, 109.95, 52.37, 42.57, 32.23, 29.54, 29.44, 29.41, 28.65, 23.95, 23.11, 14.37 
ppm; FT‐IR: ṽ = 3190, 2926, 2856, 2360, 2342, 1671, 1318, 1301, 1179, 1146 cm-1; 
HRMS: calc. for [M+H]
+
 C21H33N2O3S: 393.22064, found: 393.22175. 
 
 
N-(1-Pivaloyl-1H-indol-7-yl)thiophene-2-sulfonamide (88ah): 
The product was prepared according to the general procedure L. Yield: 83%; Brown 
amorphous solid; TLC (33% EtOAc in petroleum ether): Rf = 0.3; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.56 (brs, 1H), 7.60 (d, J = 3.9 Hz, 1H), 7.56 (dd, J = 7.8, 1.2 Hz, 
1H), 7.45 (dd, J = 7.8, 1.2 Hz, 1H), 7.42 (dd, J = 5.0, 1.3 Hz, 1H), 7.35 (t, J = 7.8 Hz, 
1H), 7.17 (dd, J = 5.0, 1.3 Hz, 1H), 6.89 – 6.87 (m, 1H), 6.64 (d, J = 3.9 Hz, 1H), 1.41 
(s, 9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 180.24, 140.92, 133.02, 132.50, 132.21, 
129.92, 127.72, 127.55, 125.67, 125.16, 123.27, 119.75, 109.84, 42.20, 29.33 ppm; 
FT‐IR: ṽ = 3094, 2360, 2342, 1662, 1328, 1300, 1180, 1157, 1013 cm-1; HRMS: calc. 
for [M+H]
+
 C17H19N2O3S2: 363.08316, found: 363.08379. 
5.3.5 Synthesis of Bioactive Compounds 88ak, 88al 
General Procedure M for the Synthesis of Compounds 88ak, 88al: 
First Step: 
N-Pivaloyl indole (0.1 mmol) was dissolved in a 12 mL screw-capped tube with 1 mL 
of DCE. Then sulfonyl azide (0.22 mmol) followed by [(IrCp*Cl2)2] (4 mol %), 
AgNTf2 (16 mol %) and LiOAc (40 mol%) were added to the reaction mixture at 
room temperature. The reaction mixture was allowed to warm up to 120 °C and 
stirred for 1-12 h. After the reaction finished, the reaction mixture was directly loaded 
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in silica gel column and purified with petroleum ether (40-60°C)/EtOAc mixture. 
 
Characterization of Compounds 88ai, 88aj: 
 
 
4-Methoxy-N-(1-pivaloyl-1H-indol-7-yl)benzenesulfonamide (88ai): 
The product was prepared according to the general procedure M. Yield: 96%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (400 
MHz, CD2Cl2) δ 9.31 (brs, 1H), 7.58 (d, J = 4.0 Hz, 1H), 7.50 (dd, J = 7.8, 1.2 Hz, 
1H), 7.43 – 7.39 (m, 3H), 7.31 (t, J = 7.7 Hz, 1H), 6.78 – 6.76 (m, 2H), 6.61 (d, J = 
4.0 Hz, 1H), 3.75 (s, 3H), 1.41 (s, 9H) ppm; 
13
C NMR (101 MHz, CD2Cl2) δ 180.23, 
163.44, 133.03, 132.36, 129.80, 129.34, 127.49, 125.91, 125.62, 122.68, 119.21, 
114.49, 109.79, 56.13, 42.25, 29.40 ppm; FT‐IR: ṽ = 3141, 2969, 2360, 2342, 1672, 
1597, 1331, 1305, 1261, 1162 cm
-1
; HRMS: calc. for [M+H]
+
 C20H23N2O4S: 
387.13730, found: 387.13848. 
 
 
N-(5-Chloro-1-pivaloyl-1H-indol-7-yl)-4-methoxybenzenesulfonamide (88aj): 
The product was prepared according to the general procedure M. Yield: 77%; Brown 
amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.47 (brs, 1H), 7.62 (d, J = 3.9 Hz, 1H), 7.50 – 7.48 (m, 3H), 7.35 (d, 
J = 2.0 Hz, 1H), 6.80 (d, J = 8.9 Hz, 2H), 6.56 (d, J = 3.9 Hz, 1H), 3.76 (s, 3H), 1.40 
(s, 9H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 180.27, 163.63, 133.99, 131.97, 130.87, 
129.41, 128.83, 128.13, 126.89, 121.70, 118.37, 114.62, 109.24, 56.17, 42.33, 29.35 
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ppm; FT‐IR: ṽ = 2932, 2360, 2342, 1667, 1582, 1501, 1328, 1303, 1266 1095 cm-1; 
HRMS: calc. for [M+H]
+
 C20H22
35
ClN2O4S: 421.09833, found: 421.09866; HRMS: 
calc. for [M+H]
+
 C20H22
37
ClN2O4S: 423.09538, found:423.09548. 
 
Second Step: 
To a solution of 88ai or 88aj (0.1 mmol) in MeOH (1.0 mL) was added Et3N (0.2 mL) 
dropwise at room temperature. Then the reaction was stirred for 24 h and quenched by 
addition of saturated NH4Cl solution. The organic layer was separated, and the 
aqueous layer was extracted with dichloromethane. Combined organic layers were 
washed with brine, dried over anhydrous MgSO4, filtered and concentrated under 
vacuum. The residue was then purified by flash chromatography over silica gel with 
petroleum ether and ethyl acetate to give the corresponding product 88ak, 88al. 
Characterization of Compounds 88ak, 88al: 
 
 
N-(1H-indol-7-yl)-4-methoxybenzenesulfonamide (88ak): 
The product was prepared according to the general procedure M. Yield: 90%; Brown 
amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.2; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.32 (brs, 1H), 7.59 – 7.56 (m, 2H), 7.48 (d, J = 7.9 Hz, 1H), 7.30 – 
7.29 (m, 1H), 6.88 – 6.84 (m, 3H), 6.55 – 6.54 (m, 1H), 6.44 (dd, J = 7.5, 0.5 Hz, 1H), 
3.81 (s, 3H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 163.93, 132.48, 130.68, 130.06, 
130.00, 125.82, 120.80, 120.25, 120.14, 118.60, 114.66, 103.08, 56.20 ppm; FT‐IR: ṽ 
= 3394, 3239, 2925, 2360, 2342, 1593, 1496, 1323, 1304, 1186 cm
-1
; HRMS: calc. 
for [M+H]
+
 C15H15N2O3S: 303.07979, found: 303.08038. 
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N-(5-Chloro-1H-indol-7-yl)-4-methoxybenzenesulfonamide (88al): 
The product was prepared according to the general procedure M. Yield: 92%; Brown 
amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.2; 
1
H NMR (500 
MHz, CD2Cl2) δ 9.47 (brs, 1H), 7.64 – 7.61 (m, 2H), 7.44 (d, J = 1.8 Hz, 1H), 7.30 (d, 
J = 2.3 Hz, 1H), 6.90 – 6.87 (m, 2H), 6.55 (d, J = 1.8 Hz, 1H), 6.49 (d, J = 2.3 Hz, 
1H), 3.81 (s, 3H) ppm; 
13
C NMR (126 MHz, CD2Cl2) δ 164.13, 131.24, 130.56, 
130.03, 129.73, 127.23, 125.02, 121.82, 119.21, 117.91, 114.85, 102.88, 56.25 ppm; 
FT‐IR: ṽ = 3400, 3244, 3196, 2928, 2838, 2360, 2342, 1302, 1262, 1120 cm-1; 
HRMS: calc. for [M+H]
+
 C15H14
35
ClN2O3S: 337.04082, found: 337.04158; HRMS: 
calc. for [M+H]
+
 C15H14
37
ClN2O3S: 339.03787, found: 339.03839. 
5.3.6 Deuterium Labeling Experiments 
N-Pivaloyl indole 86f (0.1 mmol) was dissolved in a 12 mL screw-capped tube with 1 
mL of DCE, followed by [(IrCp*Cl2)2] (4 mol %), AgNTf2 (16 mol %), LiOAc (40 
mol%) and D2O (2 equiv) were added to the reaction mixture at room temperature. 
The reaction mixture was allowed to warm up to 120 °C and stirred for 1h. After the 
reaction finished, the reaction mixture was directly loaded in silica gel column and 
purified with petroleum ether (40-60°C)/EtOAc mixture to afford the recovered 
starting material 86z in 92% yield. An analysis by 
1
H NMR showed 35% deuterium 
incorporation at the C-7 position of 86z. 
N-pivaloyl indole 86f (0.1 mmol) and TsN3 87a (0.22 mmol) were dissolved in a 12 
mL screw-capped tube with 1 mL of DCE, followed by [(IrCp*Cl2)2] (4 mol %), 
AgNTf2 (16 mol %), LiOAc (40 mol%) and D2O (2 equiv) were added to the reaction 
mixture at room temperature. The reaction mixture was allowed to warm up to 120 °C 
and stirred for 1h. After the reaction finished, the reaction mixture was directly loaded 
in silica gel column and purified with petroleum ether (40-60°C)/EtOAc mixture to 
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afford the product 88am in 76% yield. An analysis by 
1
H NMR showed no deuterium 
incorporation on the ring of 88am. 
 
5.4 Experimental Part for 3.2.1 
 
5.4.1 Synthesis of Substituted N, N-Dimethylanilines 89 
General Procedure O for the Synthesis of Compounds 89d, 89f, 89i, 89j, 89l–89q:[136] 
Alkyliodide (4.4 mmol) was added dropwise to a stirred suspension of aniline (2 
mmol) and potassium carbonate (6 mmol) in 3 mL N,N-dimethylformamide (DMF) 
under argon. The reaction mixture was stirred at 23 °C for 18 h, then it was filtered 
and diluted with water. The resultant solution was extracted three times with diethyl 
ether. The combined organic phase was washed three times with water. Then it was 
washed with saturated aqueous sodium chloride solution, dried over anhydrous 
Na2SO4, and concentrated under vacuum. The residue was purified by flash 
chromatography over silica gel. 
 
Characterization of Compounds 89d, 89f, 89i, 89j, 89l–89q: 
 
 
4-Fluoro-N,N-dimethylaniline (89d):
[136]
 
The product was prepared according to the general procedure O. Yield: 45%; 
Colourless liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 
MHz, CDCl3) δ 6.97 – 6.94 (m, 2H), 6.70 – 6.68 (m, 2H), 2.91 (s, 6H) ppm; 
13
C 
NMR (126 MHz, CDCl3) δ 155.76 (d, J = 235.2 Hz), 147.67 (d, J = 1.8 Hz), 115.50 
(d, J = 22.0 Hz), 114.09 (d, J = 7.3 Hz), 41.51 ppm. 
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4-Iodo-N,N-dimethylaniline (88f): 
The product was prepared according to the general procedure O. Yield: 41%; 
Colourless liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 
MHz, CDCl3) δ 7.48 (d, J = 8.8 Hz, 2H), 6.52 (d, J = 7.3 Hz, 2H), 2.93 (s, 6H). 
 
 
1-(3-(Dimethylamino)phenyl)ethan-1-one (89i): 
The product was prepared according to the general procedure O. Yield: 55%; White 
amorphous solid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.2; 
1
H NMR (500 
MHz, CDCl3) δ 7.34 – 7.25 (m, 3H), 6.93 (d, J = 6.7 Hz, 1H), 2.99 (s, 6H), 2.58 (s, 
3H). 
 
 
2-Benzyl-N,N-dimethylaniline (89j):
[137]
 
The product was prepared according to the general procedure O. Yield: 38%; 
Colourless liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 
MHz, CDCl3) δ 7.31 – 7.28 (m, 2H), 7.23 – 7.16 (m, 5H), 7.06 (dd, J = 7.6, 1.3 Hz, 
1H), 7.02 – 6.98 (m, 1H), 4.14 (s, 2H), 2.70 (s, 6H) ppm; 13C NMR (126 MHz, 
CDCl3) δ 152.96, 141.86, 136.03, 131.00, 129.27, 128.40, 127.04, 125.86, 123.47, 
119.65, 45.28, 36.73 ppm. 
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(2-(Dimethylamino)phenyl)(phenyl)methanone (89l):
[138]
 
The product was prepared according to the general procedure O. Yield: 40%; Yellow 
amorphous solid; TLC (5% EtOAc in petroleum ether): Rf = 0.4; 
1
H NMR (500 MHz, 
CDCl3) δ 7.84 – 7.82 (m, 2H), 7.56 – 7.52 (m, 1H), 7.43 – 7.38 (m, 3H), 7.32 (dd, J = 
7.6, 1.7 Hz, 1H), 7.00 (d, J = 8.3 Hz, 1H), 6.90 (t, J = 7.4 Hz, 1H), 2.70 (s, 6H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 198.30, 151.77, 137.87, 132.78, 131.57, 130.84, 
130.07, 129.32, 128.24, 119.03, 116.63, 43.58 ppm. 
 
 
3,4,5-Trimethoxy-N,N-dimethylaniline (89m):
[139]
 
The product was prepared according to the general procedure O. Yield: 60%; 
Colourless liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 
MHz, CDCl3) δ 5.96 (s, 2H), 3.86 (s, 6H), 3.77 (s, 3H), 2.92 (s, 6H) ppm; 
13
C NMR 
(126 MHz, CDCl3) δ 153.76, 147.81, 130.11, 91.09, 61.14, 56.12, 41.25 ppm. 
 
 
N,N-Dimethyl-3,5-bis(trifluoromethyl)aniline (89n): 
The product was prepared according to the general procedure O. Yield: 40%; 
Colourless liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (200 
MHz, CDCl3) δ 7.17 (s, 1H), 7.04 (s, 2H), 3.06 (s, 6H). 
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N-Methyl-N-phenylaniline (89o):
[105]
 
The product was prepared according to the general procedure O. Yield: 45%; 
Colourless liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (200 
MHz, CDCl3) δ 7.32 – 7.23 (m, 4H), 7.06 – 6.92 (m, 6H), 3.32 (s, 3H) ppm; 
13
C 
NMR (126 MHz, CDCl3) δ 149.17, 129.32, 121.41, 120.59, 40.38 ppm. 
 
 
N-Benzyl-N-methylaniline (89p):
[65]
 
The product was prepared according to the general procedure O. Yield: 44%; Yellow 
liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 MHz, CDCl3) 
δ 7.34 – 7.31 (m, 2H), 7.27 – 7.22 (m, 5H), 6.78 (d, J = 8.2 Hz, 2H), 6.73 (t, J = 7.2 
Hz, 1H), 4.55 (s, 2H), 3.03 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 149.7, 139.0, 
129.31, 128.69, 127.01, 126.91, 116.70, 112.54 , 56.82, 38.67 ppm. 
 
 
N-Butyl-N-methylaniline (89q):
[140]
 
The product was prepared according to the general procedure O. Yield: 42%; 
Colourless liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 
MHz, CDCl3) δ 7.25 – 7.22 (m, 2H), 6.72 – 6.67 (m, 3H), 3.33 – 3.30 (m, 2H), 2.93 
(s, 3H), 1.57 (dt, J = 12.4, 7.5 Hz, 2H), 1.36 (dq, J = 14.7, 7.5 Hz, 2H), 0.96 (t, J = 7.5 
Hz, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 149.56, 129.26, 115.93, 112.24, 52.69, 
38.42, 29.00, 20.52, 14.16 ppm. 
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General Procedures P for the Synthesis of Compounds 89c, 89g, 89h, 89k:
[141]
 
To a solution of anilines (1.5 mmol) in glacial acetic acid (5 mL) under inert 
atmosphere was added paraformaldehyde (15 mmol) and sodium cyanoborohydride 
(7.5 mmol). The addition of sodium cyanoborohydride resulted in bubbling. After 
stirring overnight, the reaction mixture was poured into a water/ice mixture (10 mL) 
containing NaOH (4 g). The addition was exothermic, and more ice was added to 
bring the total volume of the quench mixture to 30 mL. The mixture, which had pH 14, 
was extracted with dichloromethane. The combined organic layers were dried with 
anhydrous Na2SO4, filtered, and concentrated under vacuum. The residue was then 
purified by flash chromatography over silica gel. 
 
Characterization of Compounds 89c, 89g, 89h, 89k: 
 
 
4-Ethyl-N,N-dimethylaniline (89c):
[104]
 
The product was prepared according to the general procedure P. Yield: 37%; 
Colourless liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 
MHz, CDCl3) δ 7.14 – 7.12 (m, 2H), 6.77 – 6.74 (m, 2H), 2.95 (s, 6H), 2.61 (q, J = 
7.6 Hz, 2H), 1.25 (t, J = 7.6 Hz, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 149.12, 
132.81, 128.53, 113.29, 41.14, 27.95, 16.06 ppm. 
 
 
 
Methyl 4-(dimethylamino)benzoate (89g):
[142]
 
The product was prepared according to the general procedure P. Yield: 65%; White 
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amorphous solid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (300 
MHz, CDCl3) δ 7.91 (d, J = 9.1 Hz, 2H), 6.67 (d, J = 9.1 Hz, 2H), 3.86 (s, 3H), 3.04 
(s, 6H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 167.60, 153.39, 131.38, 117.21, 110.89, 
51.61, 40.21 ppm. 
 
 
3-Methoxy-N,N-dimethylaniline (89h):
[136]
 
The product was prepared according to the general procedure P. Yield: 38%; 
Colourless liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (300 
MHz, CDCl3) δ 7.16 (t, J = 8.3 Hz, 1H), 6.40 – 6.30 (m, 3H), 3.81 (s, 3H), 2.95 (s, 
6H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 160.83, 152.09, 129.89, 105.98, 101.68, 
99.40, 55.27, 40.82 ppm. 
 
 
N,N-Dimethyl-[1,1'-biphenyl]-2-amine (89k):
[143]
 
The product was prepared according to the general procedure P. Yield: 43%; 
Colourless liquid; TLC (0.5% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (300 
MHz, CDCl3) δ 7.58 (d, J = 7.3 Hz, 2H), 7.40 (t, J = 7.5 Hz, 2H), 7.32 – 7.22 (m, 3H), 
7.06 – 6.99 (m, 2H), 2.55 (s, 6H) ppm; 13C NMR (126 MHz, CDCl3) δ 151.39, 
142.15, 134.29, 131.84, 128.80, 128.42, 128.18, 126.59, 121.57, 117.70, 43.48 ppm. 
 
5.4.2 Synthesis of Pyrrolo[3,4-c]quinolone Derivatives 91a–91ab 
General Procedure Q for the Synthesis of Compounds 91a–91ab: 
To a screw-capped vial maleimides (0.1 mmol, 1 equiv), tertiary anilines (0.2 mmol, 2 
equiv), tetrabutyl ammonium iodides 3.69 mg (TBAI, 10 mol%), TBHP 55 µL (70% 
in H2O, 0.4 mmol, 4 equiv) and DCE (1.0 mL) were added. The reaction mixture was 
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heated to 70 
o
C. The progress of the reaction was monitored by thin layer 
chromatography (ethyl acetate/petroleum ether mixture) and GC-MS. Upon 
completion, the crude reaction mixture was concentrated under vacuum and 
subsequently purified by flash column chromatography over silica gel using 
petroleum ether/ethyl acetate as an eluent system. 
 
Characterization of Compounds 91a–91ab: 
 
 
(3aR*,9bS*)-5-Methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quinoline
-1,3(2H)-dione (91a) 
The product was prepared according to the general procedure Q. Yield: 91%; Light 
yellow amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR 
(400 MHz, CDCl3) δ 7.55 – 7.53 (m, 1H), 7.46 – 7.41 (m, 2H), 7.38 – 7.34 (m, 1H), 
7.29 – 7.23 (m, 3H), 6.92 (ddd, J = 7.5, 7.5, 1.1 Hz, 1H), 6.76 – 6.75 (m, 1H), 4.17 (d, 
J = 9.6 Hz, 1H), 3.62 (dd, J = 11.5, 2.8 Hz, 1H), 3.54 (ddd, J = 9.6, 4.4, 2.8 Hz, 1H), 
3.13 (dd, J = 11.5, 4.4 Hz, 1H), 2.85 (s, 3H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 
177.80, 175.88, 148.63, 132.15, 130.47, 129.12, 128.82, 128.63, 126.49, 119.79, 
118.67, 112.66, 50.81, 43.72, 42.28, 39.56 ppm; FT‐IR: ṽ = 1708, 1598, 1497, 1392, 
1197, 1180 cm
-1
; HRMS: calc. for [M+H]
+
 C18H17O2N2: 293.12845, found: 
293.12911. 
 
 
(3aR*,9bS*)-5,8-Dimethyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quino
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line-1,3(2H)-dione (91b) 
The product was prepared according to the general procedure Q. Yield: 94%; Light 
brown amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR 
(300 MHz, CDCl3) δ 7.45 – 7.32 (m, 4H), 7.28 – 7.25 (m, 2H), 7.03 (dd, J = 8.3, 1.9 
Hz, 1H), 6.65 (d, J = 8.3 Hz, 1H), 4.11 (d, J = 9.6 Hz, 1H), 3.58 (dd, J = 11.3, 2.7 Hz, 
1H), 3.51 (ddd, J = 9.6, 4.3, 2.7 Hz, 1H), 3.05 (dd, J = 11.3, 4.3 Hz, 1H), 2.80 (s, 3H), 
2.30 (s, 3H) ppm; 
13
C NMR (75 MHz, CDCl3) δ 177.95, 176.00, 146.46, 132.12, 
130.93, 129.36, 129.11, 128.62, 126.49, 118.63, 112.68, 51.06, 43.68, 42.29, 39.71, 
20.57 ppm; FT‐IR: ṽ = 1711, 1508, 1395, 1192, 806 cm-1; HRMS: calc. for [M+H]+ 
C19H19O2N2: 307.14410, found: 307.14528. 
 
 
(3aR*,9bS*)-8-Ethyl-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]q
uinoline-1,3(2H)-dione (91c) 
The product was prepared according to the general procedure Q. Yield: 79%; Light 
brown amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR 
(300 MHz, CDCl3) δ 7.43 – 7.30 (m, 4H), 7.27 – 7.23 (m, 2H), 7.05 (dd, J = 8.3, 1.8 
Hz, 1H), 6.65 (d, J = 8.3 Hz, 1H), 4.11 (d, J = 9.5 Hz, 1H), 3.56 (dd, J = 11.3, 2.7 Hz, 
1H), 3.52 – 3.46 (m, 1H), 3.05 (dd, J = 11.3, 4.3 Hz, 1H), 2.79 (s, 3H), 2.58 (q, J = 
7.6 Hz, 2H), 1.20 (t, J = 7.6 Hz, 3H) ppm; 
13
C NMR (75 MHz, CDCl3) δ 177.95, 
175.99, 146.62, 135.59, 132.11, 129.86, 129.10, 128.60, 128.10, 126.48, 118.61, 
112.65, 50.98, 43.66, 42.29, 39.69, 28.02, 15.87 ppm; FT‐IR: ṽ = 1708, 1506, 1396, 
1319, 1194, 810 cm
-1
; HRMS: calc. for [M+H]
+
 C20H21O2N2: 321.15975, found: 
321.16016. 
 
Experimental Part                                                   155 
 
 
(3aR*,9bS*)-8-Fluoro-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]
quinoline-1,3(2H)-dione (91d) 
The product was prepared according to the general procedure Q. Yield: 81%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.48 – 7.45 (m, 2H), 7.41 – 7.38 (m, 1H), 7.32 – 7.29 (m, 3H), 6.99 – 
6.95 (m, 1H), 6.70 (dd, J = 9.0, 4.6 Hz, 1H), 4.14 (d, J = 9.6 Hz, 1H), 3.61 (dd, J = 
11.5, 2.8 Hz, 1H), 3.56 (ddd, J = 9.6, 4.3, 2.8 Hz, 1H), 3.11 (dd, J = 11.5, 4.3 Hz, 1H), 
2.84 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 177.51, 175.29, 156.81 (d, J = 
238.8 Hz), 145.10, 132.04, 129.19, 128.75, 126.47, 120.18 (d, J = 7.8 Hz), 117.13 (d, 
J = 23.4 Hz), 115.23 (d, J = 21.9 Hz), 113.54 (d, J = 7.5 Hz), 51.20, 43.57, 42.37, 
39.89 ppm; FT‐IR: ṽ = 1705, 1503, 1392, 1320, 1246, 1191 cm-1; HRMS: calc. for 
[M+H]
+
 C18H16O2N2F: 311.11903, found: 311.11982. 
 
 
(3aR*,9bS*)-8-Bromo-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]
quinoline-1,3(2H)-dione (91e) 
The product was prepared according to the general procedure Q. Yield: 86%; Light 
yellow amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR 
(300 MHz, CDCl3) δ 7.63 – 7.62 (m, 1H), 7.45 – 7.22 (m, 6H), 6.59 (d, J = 8.8 Hz, 
1H), 4.08 (d, J = 9.5 Hz, 1H), 3.59 (dd, J = 11.5, 2.8 Hz, 1H), 3.52 (ddd, J = 9.5, 4.3, 
2.8 Hz, 1H), 3.09 (dd, J = 11.5, 4.3 Hz, 1H), 2.80 (s, 3H) ppm; 
13
C NMR (75 MHz, 
CDCl3) δ 177.40, 175.27, 147.61, 132.83, 131.92, 131.56, 129.18, 128.76, 126.41, 
120.49, 114.36, 111.79, 50.48, 43.40, 41.89, 39.58 ppm; FT‐IR: ṽ = 2924, 1710, 1593, 
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1495, 1371, 1176 cm
-1
; HRMS: calc. for [M+H]
+
 C18H16O2N2
79
Br: 371.03897, found: 
371.04033; C18H16O2N2
81
Br: 373.03692, found: 373.03816.  
 
 
(3aR*,9bS*)-8-Iodo-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]qu
inoline-1,3(2H)-dione (91f) 
The product was prepared according to the general procedure Q. Yield: 77%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.81 – 7.80 (m, 1H), 7.49 (dd, J = 8.6, 2.0 Hz, 1H), 7.46 – 7.42 (m, 
2H), 7.38 – 7.35 (m, 1H), 7.28 – 7.26 (m, 2H), 6.50 (d, J = 8.7 Hz, 1H), 4.09 (d, J = 
9.6 Hz, 1H), 3.60 (dd, J = 11.6, 2.8 Hz, 1H), 3.52 (ddd, J = 9.6, 4.3, 2.8 Hz, 1H), 3.12 
(dd, J = 11.6, 4.3 Hz, 1H), 2.81 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 177.29, 
175.23, 148.21, 138.57, 137.51, 131.98, 129.16, 128.74, 126.41, 120.90, 114.89, 
81.30, 50.37, 43.39, 41.70, 39.46 ppm; FT‐IR: ṽ = 1709, 1493, 1369, 1319, 1177, 
1101 cm
-1
; HRMS: calc. for [M+H]
+ 
C18H16O2N2I: 419.02510, found: 419.02558. 
 
 
(3aR*,9bS*)-Methyl 
5-methyl-1,3-dioxo-2-phenyl-2,3,3a,4,5,9b-hexahydro-1H-pyrrolo[3,4-c]quinoline
-8-carboxylate (91g) 
The product was prepared according to the general procedure Q. Yield: 45%; Yellow 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 8.22 (d, J = 1.2 Hz, 1H), 7.91 (dd, J = 8.7, 1.9 Hz, 1H), 7.44 – 7.41 
(m, 2H), 7.37 – 7.34 (m, 1H), 7.27 – 7.25 (m, 2H), 6.74 (d, J = 8.7 Hz, 1H), 4.19 (d, J 
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= 9.6 Hz, 1H), 3.88 (s, 3H), 3.68 (dd, J = 11.7, 2.9 Hz, 1H), 3.58 (ddd, J = 9.6, 4.3, 
2.9 Hz, 1H), 3.25 (dd, J = 11.7, 4.3 Hz, 1H), 2.93 (s, 3H) ppm; 
13
C NMR (126 MHz, 
CDCl3) δ 177.16, 175.35, 166.98, 151.81, 132.06, 131.97, 130.84, 129.15, 128.73, 
126.38, 120.98, 117.43, 112.13, 51.92, 49.83, 43.20, 41.82, 39.52 ppm; FT‐IR: ṽ = 
1706, 1607, 1498, 1374, 1275, 1177 cm
-1
; HRMS: calc. for [M+H]
+
 C20H19O4N2: 
351.13393, found: 351.13477. 
 
 
(3aR*,9bS*)-9-Methoxy-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-
c]quinoline-1,3(2H)-dione (91h) 
The product was prepared according to the general procedure Q. Yield: 56%; Brown 
amorphous solid ; TLC (20% EtOAc in petroleum ether): Rf = 0.25; [A-major 
product]-
1
H NMR (500 MHz, CDCl3) δ 7.44 – 7.41 (m, 2H), 7.36 – 7.33 (m, 1H), 
7.30 – 7.28 (m, 2H), 7.20 – 7.17 (m, 1H), 6.56 (d, J = 8.3 Hz, 1H), 6.42 (d, J = 8.2 Hz, 
1H), 4.78 (d, J = 9.9 Hz, 1H), 3.91 (s, 3H), 3.56 (dd, J = 11.4, 1.8 Hz, 1H), 3.49 (ddd, 
J = 9.9, 4.9, 1.8 Hz, 1H), 2.98 (dd, J = 11.4, 4.9 Hz, 1H), 2.80 (s, 3H) ppm; 
13
C NMR 
(126 MHz, CDCl3) δ 178.64, 175.51, 158.82, 151.01, 132.38, 129.07, 129.00, 128.54, 
126.61, 109.23, 105.93, 103.74, 56.36, 52.72, 44.34, 39.86, 36.82 ppm; FT‐IR: ṽ = 
1705, 1597, 1495, 1389, 1184, 1061 cm
-1
; HRMS: calc. for [M+H]
+
 C19H19O3N2: 
323.13902, found: 323.13990. 
 
 
(3aR*,9bS*)-7-Methoxy-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-
c]quinoline-1,3(2H)-dione (91h) 
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The product was prepared according to the general procedure Q. Yield: 35%; Brown 
amorphous solid ; TLC (25% EtOAc in petroleum ether): Rf = 0.25; [B-minor 
product]-
1
H NMR (500 MHz, CDCl3) δ 7.46 – 7.41 (m, 3H), 7.37 – 7.34 (m, 1H), 
7.27 – 7.26 (m, 2H), 6.48 – 6.46 (m, 1H), 6.31 (d, J = 2.3 Hz, 1H), 4.11 (d, J = 9.6 Hz, 
1H), 3.80 (s, 3H), 3.61 (dd, J = 11.5, 2.8 Hz, 1H), 3.52 (ddd, J = 9.6, 4.4, 2.8 Hz, 1H), 
3.14 (dd, J = 11.5, 4.4 Hz, 1H), 2.83 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 
177.75, 176.21, 160.43, 149.52, 132.17, 131.25, 129.14, 128.64, 126.51, 111.17, 
104.51, 99.91, 55.43 , 50.61, 43.32, 41.60, 39.69 ppm; HRMS: calc. for [M+H]
+
 
C19H19O3N2: 323.13902, found: 323.14017. 
 
 
(3aR*,9bS*)-9-Acetyl-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]
quinoline-1,3(2H)-dione (91i) 
The product was prepared according to the general procedure Q. Yield: 48%; Brown 
amorphous solid ; TLC (20% EtOAc in petroleum ether): Rf = 0.25; [A-major 
product]-
1
H NMR (500 MHz, CDCl3) δ 7.45 – 7.42 (m, 2H), 7.38 – 7.35 (m, 1H), 
7.31 – 7.25 (m, 3H), 7.17 (dd, J = 7.6, 0.8 Hz, 1H), 6.88 (d, J = 8.1 Hz, 1H), 5.57 (d, J 
= 9.9 Hz, 1H), 3.62 (dd, J = 11.5, 2.5 Hz, 1H), 3.56 (ddd, J = 9.9, 4.6, 2.5 Hz, 1H), 
3.18 (dd, J = 11.5, 4.6 Hz, 1H), 2.89 (s, 3H), 2.71 (s, 3H) ppm; 
13
C NMR (75 MHz, 
CDCl3) δ 204.82, 178.20, 176.07, 149.88, 141.26, 132.02, 129.23, 128.77, 128.10, 
126.51, 119.66, 116.80, 115.33, 51.04, 43.56, 40.05, 36.94, 30.46 ppm; FT‐IR: ṽ = 
1703, 1588, 1490, 1333, 1212, 1168 cm
-1
; HRMS: calc. for [M+H]
+ 
C20H19O3N2: 
335.13902, found: 335.14033.  
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(3aR*,9bS*)-7-Acetyl-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]
quinoline-1,3(2H)-dione (91i) 
The product was prepared according to the general procedure Q. Yield: 28%; Brown 
amorphous solid ; TLC (25% EtOAc in petroleum ether): Rf = 0.25; [B-minor 
product]-
1
H NMR (500 MHz, CDCl3) δ 7.62 (d, J = 7.9 Hz, 1H), 7.47 – 7.42 (m, 
3H), 7.38 – 7.34 (m, 2H), 7.26 – 7.25 (m, 2H), 4.22 (d, J = 9.6 Hz, 1H), 3.66 (dd, J = 
11.6, 2.7 Hz, 1H), 3.57 (ddd, J = 9.6, 4.4, 2.7 Hz, 1H), 3.16 (dd, J = 11.6, 4.4 Hz, 1H), 
2.92 (s, 3H), 2.59 (s, 3H) ppm; 
13
C NMR (75 MHz, CDCl3) δ 198.38, 177.42, 175.17, 
148.84, 137.51, 131.92, 130.60, 129.23, 128.84, 126.44, 123.86, 120.27, 111.64, 
50.65, 43.53, 42.41, 39.68, 26.88 ppm; FT‐IR: ṽ = 1699, 1500, 1391, 1282, 1170, 752, 
696 cm
-1
; HRMS: calc. for [M+H]
+
 C20H19O3N2: 335.13902, found: 335.13952. 
 
 
(3aR*,9bS*)-6-Benzyl-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]
quinoline-1,3(2H)-dione (91j) 
The product was prepared according to the general procedure Q. Yield: 51%; Light 
yellow amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR 
(500 MHz, CDCl3) δ 7.63 (d, J = 7.5 Hz, 1H), 7.48 – 7.46 (m, 2H), 7.41 – 7.38 (m, 
1H), 7.30 – 7.26 (m, 4H), 7.22 – 7.17 (m, 3H), 7.10 (t, J = 7.6 Hz, 1H), 7.03 (d, J = 
7.5 Hz, 1H), 4.22 (d, J = 9.0 Hz, 1H), 4.08 (s, 2H), 3.61 – 3.51 (m, 2H), 3.43 (dd, J = 
13.8, 6.6 Hz, 1H), 2.74 (s, 3H) ppm; 
13
C NMR (75 MHz, CDCl3) δ 177.94, 175.86, 
146.57, 141.14, 136.16, 132.07, 130.59, 129.33, 129.15, 129.03, 128.83, 128.53, 
126.39, 126.12, 124.55, 123.67, 51.49, 43.32, 41.63, 38.82, 36.32 ppm; FT‐IR: ṽ = 
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1707, 1496, 1378, 1174, 909 cm
-1
; HRMS: calc. for [M+H]
+
 C25H23O2N2: 383.17540, 
found: 383.17681. 
 
 
(3aR*,9bS*)-5-Methyl-2,6-diphenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quino
line-1,3(2H)-dione (91k) 
The product was prepared according to the general procedure Q. Yield: 63%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.70 (dd, J = 7.5, 1.0 Hz, 1H), 7.52 – 7.50 (m, 2H), 7.48 – 7.46 (m, 
2H), 7.42 – 7.37 (m, 3H), 7.35 – 7.27 (m, 3H), 7.22 – 7.15 (m, 2H), 4.22 (d, J = 8.5 
Hz, 1H), 3.57 – 3.49 (m, 2H), 3.46 – 3.42 (m, 1H), 2.38 (s, 3H) ppm; 13C NMR (126 
MHz, CDCl3) δ 177.69, 175.87, 145.90, 140.53, 135.71, 132.15, 131.06, 130.33, 
129.29, 128.95, 128.78, 128.44, 127.08, 126.44, 123.42, 122.80, 50.98, 42.36, 42.14, 
39.62 ppm; FT‐IR: ṽ = 1708, 1497, 1378, 1172, 908, 821 cm-1; HRMS: calc. for 
[M+H]
+
 C24H21O2N2: 369.15975, found: 369.16082. 
 
 
(3aR*,9bS*)-6-Benzoyl-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c
]quinoline-1,3(2H)-dione (91l) 
The product was prepared according to the general procedure Q. Yield: 45%; Yellow 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.82 – 7.80 (m, 2H), 7.77 (d, J = 7.6 Hz, 1H), 7.58 – 7.56 (m, 1H), 
7.48 – 7.42 (m, 4H), 7.41 – 7.38 (m, 1H), 7.29 – 7.24 (m, 3H), 7.05 (t, J = 7.6 Hz, 1H), 
4.23 (d, J = 9.2 Hz, 1H), 3.56 – 3.51 (m, 1H), 3.41 – 3.40 (m, 2H), 2.69 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 197.56, 177.28, 175.61, 146.85, 137.57, 133.32, 
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133.01, 132.02, 130.45, 130.09, 129.71, 129.31, 128.86, 128.51, 126.41, 121.84, 
120.95, 50.20, 44.05, 42.13, 41.52 ppm; FT‐IR: ṽ = 1709, 1497, 1375, 1174, 669 cm-1; 
HRMS: calc. for [M+H]
+
 C25H21O3N2: 397.15467, found: 397.15523. 
 
 
(3aR*,9bS*)-7,8,9-Trimethoxy-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrro
lo[3,4-c]quinoline-1,3(2H)-dione (91m) 
The product was prepared according to the general procedure Q. Yield: 93%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25;
 1
H NMR (500 
MHz, CDCl3) δ 7.45 – 7.42 (m, 2H), 7.37 – 7.34 (m, 1H), 7.30 – 7.28 (m, 2H), 6.11 
(s, 1H), 4.66 (d, J = 9.9 Hz, 1H), 4.11 (s, 3H), 3.87 (s, 3H), 3.82 (s, 3H), 3.53 (dd, J = 
11.4, 1.5 Hz, 1H), 3.47 (ddd, J = 9.9, 5.0, 1.5 Hz, 1H), 2.92 (dd, J = 11.4, 5.0 Hz, 1H), 
2.78 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 178.74, 175.99, 153.56, 153.00, 
146.59, 135.91, 132.33, 129.15, 128.63, 126.61, 106.62, 93.45, 61.76, 60.87, 56.20, 
53.33, 44.39, 39.74, 37.14 ppm; FT‐IR: ṽ = 1708, 1599, 1495, 1372, 1180, 1113, 
1029 cm
-1
; HRMS: calc. for [M+H]
+
 C21H23O5N2: 383.16015, found: 383.16114. 
 
 
(3aR*,9bS*)-5-Methyl-2-phenyl-7,9-bis(trifluoromethyl)-3a,4,5,9b-tetrahydro-1H
-pyrrolo[3,4-c]quinoline-1,3(2H)-dione (91n) 
The product was prepared according to the general procedure Q. Yield: 40%; Light 
yellow amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR 
(500 MHz, CDCl3) δ 7.55 (s, 1H), 7.47 – 7.44 (m, 2H), 7.40 – 7.37 (m, 1H), 7.30 – 
7.28 (m, 2H), 7.19 (s, 1H), 4.74 (d, J = 9.6 Hz, 1H), 3.66 – 3.62 (m, 2H), 3.04 (dd, J = 
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11.8, 5.9 Hz, 1H), 2.90 (s, 3H) ppm; 
13
C NMR (151 MHz, CDCl3) δ 177.66, 173.53, 
152.61, 134.35, 131.88, 131.63 (q, J = 31.1 Hz), 131.09 (q, J = 33.3 Hz), 129.28, 
129.01, 128.13, 126.40, 126.22, 124.27, 123.57 (q, J = 274.33), 123.50 (q, J = 273.1 ), 
119.97, 115.10 – 115.03 (m), 113.00 – 112.98 (m), 53.98, 46.01, 40.08 (d, J = 1.4 Hz), 
39.86 ppm; FT‐IR: ṽ = 1715, 1483, 1390, 1348, 1273, 1123, 1007 cm-1; HRMS: calc. 
for [M+H]
+
 C20H15O2N2F6: 429.10322, found: 429.10435. 
 
 
(3aR*,9bS*)-2,5-Diphenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quinoline-1,3(2
H)-dione (91o) 
The product was prepared according to the general procedure Q. Yield: 67%; Yellow 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.60 (d, J = 7.5 Hz, 1H), 7.43 – 7.40 (m, 2H), 7.37 – 7.32 (m, 3H), 
7.19 – 7.17 (m, 2H), 7.12 – 7.08 (m, 4H), 6.97 (ddd, J = 7.5, 7.5, 1.1 Hz, 1H), 6.78 – 
6.77 (m, 1H), 4.24 (d, J = 9.4 Hz, 1H), 4.20 (dd, J = 12.0, 3.1 Hz, 1H), 3.70 (dd, J = 
12.0, 4.5 Hz, 1H), 3.65 (ddd, J = 9.4, 4.5, 3.1 Hz, 1H) ppm; 
13
C NMR (126 MHz, 
CDCl3) δ 177.18, 175.73, 146.54, 146.33, 132.09, 130.87, 129.70, 129.19, 128.72, 
128.47, 126.48, 124.02, 123.10, 121.60, 120.68, 117.45, 48.54, 44.70, 42.54 ppm; 
FT‐IR: ṽ = 1705, 1592, 1491, 1390, 1181 cm-1; HRMS: calc. for [M+H]+ 
C23H19O2N2: 355.14410, found: 355.14520. 
 
 
(3aR*,9bS*)-5-Benzyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quinoline-
1,3(2H)-dione (91p) 
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The product was prepared according to the general procedure Q. Yield: 46%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.55 (d, J = 7.5 Hz, 1H), 7.46 (t, J = 7.7 Hz, 2H), 7.40 – 7.37 (m, 1H), 
7.31 – 7.23 (m, 7H), 7.16 – 7.13 (m, 1H), 6.89 (t, J = 7.5 Hz, 1H), 6.75 – 6.74 (m, 1H), 
4.48 (d, J = 15.3 Hz, 1H), 4.29 (d, J = 15.3 Hz, 1H), 4.20 (d, J = 9.5 Hz, 1H), 3.69 (dd, 
J = 11.7, 2.9 Hz, 1H), 3.56 (ddd, J = 9.5, 4.2, 2.9 Hz, 1H), 3.28 (dd, J = 11.7, 4.2 Hz, 
1H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 177.55, 175.89, 147.60, 137.80, 132.22, 
130.70, 129.22, 128.74, 128.70, 127.58, 127.48, 126.48, 119.93, 119.04, 113.66, 
55.59, 49.18, 44.25, 42.57 ppm; FT‐IR: ṽ = 1708, 1598, 1496, 1386, 1200 cm-1; 
HRMS: calc. for [M+H]
+
 C24H21O2N2 : 369.15975, found: 369.16074. 
 
 
(3aR*,9bS*)-5-Butyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quinoline-1
,3(2H)-dione (91q) 
The product was prepared according to the general procedure Q. Yield: 65%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.51 (d, J = 7.5 Hz, 1H), 7.44 – 7.41 (m, 2H), 7.37 – 7.34 (m, 1H), 
7.26 – 7.25 (m, 2H), 7.22 – 7.19 (m, 1H), 6.85 (ddd, J = 7.5, 7.5, 0.8 Hz, 1H), 6.76 – 
6.75 (m, 1H), 4.13 (d, J = 9.5 Hz, 1H), 3.66 (dd, J = 11.7, 2.9 Hz, 1H), 3.55 – 3.52 (m, 
1H), 3.31 – 3.25 (m, 1H), 3.19 (dd, J = 11.7, 4.3 Hz, 1H), 3.13 – 3.07 (m, 1H), 1.65 – 
1.50 (m, 2H), 1.36 (q, 7.4 Hz, 2H), 0.94 (t, J = 7.4 Hz, 3H) ppm; 
13
C NMR (126 
MHz, CDCl3) δ 177.85, 175.95, 147.66, 132.20, 130.82, 129.15, 128.69, 128.63, 
126.47, 119.15, 118.70, 112.72, 50.75, 48.46, 44.20, 42.50, 28.38, 20.50, 14.02 ppm; 
FT‐IR: ṽ = 1709, 1598, 1496, 1374, 1175 cm-1; HRMS: calc. for [M+H]+ 
C21H23O2N2: 335.17540, found: 335.17657. 
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(3aR*,9bS*)-5-Ethyl-4-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]q
uinoline-1,3(2H)-dione (91r) 
The product was prepared according to the general procedure Q. Yield: 18%; White 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; [A-minor 
product]-
1
H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 7.4 Hz, 1H), 7.45 – 7.42 (m, 
2H), 7.37 – 7.34 (m, 1H), 7.27 – 7.24 (m, 2H), 7.23 – 7.19 (m, 1H), 6.86 – 6.83 (m, 
1H), 6.73 – 6.72 (m, 1H), 4.18 – 4.12 (m, 2H), 3.43 – 3.34 (m, 2H), 3.03 – 2.96 (m, 
1H), 1.23 (t, J = 7.1 Hz, 3H), 1.11 (d, J = 6.7 Hz, 3H) ppm; 
13
C NMR (126 MHz, 
CDCl3) δ 177.64, 176.02, 144.39, 132.19, 130.17, 129.13, 129.02, 128.58, 126.44, 
118.87, 118.60, 113.54, 51.69, 50.14, 43.65, 41.28, 15.07, 13.46 ppm; FT‐IR: ṽ = 
1705, 1598, 1496, 1381, 1165 cm
-1
; HRMS: calc. for [M+H]
+
 C20H21O2N2: 
321.15975, found: 321.16133. 
 
 
(3aR*,9bS*)-5-Ethyl-4-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]q
uinoline-1,3(2H)-dione (91r) 
The product was prepared according to the general procedure Q. Yield: 45%; White  
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.2; [B-major 
product]-
1
H NMR (500 MHz, CDCl3) δ 7.48 (d, J = 7.4 Hz, 1H), 7.43 – 7.40 (m, 
2H), 7.36 – 7.33 (m, 1H), 7.26 – 7.23 (m, 2H), 7.21 – 7.18 (m, 1H), 6.84 – 6.81 (m, 
1H), 6.70 – 6.69 (m, 1H), 4.16 – 4.10 (m, 2H), 3.41 – 3.32 (m, 2H), 3.01 – 2.94 (m, 
1H), 1.21 (t, J = 7.1 Hz, 3H), 1.09 (d, J = 6.7 Hz, 3H) ppm; 
13
C NMR (126 MHz, 
CDCl3) δ 177.65, 176.02, 132.19, 130.16, 129.13, 129.01, 128.58, 126.44, 118.81, 
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118.58, 113.54, 51.69, 50.15, 43.68, 41.29, 15.07, 13.46 ppm; HRMS: calc. for 
[M+H]
+
 C20H21O2N2: 321.15975, found: 321.16136. 
 
 
(3aR*,3bS*,11bS*)-2-Phenyl-3a,3b,4,5,6,11b-hexahydro-1H-dipyrrolo[1,2-a:3',4'-
c]quinoline-1,3(2H)-dione (91s) 
The product was prepared according to the general procedure Q. Yield: 26%; White 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; [A-minor 
product]-
1
H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 7.7 Hz, 1H), 7.49 – 7.46 (m, 
2H), 7.41 – 7.38 (m, 1H), 7.31 – 7.29 (m, 2H), 7.26 – 7.23 (m, 1H), 6.90 (ddd, J = 7.6, 
7.6, 0.9 Hz,  1H), 6.69 – 6.68 (m, 1H), 4.13 (d, J = 8.1 Hz, 1H), 3.56 – 3.51 (m, 1H), 
3.20 – 3.10 (m, 2H), 2.97 – 2.92 (m, 1H), 2.47 – 2.43 (m, 1H), 2.20 – 2.16 (m, 1H), 
2.13 – 1.98 (m, 2H) ppm; 13C NMR (126 MHz, CDCl3) δ 175.90, 175.65, 144.81, 
132.03, 130.80, 129.30, 128.76, 128.70, 126.58, 118.43, 116.02, 112.86, 58.60, 47.25, 
46.09, 41.64, 31.44, 22.66 ppm; FT‐IR: ṽ = 1699, 1600, 1501, 1458, 1375, 1158 cm-1; 
HRMS: calc. for [M+H]
+
 C20H19O2N2: 319.14410; found: 319.14568. 
 
 
(3aR*,3bR*,11bS*)-2-Phenyl-3a,3b,4,5,6,11b-hexahydro-1H-dipyrrolo[1,2-a:3',4'-
c]quinoline-1,3(2H)-dione (91s) 
The product was prepared according to the general procedure Q. Yield: 52%; White 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.2; [B-major 
product]-
1
H NMR (500 MHz, CDCl3) δ 7.54 (d, J = 7.5 Hz, 1H), 7.42 – 7.39 (m, 
2H), 7.35 – 7.32 (m, 1H), 7.22 – 7.19 (m, 3H), 6.86 (ddd, J = 7.5, 7.5, 0.9 Hz, 1H), 
6.65 – 6.63 (m, 1H), 4.22 (d, J = 9.2 Hz, 1H), 3.65 (dd, J = 9.2, 3.9 Hz, 1H), 3.51 – 
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3.47 (m, 1H), 3.30 – 3.26 (m, 1H), 3.00 – 2.90 (m, 2H), 2.15 – 2.07 (m, 2H), 2.00 – 
1.94 (m, 1H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 176.14, 175.69, 147.86, 132.07, 
129.99, 129.05, 128.69, 128.54, 126.59, 119.20, 118.36, 112.83, 59.15, 48.04, 45.93, 
44.47, 26.45, 23.45 ppm; HRMS: calc. for [M+H]
+
 C20H19O2N2: 319.14410, found: 
319.14567. 
 
 
(3aS*,12aS*,12bR*)-2-Phenyl-9,10,11,12,12a,12b-hexahydropyrido[1,2-a]pyrrolo
[3,4-c]quinoline-1,3(2H,3aH)-dione and 
(3aS*,12aR*,12bR*)-2-phenyl-9,10,11,12,12a,12b-hexahydropyrido[1,2-a]pyrrolo
[3,4-c]quinoline-1,3(2H,3aH)-dione (91t)  
The product was prepared according to the general procedure Q. Yield: 73%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3, # denotes major signals, * denotes minor signals) δ 7.66 – 7.62#* (m), 
7.46 – 7.41#* (m), 7.39 – 7.34#* (m), 7.28 – 7.21 #* (m), 6.92 – 6.84#* (m), 4.12 – 
4.10#* (m), 3.96 – 3.94#* (m), 3.78 – 3.76* (m), 3.59 – 3.56# (m), 3.50 – 3.46# (m), 
3.24* (d, J = 6.4 Hz), 3.03* (t, J = 12.0 Hz), 2.83# (td, J = 12.9, 3.0 Hz), 2.11# (qd, J 
= 12.8, 3.9 Hz), 1.88 – 1.86#* (m), 1.76 – 1.62#* (m), 1.54 – 1.47#* (m) ppm; 13C 
NMR (126 MHz, CDCl3) δ major and minor isomers: 175.98, 175.80, 146.26, 
132.07, 131.98, 130.89, 130.38, 129.19, 129.12, 128.93, 128.66,128.61, 126.54, 
126.50, 119.20, 117.07, 114.11, 56.57, 56.33, 49.46, 44.89, 41.59, 40.30, 25.71, 24.69, 
22.53 , 20.90 ppm; FT‐IR: ṽ = 1705, 1598, 1494, 1376, 1137 cm-1; HRMS: calc. for 
[M+H]
+
 C21H21O2N2: 333.15975, found: 333.16138. 
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(3aR*,9bS*)-2,5-Dimethyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quinoline-1,3(2
H)-dione (91u): 
The product was prepared according to the general procedure Q. Yield: 62%; Light 
brown amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.4; 
1
H NMR 
(500 MHz, CDCl3) δ 7.49 – 7.47 (m, 1H), 7.23 – 7.19 (m, 1H), 6.89 (ddd, J = 7.5, 7.5, 
1.0 Hz, 1H), 6.71 – 6.69 (m, 1H), 4.00 (d, J = 9.4 Hz, 1H), 3.53 (dd, J = 11.5, 2.4 Hz, 
1H), 3.36 (ddd, J = 9.4, 4.3, 2.4 Hz, 1H), 3.04 (dd, J = 11.5, 4.3 Hz, 1H), 2.99 (s, 3H), 
2.80 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 178.85, 176.92, 148.50, 130.33, 
128.72, 119.78, 118.86, 112.63, 50.62, 43.72, 42.16, 39.54, 25.48 ppm; FT‐IR: ṽ = 
1693, 1435, 1314, 1095, 1020 cm
-1
; HRMS: calc. for [M+H]
+
 C13H15O2N2: 
231.11280, found: 231.11355. 
 
 
(3aR*,9bS*)-5-Methyl-2-propyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quinoline
-1,3(2H)-dione (91v) 
The product was prepared according to the general procedure Q. Yield: 66%; Brown 
amorphous solid; TLC (10% EtOAc in petroleum ether): Rf = 0.15; 
1
H NMR (500 
MHz, CDCl3) δ 7.48 – 7.46 (m, 1H), 7.22 – 7.19 (m, 1H), 6.90 – 6.87 (m, 1H), 6.71 – 
6.69 (m, 1H), 3.97 (d, J = 9.4 Hz, 1H), 3.51 – 3.42 (m, 3H), 3.35 (ddd, J = 9.3, 4.4, 
2.7 Hz, 1H), 3.03 (dd, J = 11.5, 4.4 Hz, 1H), 2.80 (s, 3H), 1.60 – 1.52 (m, 2H), 0.82 (t, 
J = 7.5 Hz, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 178.86, 176.90, 148.56, 130.34, 
128.64, 119.75, 119.13, 112.54, 50.90, 43.65, 42.14, 40.95, 39.47, 21.00, 11.13 ppm; 
FT‐IR: ṽ = 1696, 1498, 1400, 1324, 1201, 1122, 1094, 1043 cm-1; HRMS: calc. for 
[M+H]
+
 C15H19O2N2: 259.14410, found: 259.14461. 
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(3aR*,9bS*)-2-Cyclohexyl-5-methyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quino
line-1,3(2H)-dione (91w): 
The product was prepared according to the general procedure Q. Yield: 87%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.48 – 7.46 (m, 1H), 7.22 – 7.18 (m, 1H), 6.90 – 6.87 (m, 1H), 6.71 – 
6.69 (m, 1H), 3.97 – 3.89 (m, 2H), 3.45 (dd, J = 11.4, 2.9 Hz, 1H), 3.28 (ddd, J = 9.3, 
4.6, 2.9 Hz, 1H), 3.03 (dd, J = 11.4, 4.6 Hz, 1H), 2.79 (s, 3H), 2.17 – 2.02 (m, 2H), 
1.79 – 1.76 (m, 2H), 1.63 – 1.61 (m, 1H), 1.56 – 1.51 (m, 2H), 1.32 – 1.25 (m, 2H), 
1.23 – 1.14 (m, 1H) ppm; 13C NMR (126 MHz, CDCl3) δ 178.82, 176.96, 148.52, 
130.34, 128.56, 119.61, 119.17, 112.50, 52.33, 50.97, 43.21, 41.88, 39.52, 29.00, 
28.89, 25.96, 25.91, 25.19 ppm; FT‐IR: ṽ = 2929, 1695, 1601, 1498, 1450, 1366, 
1184, 1132 cm
-1
; HRMS: calc. for [M+H]
+
 C18H23O2N2: 299.17540, found: 
299.17594. 
 
 
(3aR*,9bS*)-2-(4-Bromophenyl)-5-methyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c
]quinoline-1,3(2H)-dione (91x):  
The product was prepared according to the general procedure Q. Yield: 68%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.56 – 7.51 (m, 3H), 7.26 – 7.22 (m, 1H), 7.20 – 7.18 (m, 2H), 6.91 
(ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.75 – 6.74 (m, 1H), 4.15 (d, J = 9.6 Hz, 1H), 3.60 (dd, 
J = 11.5, 2.6 Hz, 1H), 3.53 (ddd, J = 9.6, 4.4, 2.6 Hz, 1H), 3.11 (dd, J = 11.5, 4.4 Hz, 
1H), 2.84 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 177.47, 175.55, 148.61, 
132.28, 131.12, 130.43, 128.92, 127.98, 122.42, 119.89, 118.47, 112.74, 50.75, 43.75, 
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42.27, 39.57 ppm; FT‐IR: ṽ = 1710, 1488, 1396, 1198, 812 cm-1; HRMS: calc. for 
[M+H]
+
 C18H16O2N2
79
Br: 371.03897, found: 371.03996; HRMS: calc. for [M+H]
+
 
C18H16O2N2
81
Br: 373.03692, found: 373.03747.  
 
 
(3aR*,9bR*)-3a,5-Dimethyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]qui
noline-1,3(2H)-dione (91y): 
The product was prepared according to the general procedure Q. Yield: 11%; Yellow 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; [A-minor 
product]-
1
H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 7.5 Hz, 1H), 7.44 – 7.41 (m, 2H), 
7.37 – 7.34 (m, 1H), 7.27 – 7.22 (m, 3H), 6.91 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.76 – 
6.75 (m, 1H), 3.74 (s, 1H), 3.51 (d, J = 11.3 Hz, 1H), 2.84 (s, 3H), 2.83 (d, J = 11.3 Hz, 
1H), 1.51 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 180.82, 175.27, 147.98, 132.21, 
130.57, 129.11, 128.83, 128.60, 126.49, 119.76, 119.07, 112.54, 58.05, 50.26, 47.91, 
39.46, 22.51 ppm; FT‐IR: ṽ = 1707, 1603, 1495, 1392, 1337, 1208, 1130 cm-1; HRMS: 
calc. for [M+H]
+
 C19H19O2N2: 307.14410, found: 307.14471. 
 
 
(3aR*,9bS*)-5,9b-Dimethyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quin
oline-1,3(2H)-dione (91y) 
The product was prepared according to the general procedure Q. Yield: 34%; Yellow 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.2; [B-major 
product]-
1
H NMR (500 MHz, CDCl3) δ 7.65 (dd, J = 7.8, 1.4 Hz, 1H), 7.41 – 7.38 
(m, 2H), 7.34 – 7.31 (m, 1H), 7.23 – 7.18 (m, 3H), 6.87 – 6.83 (m, 1H), 6.70 – 6.68 
(m, 1H), 3.71 (dd, J = 11.7, 2.9 Hz, 1H), 3.21 (dd, J = 11.7, 3.6 Hz, 1H), 3.12 – 3.11 
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(m, 1H), 2.90 (s, 3H), 1.83 (s, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 179.20, 
176.15, 146.88, 132.19, 129.05, 128.97, 128.90, 128.48, 126.38, 122.33, 119.00, 
112.35, 50.83, 47.59, 44.46, 39.65, 26.56 ppm; FT‐IR: ṽ = 1707, 1603, 1495, 1392, 
1337, 1208, 1130. 
 
 
(3aR*,9bS*)-5-Methyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quinoline-1,3(2H)-
dione (91z) 
The product was prepared according to the general procedure Q. Yield: 78%; Light 
brown amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR 
(300 MHz, CD3CN) δ 8.99 (brs, 1H), 7.35 – 7.32 (m, 1H), 7.22 – 7.16 (m, 1H), 6.84 
(ddd, J = 7.5, 7.5, 1.1 Hz, 1H), 6.77 – 6.74 (m, 1H), 4.00 (d, J = 9.5 Hz, 1H), 3.44 – 
3.37 (m, 2H), 2.90 (dd, J = 11.5, 4.5 Hz, 1H), 2.76 (s, 3H) ppm; 
13
C NMR (75 MHz, 
CD3CN) δ 180.38, 178.37, 149.92, 131.08, 129.22, 120.75, 120.09, 113.44, 51.59, 
45.57, 44.14, 39.81 ppm; FT‐IR: ṽ = 3179, 1768, 1700, 1497, 1308, 1176, 1042 cm-1; 
HRMS: calc. for [M+H]
+
 C12H13O2N2: 217.09715, found: 217.09746. 
 
 
(3R*,4R*)-Diethyl 1-methyl-1,2,3,4-tetrahydroquinoline-3,4-dicarboxylate 
(91ab): 
The product was prepared according to the general procedure Q. Yield: 60%; Light 
green amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 
MHz, CDCl3) δ 7.22 (d, J = 7.6 Hz, 1H), 7.16 – 7.12 (m, 1H), 6.70 – 6.64 (m, 2H), 
4.23 – 4.12 (m, 5H), 3.56 – 3.51 (m, 1H), 3.43 – 3.37 (m, 2H), 2.92 (s, 3H), 1.29 (t, J 
= 7.1 Hz, 3H), 1.23 (t, J = 7.1 Hz, 3H) ppm; 
13
C NMR (151 MHz, CDCl3) δ 173.19, 
172.09, 145.61, 129.16, 128.51, 118.14, 117.57, 112.22, 61.36, 61.24, 50.37, 44.82, 
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41.18, 39.60, 14.32, 14.27 ppm; FT‐IR: ṽ = 2980, 1728, 1602, 1504, 1181, 1025 cm-1; 
HRMS: calc. for [M+H]
+
 C16H22O4N: 292.15433, found: 292.15505. 
 
5.4.3 Synthesis of Analogues 91ad–91an 
General Procedure R for the Synthesis of Compounds 91ad–91ah, 91an: 
To a screw-capped vial maleimides (0.1 mmol, 1 equiv), tertiary anilines (0.2 mmol, 2 
equiv), tetrabutyl ammonium iodides 3.69 mg (TBAI, 10 mol%), TBHP 55 µL (70% 
in H2O, 0.4 mmol, 4 equiv) and DCE (1.0 mL) were added. The reaction mixture was 
heated to 70 
o
C. The progress of the reaction was monitored by thin layer 
chromatography (ethyl acetate/petroleum ether mixture) and GC-MS. Upon 
completion, the crude reaction mixture was concentrated under vacuum and 
subsequently purified by flash column chromatography over silica gel using 
petroleum ether/ethyl acetate as an eluent system. 
 
Characterization of Compounds 91ad–91ah, 91an: 
 
 
(3aR*,9bS*)-2-(4-Bromophenyl)-5-methyl-6-phenyl-3a,4,5,9b-tetrahydro-1H-pyr
rolo[3,4-c]quinoline-1,3(2H)-dione (91ad): 
The product was prepared according to the general procedure R. Yield: 65%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.67 (dd, J = 7.5, 0.9 Hz, 1H), 7.60 – 7.58 (m, 2H), 7.51 – 7.49 (m, 
2H), 7.40 (t, J = 7.5 Hz, 2H), 7.32 (t, J = 7.4 Hz, 1H), 7.22 – 7.15 (m, 4H), 4.21 (d, J 
= 8.5 Hz, 1H), 3.56 – 3.48 (m, 2H), 3.45 – 3.40 (m, 1H), 2.37 (s, 3H); 13C NMR (126 
MHz, CDCl3) δ 177.34, 175.55, 145.84, 140.45, 135.74, 132.48, 131.17, 131.12, 
130.26, 128.93, 128.45, 127.90, 127.12, 123.47, 122.62, 122.52, 50.95, 42.36, 42.13, 
39.63. 
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(3aR*,9bS*)-2-Cyclohexyl-5-methyl-6-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,
4-c]quinoline-1,3(2H)-dione (91ae): 
The product was prepared according to the general procedure R. Yield: 75%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.62 (dd, J = 7.4, 1.1 Hz, 1H), 7.49 – 7.47 (m, 2H), 7.38 (t, J = 7.5 
Hz, 2H), 7.30 (t, J = 7.4 Hz, 1H), 7.18 – 7.12 (m, 2H), 4.01 – 3.94 (m, 2H), 4.05 – 
3.40 (m, 1H), 3.28 – 3.23 (m, 2H), 2.29 (s, 3H), 2.19 – 2.07 (m, 2H), 1.81 (d, J = 12.9 
Hz, 2H), 1.65 (d, J = 12.4 Hz, 1H), 1.56 (d, J = 12.3 Hz, 2H), 1.34 – 1.16 (m, 3H). 
 
 
(3aR*,9bS*)-2,5-Dimethyl-6-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quino
line-1,3(2H)-dione (91af): 
The product was prepared according to the general procedure R. Yield: 73%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.67 – 7.65 (m, 1H), 7.48 – 7.46 (m, 2H), 7.40 – 7.37 (m, 2H), 7.32 – 
7.29 (m, 1H), 7.18 – 7.12 (m, 2H), 4.03 (d, J = 8.5 Hz, 1H), 3.45 (dd, J = 13.1, 4.6 Hz, 
1H), 3.37 – 3.28 (m, 2H), 3.02 (s, 3H), 2.30 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 
178.80, 176.99, 145.83, 140.59, 135.55, 130.96, 130.10, 128.92, 128.40, 127.02, 
123.24, 122.94, 50.69, 42.14, 42.00, 39.70, 25.51. 
 
 
(3aR*,9bS*)-5-Methyl-6-phenyl-2-propyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]
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quinoline-1,3(2H)-dione (91ag): 
The product was prepared according to the general procedure R. Yield: 77%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.67 – 7.65 (m, 1H), 7.48 (dd, J = 8.0, 1.0 Hz, 2H), 7.40 – 7.37 (m, 
2H), 7.32 – 7.29 (m, 1H), 7.18 – 7.12 (m, 2H), 4.01 (d, J = 8.6 Hz, 1H), 3.51 – 3.44 (m, 
3H), 3.34 – 3.30 (m, 1H), 3.27 – 3.23 (m, 1H), 2.30 (s, 3H), 1.63 – 1.56 (m, 2H), 0.88 (t, 
J = 7.4 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 178.72, 176.92, 145.84, 140.64, 
135.50, 130.91, 130.17, 128.94, 128.39, 127.00, 123.20, 122.99, 50.96, 42.18, 41.89, 
40.91, 39.34, 21.04, 11.40. 
 
 
(3aR*,9bS*)-5-Methyl-6-phenyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]quinoline
-1,3(2H)-dione (91ah): 
The product was prepared according to the general procedure R. Yield: 65%; Light 
brown amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR 
(500 MHz, CDCl3) δ 8.07 (brs, 1H), 7.61 (dd, J = 7.6, 0.9 Hz, 1H), 7.48 (dd, J = 8.0, 
1.0 Hz, 2H), 7.40 – 7.37 (m, 2H), 7.33 – 7.30 (m, 1H), 7.18 (dd, J = 7.5, 1.5 Hz, 1H), 
7.13 (t, J = 7.6 Hz, 1H), 4.09 (d, J = 8.3 Hz, 1H), 3.46 (dd, J = 12.8, 4.2 Hz, 1H), 3.39 – 
3.30 (m, 2H), 2.34 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 178.32, 176.65, 145.80, 
140.57, 135.59, 131.10, 130.01, 128.92, 128.43, 127.07, 123.22, 122.34, 50.77, 43.18, 
42.16, 40.46. 
 
 
Diethyl 
(3S*,4S*)-1-methyl-8-phenyl-1,2,3,4-tetrahydroquinoline-3,4-dicarboxylate 
(91an) 
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The product was prepared according to the general procedure R. Yield: 71%; Light 
green amorphous solid; TLC (2% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR (500 
MHz, CDCl3) δ 7.51 (dd, J = 8.1, 1.0 Hz, 2H), 7.40 – 7.37 (m, 2H), 7.31 – 7.27 (m, 
2H), 7.12 – 7.11 (m, 1H), 6.98 (t, J = 7.6 Hz, 1H), 4.31 – 4.17 (m, 5H), 3.42 – 3.35 (m, 
2H), 3.28 – 3.23 (m, 1H), 2.39 (s, 3H), 1.33 (t, J = 7.1 Hz, 3H), 1.27 (t, J = 7.1 Hz, 3H); 
13
C NMR (126 MHz, CDCl3) δ 173.53, 172.94, 145.60, 141.46, 134.77, 131.04, 
128.80, 128.47, 127.65, 126.79, 124.29, 121.97, 61.47, 61.21, 51.96, 46.38, 43.10, 
37.95, 14.37, 14.32. 
 
General Procedure S for the Synthesis of Compounds 91ai–91am: 
First step:
[126]
 
To a stirred solution of phenylboronic acid (0.86 mmol) in EtOH (5mL) was added 
anilines (0.71 mmol), K2CO3 (1.78 mmol), Pd(PPh3)4 (10% mmol). The reaction was 
refluxed for 24 h under argon atmosphere before EtOH was removed by rotary 
evaporation. The remained mixture was extracted with EtOAc, and the combined 
organic layers were washed with H2O and brine, dried over anhydrous Na2SO4, 
evaporated under vacuum. The product was purified by normal silica gel column with 
petroleum ether (40-60°C)/EtOAc mixture. 
Second step: 
To a solution of 2-phenyl anilines (0.8 mmol) in glacial acetic acid (2.5 mL) under 
inert atmosphere was added paraformaldehyde (10 mmol) and sodium 
cyanoborohydride (3.5 mmol). The addition of sodium cyanoborohydride resulted in 
bubbling. After stirring overnight, the reaction mixture was poured into a water/ice 
mixture (10 mL) containing NaOH (4 g). The addition was exothermic, and more ice 
was added to bring the total volume of the quench mixture to 30 mL. The mixture, 
which had pH 14, was extracted with dichloromethane. The combined organic layers 
were dried with anhydrous Na2SO4, filtered, and concentrated under vacuum. The 
residue was then purified by flash chromatography over silica gel. 
Third step: 
To a screw-capped vial maleimides (0.1 mmol, 1 equiv), 2-phenyl tertiary anilines 
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(0.2 mmol, 2 equiv), tetrabutyl ammonium iodides 3.69 mg (TBAI, 10 mol%), TBHP 
55 µL (70% in H2O, 0.4 mmol, 4 equiv) and DCE (1.0 mL) were added. The reaction 
mixture was heated to 70 
o
C. The progress of the reaction was monitored by thin layer 
chromatography (ethyl acetate/petroleum ether mixture) and GC-MS. Upon 
completion, the crude reaction mixture was concentrated under vacuum and 
subsequently purified by flash column chromatography over silica gel using 
petroleum ether/ethyl acetate as an eluent system. 
 
Characterization of Compounds 91ai–91am: 
 
 
(3aR*,9bS*)-6-(4-Acetylphenyl)-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyrr
olo[3,4-c]quinoline-1,3(2H)-dione (91ai): 
The product was prepared according to the general procedure S. Yield: 21%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.20; 
1
H NMR (500 
MHz, CDCl3) δ 8.01 – 7.99 (m, 2H), 7.73 (ddd, J = 7.1, 2.1, 0.7 Hz, 1H), 7.64 – 7.61 
(m, 2H), 7.48 – 7.44 (m, 2H), 7.41 – 7.37 (m, 1H), 7.29 – 7.27 (m, 2H), 7.22 – 7.17 (m, 
2H), 4.23 (d, J = 8.6 Hz, 1H), 3.58 – 3.50 (m, 2H), 3.47 – 3.43 (m, 1H), 2.64 (s, 3H), 
2.38 (s, 3H); 
13
C NMR (126 MHz, CDCl3) δ 197.96, 177.52, 175.72, 145.92, 145.59, 
135.83, 134.47, 132.06, 131.11, 130.86, 129.33, 129.13, 128.85, 128.62, 126.40, 
123.65, 123.09, 50.79, 42.70, 42.02, 39.46, 26.77. 
 
 
(3aR*,9bS*)-6-(4-acetylphenyl)-5-methyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c]
quinoline-1,3(2H)-dione (91aj): 
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The product was prepared according to the general procedure S. Yield: 25%; Light 
brown amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR 
(500 MHz, CDCl3) δ 8.11 (brs, 1H), 8.00 – 7.99 (m, 1H), 7.98 – 7.98 (m, 1H), 7.65 
(ddd, J = 7.3, 2.0, 0.8 Hz, 1H), 7.61 – 7.58 (m, 2H), 7.20 – 7.14 (m, 2H), 4.10 (d, J = 8.4 
Hz, 1H), 3.46 (dd, J = 12.9, 4.5 Hz, 1H), 3.40 – 3.31 (m, 2H), 2.63 (s, 3H), 2.33 (s, 3H). 
 
 
(3aR*,9bS*)-6-(4-Fluorophenyl)-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyr
rolo[3,4-c]quinoline-1,3(2H)-dione (91ak): 
The product was prepared according to the general procedure S. Yield: 23%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.20; 
1
H NMR (500 
MHz, CDCl3) δ 7.69 (ddd, J = 6.4, 2.9, 0.7 Hz, 1H), 7.51 – 7.44 (m, 4H), 7.40 – 7.35 
(m, 1H), 7.29 – 7.27 (m, 2H), 7.19 – 7.15 (m, 2H), 7.12 – 7.07 (m, 2H), 4.22 (d, J = 8.8 
Hz, 1H), 3.56 – 3.49 (m, 2H), 3.46 – 3.41 (m, 1H), 2.38 (s, 3H); 13C NMR (126 MHz, 
CDCl3) δ 177.68, 175.83, 162.10 (d, J = 246.1 Hz), 145.84, 136.23 (d, J = 3.4 Hz), 
134.80, 132.00, 130.89, 130.55, 130.47 (d, J = 4.7 Hz), 129.33, 128.84, 126.40, 
123.64, 122.97, 115.36 (d, J = 21.2 Hz), 50.90, 42.26, 42.00, 39.32. 
 
 
(3aR*,9bS*)-6-(3-Fluorophenyl)-5-methyl-2-phenyl-3a,4,5,9b-tetrahydro-1H-pyr
rolo[3,4-c]quinoline-1,3(2H)-dione (91al): 
The product was prepared according to the general procedure S. Yield: 21%; Brown 
amorphous solid; TLC (20% EtOAc in petroleum ether): Rf = 0.20; 
1
H NMR (500 
MHz, CDCl3) δ 7.71 (ddd, J = 7.3, 2.0, 0.7 Hz, 1H), 7.49 – 7.44 (m, 2H), 7.40 – 7.34 
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(m, 3H), 7.29 – 7.25 (m, 3H), 7.21 – 7.15 (m, 2H), 7.04 – 7.00 (m, 1H), 4.22 (d, J = 8.6 
Hz, 1H), 3.57 – 3.49 (m, 2H), 3.47 – 3.42 (m, 1H), 2.41 (s, 3H). 
 
 
(3aR*,9bS*)-6-(4-Fluorophenyl)-5-methyl-3a,4,5,9b-tetrahydro-1H-pyrrolo[3,4-c
]quinoline-1,3(2H)-dione (91am): 
The product was prepared according to the general procedure S. Yield: 26%; Light 
brown amorphous solid; TLC (25% EtOAc in petroleum ether): Rf = 0.1; 
1
H NMR 
(500 MHz, CDCl3) δ 8.05 (brs, 1H), 7.61 (ddd, J = 6.7, 2.6, 0.8 Hz, 1H), 7.47 – 7.44 
(m, 2H), 7.16 – 7.12 (m, 2H), 7.09 – 7.06 (m, 2H), 4.09 (d, J = 8.6 Hz, 1H), 3.45 (dd, 
J = 13.1, 4.7 Hz, 1H), 3.39 – 3.35 (m, 1H), 3.33 – 3.29 (m, 1H), 2.33 (s, 3H). 
 
5.5 Experimental Part for 3.2.2 
 
5.5.1 Synthesis of Compounds 92 
Procedure for the Synthesis of Compound 92a: 
3-Amino-2-chloro-pyridines (2.33 mmol) was dissolved in a 10 mL microwave tube 
with 2.5 mL pyridines. The reaction proceeded in microwave with 150 W at 200 
o
C. 
The starting materials completed, after 35 min. The reaction mixture was quenched at 
room temperature with saturated NH4Cl solution. Then it was extracted with EtOAc, 
washed with water, brine and dried over anhydrous MgSO4. The organic extracts were 
concentrated under vacuum and purified by normal silica gel column chromatography. 
 
Characterization of Compound 92a: 
 
2-(Piperidin-1-yl)pyridin-3-amine (92a):
[112]
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The product was prepared according to the general procedure. Yield: 75%; White 
amorphous solid; TLC (2% methanol in dichloromethane): Rf = 0.2; 
1
H NMR (500 
MHz, CDCl3) δ 7.78 (dd, J = 4.8, 1.6 Hz, 1H), 6.91 (dd, J = 7.7, 1.6 Hz, 1H), 6.79 (dd, 
J = 7.7, 4.8 Hz, 1H), 3.80 (brs, 2H), 3.04 – 3.02 (m, 4H), 1.72 – 1.67 (m, 4H), 1.62 – 
1.57 (m, 2H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 152.32, 137.56, 135.73, 121.36, 
119.30, 50.25, 26.58, 24.60 ppm. 
 
General Procedure T for the Synthesis of Compounds 92b, 92c, 92e, 92f:
[115]
 
First Step: 
2-Chloro-3-nitropyridine (6.31 mmol), Et3N (12.61 mmol) and amine (7.57 mmol) 
were dissolved in n-BuOH (25 mL). After refluxing for 3 h, the starting materials 
completed. The solvent was removed under vacuum, and the residue was partitioned 
between water and EtOAc. The organic layer was washed with saturated NaHCO3 and 
brine, dried over anhydrous Na2SO4 and concentrated under vacuum. The product was 
used for the second step without purification. 
Second Step: 
To a solution of nitropyridines (6.3 mmol) in ethanol (10 mL) was added 10% 
palladium on charcoal catalyst (10% w/w). The suspension was hydrogenated at room 
temperature overnight. The Pd/C was removed by filtration through a pad of celite, 
and the extracts were concentrated under vacuum. The product was purified by 
column chromatography on silica gel. 
 
Characterization of Compound 92b, 92c, 92e, 92f: 
 
 
N
2
,N
2
-Diethylpyridine-2,3-diamine (92b): 
The product was prepared according to the general procedure T. Yield: 46%; Dark red 
liquid; TLC (2% methanol in dichloromethane): Rf = 0.2; 
1
H NMR (500 MHz, 
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CDCl3) δ 7.82 – 7.80 (m, 1H), 6.94 – 6.92 (m, 1H), 6.81 (dd, J = 7.6, 4.8 Hz, 1H), 
3.88 (brs, 2H), 3.11 (q, J = 7.1 Hz, 4H), 1.02 (t, J = 7.1 Hz, 6H) ppm; 
13
C NMR (126 
MHz, CDCl3) δ 150.74, 137.73, 137.53, 121.50, 119.60, 45.18, 13.14; FT‐IR: ṽ = 
2970, 2360, 1603, 1444, 1382, 1305, 1243, 1131 cm
-1
; HRMS: calc. for [M+H]
+
 
C9H16N3:166.13387, found: 166.13415. 
 
 
N
2
-Benzylpyridine-2,3-diamine (92c):
[144]
 
The product was prepared according to the general procedure T. Yield: 58%; Pink 
amorphous solid; TLC (2% methanol in dichloromethane): Rf = 0.25; 
1
H NMR (500 
MHz, CDCl3) δ 7.77 (d, J = 4.0 Hz, 1H), 7.41 (d, J = 7.4 Hz, 2H), 7.34 (t, J = 7.4 Hz, 
2H), 7.29 (d, J = 7.3 Hz, 1H), 6.88 (dd, J = 7.4, 1.5 Hz, 1H), 6.57 (dd, J = 7.4, 5.2 Hz, 
1H), 4.65 (d, J = 3.6 Hz, 2H), 4.59 (brs, 1H), 3.27 (brs, 2H) ppm; 
13
C NMR (126 
MHz, CDCl3) δ 150.14, 139.93, 139.02, 128.61, 128.51, 128.11, 127.24, 122.04, 
113.78, 46.12 ppm. 
 
 
N
2
-Propylpyridine-2,3-diamine (92e):
[145]
 
The product was prepared according to the general procedure T. Yield: 60%; Black 
amorphous solid; TLC (2% methanol in dichloromethane): Rf = 0.2; 
1
H NMR (500 
MHz, CDCl3) δ 7.75 (dd, J = 5.2, 1.4 Hz, 1H), 6.84 (dd, J = 7.4, 1.4 Hz, 1H), 6.50 (dd, 
J = 7.4, 5.2 Hz, 1H), 4.21 (brs, 1H), 3.40 (t, J = 7.1 Hz, 2H), 3.19 (brs, 2H), 1.72 – 1.64 
(m, 2H), 1.01 (t, J = 7.4 Hz, 3H) ppm; 
13
C NMR (126 MHz, CDCl3) δ 150.76, 139.19, 
128.35, 122.09, 113.17, 43.85, 23.18, 11.83 ppm. 
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N
2
-Hexylpyridine-2,3-diamine (92f): 
The product was prepared according to the general procedure T. Yield: 56%; Black 
liquid; TLC (2% methanol in dichloromethane): Rf = 0.25; 
1
H NMR (400 MHz, 
CDCl3) δ 7.75 (dd, J = 5.1, 1.5 Hz, 1H), 6.84 (dd, J = 7.4, 1.5 Hz, 1H), 6.50 (dd, J = 7.4, 
5.1 Hz, 1H), 4.18 (brs, 1H), 3.42 (t, J = 7.3 Hz, 2H), 3.20 (brs, 2H), 1.68 – 1.61 (m, 2H), 
1.45 – 1.38 (m, 2H), 1.36 – 1.29 (m, 4H), 0.90 – 0.87 (m, 3H) ppm; 13C NMR (101 
MHz, CDCl3) δ 150.75, 139.14, 128.37, 122.03, 113.16, 42.11, 31.82, 29.95, 27.05, 
22.77, 14.20 ppm; FT‐IR: ṽ = 2923, 2855, 2360, 2341, 1601, 1504, 1463, 1255 cm-1; 
HRMS: calc. for [M+H]
+
 C11H20N3: 194.16517, found: 194.16531. 
 
Procedure for the Synthesis of Compound 92d:
 
First Step:
[115]
 
2-Chloro-3-nitropyridines (6.31 mmol), Et3N (12.61 mmol) and benzylamines (7.57 
mmol) were dissolved in n-BuOH (25 mL). After refluxing for 3 h, the starting 
materials completed. The solvent was removed under vacuum, and the residue was 
partitioned between water and EtOAc. The organic layer was washed with saturated 
NaHCO3 and brine, dried over anhydrous Na2SO4, and concentrated under vacuum. 
The product was used for the next step without purification. 
Second Step:
[117]
 
To a solution of 2-benzylamino-3-nitropyridines (6.31 mmol) in 10 mL DMF was 
added NaH (60% in mineral oil, 7.57 mmol) and MeI (6.94 mmol) at 0 
o
C. Then it 
was heated up to 60 
o
C for 12 h. After the reaction cooled to room temperature, a 
saturated solution of NH4Cl was carefully added, and the resulting mixture was 
extracted three times with EtOAc. The combined organic layers were washed with 
water and brine, dried over anhydrous MgSO4, and the solvent evaporated under 
vacuum. The product was purified by column chromatography on silica gel. 
Third Step:
[115]
 
To a solution of nitropyridines (6.3 mmol) in ethanol (10 mL) was added 10% 
palladium on charcoal catalyst (10% w/w). The suspension was hydrogenated at room 
temperature overnight. The Pd/C was removed by filtration through a pad of celite 
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and concentrated under vacuum. The product was purified by column 
chromatography on silica gel. 
 
Characterization of Compound 92d: 
 
 
N
2
-Benzyl-N
2
-methylpyridine-2,3-diamine (92d): 
Yield: 32%; Brown liquid; TLC (2% methanol in dichloromethane): Rf = 0.25; 
1
H 
NMR (400 MHz, CDCl3) δ 7.82 (dd, J = 4.8, 1.6 Hz, 1H), 7.38 – 7.31 (m, 4H), 7.28 
– 7.24 (m, 1H), 6.96 (dd, J = 7.7, 1.6 Hz, 1H), 6.85 (dd, J = 7.7, 4.8 Hz, 1H), 4.24 (s, 
2H), 3.87 (brs, 2H), 2.70 (s, 3H) ppm; 
13
C NMR (101 MHz, CDCl3) δ 151.90, 139.06, 
137.42, 135.79, 128.54, 128.34, 127.16, 121.86, 119.56, 57.31, 38.51 ppm; FT‐IR: ṽ 
= 2360, 1604, 1584, 1494, 1449, 1361, 1234, 1107 cm
-1
; HRMS: calc. for [M+H]
+
 
C13H16N3: 214.13387, found: 214.13437. 
 
5.5.2 Synthesis of Compound 127 
 
 
Procedure for the Synthesis of Compound 127:
[146]
 
To a suspension of TEMPO (11.39 mmol) in H2O (32 mL, 2 M) was dropwise added 
42% HBF4 (1.75 mL) over 1 h at room temperature. After the solution turned to 
amber color, NaOCl (11-14%, 3.9 mL) was added over 1 h at 0 °C and stirred for an 
additional 1 h at 0°C. The reaction mixture was filtered, and the yellow crystalline 
precipitate was washed with ice-cold 5% NaHCO3 (4 mL), water (8 mL) and ice-cold 
Et2O (80 mL). The solid was dried over 24 h at 50 °C under vacuum to yield T
+
BF4
-
 
127 as the bright yellow solid in 75% yield . 
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5.5.3 Synthesis of Imidazo[4,5-b]pyridines 93 
General Procedure U for the Synthesis of Compounds 93: 
To a solution of 92 (0.2 mmol) in DCE (1 mL) was added 127 (T
+
BF4
-
) at room 
temperature. After 30 min, starting materials completed. The reaction mixture was 
directly loaded in silica gel column and purified with DCM/MeOH mixture. 
Characterization of Compound 93a,93b: 
 
 
6,7,8,9-Tetrahydroimidazo[1,2-a:5,4-b']dipyridine (93a): 
The product was prepared according to the general procedure U. Yield: 70%; Pink 
amorphous solid; TLC (2% MeOH in DCM): Rf = 0.25; 
1
H NMR (300 MHz, CDCl3) 
δ 8.35 (dd, J = 4.8, 1.4 Hz, 1H), 7.99 (dd, J = 8.0, 1.4 Hz, 1H), 7.27 – 7.23 (m, 1H), 4.27 
(t, J = 6.0 Hz, 2H), 3.19 (t, J = 6.4 Hz, 2H), 2.20 – 2.03 (m, 4H) ppm; 13C NMR (75 
MHz, CDCl3) δ 153.22, 143.72, 132.90, 125.85, 119.11, 77.36, 41.78, 25.28, 22.25, 
20.21 ppm; FT‐IR: ṽ = 2361, 1598, 1506, 1441, 1395, 1279, 1213, 1151, 1111 cm-1; 
HRMS: calc. for [M+H]
+
 C10H12N3: 174.10257, found: 174.10283. 
 
 
3-Ethyl-2-methyl-3H-imidazo[4,5-b]pyridine (93b): 
The product was prepared according to the general procedure U. Yield: 57%; Brown 
liquid; TLC (2% MeOH in DCM): Rf = 0.2;
1
H NMR (300 MHz, CDCl3) δ 8.31 (dd, J 
= 4.8, 1.4 Hz, 1H), 7.93 (dd, J = 8.0, 1.4 Hz, 1H), 7.17 (dd, J = 8.0, 4.8 Hz, 1H), 4.31 (q, 
J = 7.3 Hz, 2H), 2.65 (s, 3H), 1.43 (t, J = 7.3 Hz, 3H) ppm; 13C NMR (75 MHz, 
CDCl3) δ 152.75, 147.91, 143.15, 134.68, 126.27, 118.15, 37.46, 15.23, 14.40 ppm; 
FT‐IR: ṽ = 2360, 2341, 1509, 1427, 1391, 1269, 1133, 1035 cm-1; HRMS: calc. for 
[M+H]
+
 C9H16N3: 166.13387, found: 166.13415. 
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VII Appendix 
7.1 X-Ray Crystal Structure Data 
 
Figure 7.1 Crystal structure of product 88f. X-Ray structure analysis was performed 
by Christopher Golz (TU Dortmund). 
 
Table 7.1 Crystal data and structure refinement for 81a. 
Empirical formula C20H22N2O3S 
Formula weight 370.45 
Temperature 100(2) K 
Wavelength 0.71073 Å 
Crystal system monoclinic 
Space group P 1 21/c 1 
Unit cell dimensions 
a = 13.479(3) Å α = 90° 
b = 9.092(2) Å β = 100.304(5)° 
c = 15.294(3) Å γ = 90° 
Volume 1844.1(7) Å
3
 
Z 4 
Density (calculated) 1. 334 g/cm
3
 
Absorption coefficient 0.198 mm
-1
 
F(000) 784 
Crystal size 0.092 x 0.134 x 0.208 mm 
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Theta range for data collection 2.62 to 29.00° 
Index ranges -18<=h<=18, -12<=k<=12, -17<=1<=20 
Reflections collected 25217 
Independent reflections 4904 [R(int) = 0.0510] 
Completeness to theta = 28.998° 99.9% 
Max. and min. transmission 0.746 and 0.621 
Data / restraints / parameters 4904 / 0 / 239 
Refinement method Full-matrix least-squares on F2 
Goodness-of-fit on F
2
 1.040 
Final R indices [I>2sigma(I)] R1 = 0.0386, wR2 = 0.0969 
R indices (all data) R1 = 0.0492, wR2 = 0.1029 
Largest diff. peak and hole 0.372 and -0.593 eÅ
-3
 
 
Table 7.2 Atomic coordinates (× 10
4
) and equivalent isotropic atomic displacement 
parameters (Å
2
 × 10
3
) for 81a. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 x y z U(eq) 
S(1) 0.21185(2) 4748(3) 6119(2) 113(9) 
O(1) 0.11208(7) 4143(11) 5920(7) 170(2) 
O(2) 0.29598(7) 3943(11) 5902(6) 161(2) 
O(3) 0.13419(7) 7224(10) 7820(7) 164(2) 
N(1) 0.23274(8) 5032(12) 7196(7) 119(2) 
N(2) 0.29221(8) 8162(12) 8130(7) 119(2) 
C(1) 0.20967(10) 6489(14) 5613(8) 119(2) 
C(2) 0.11742(10) 7170(15) 5301(9) 144(3) 
C(3) 0.11729(11) 8560(15) 4923(9) 169(3) 
C(4) 0.20693(11) 9279(15) 4854(8) 165(3) 
C(5) 2981(11) 8564(15) 5158(9) 166(3) 
C(6) 3005(10) 7171(15) 5538(9) 146(3) 
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C(7) 2056(13) 806(16) 4470(10) 240(3) 
C(8) 3291(10) 5488(14) 7666(8) 114(2) 
C(9) 4078(10) 4468(15) 7748(9) 153(3) 
C(10) 5054(11) 4803(16) 81789(9) 182(3) 
C(11) 5274(10) 6158(16) 8567(9) 172(3) 
C(12) 4494(10) 7185(15) 8525(9) 138(3) 
C(13) 3504(9) 6864(14) 8081(8) 110(2) 
C(14) 4503(10) 8665(15) 8857(9) 167(3) 
C(15) 3568(10) 9216(15) 8614(9) 156(3) 
C(16) 1872(10) 8316(14) 7899(8) 110(2) 
C(17) 1403(10) 9851(14) 7709(9) 124(2) 
C(18) 2010(12) 812(15) 7165(10) 195(3) 
C(19) 1257(11) 616(15) 8576(9) 170(3) 
C(20) 349(10) 9600(16) 7156(9) 181(3) 
 
Table 7.3 Bond lengths (Å) and angles [°] for 81a. 
S(1)-O(1) 1.4345(10) S(1)-O(2) 1.4375(10) 
S(1)-N(1) 1.6412(12) S(1)-C(1) 1.7598(14) 
O(3)-C(16) 1.2165(16) N(1)-C(8) 1.4288(17) 
N(1)-H(1) 0.8801 N(2)-C(16) 1.4039(17) 
N(2)-C(15) 1.4118(17) N(2)-C(13) 1.4265(16) 
C(1)-C(2) 1.3946(18) C(1)-C(6) 1.3952(19) 
C(2)-C(3) 1.3895(19) C(2)-H(2) 0.95 
C(3)-C(4) 1.394(2) C(3)-H(3) 0.95 
C(4)-C(5) 1.394(2) C(4)-C(7) 1.5064(19) 
C(5)-C(6) 1.3919(19) C(5)-H(5) 0.95 
C(6)-H(6) 0.95 C(7)-H(7)A 0.98 
C(7)-H(7)B 0.98 C(7)-H(7)C 0.98 
C(8)-C(9) 1.3977(18) C(8)-C(13) 1.4094(18) 
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C(9)-C(10) 1.3944(19) C(9)-H(9) 0.95 
C(10)-C(11) 1.377(2) C(10)-H(10) 0.95 
C(11)-C(12) 1.3992(19) C(11)-H(11) 0.95 
C(12)-C(13) 1.4150(18) C(12)-C(14) 1.4366(19) 
C(14)-C(15) 1.346(2) C(14)-H(14) 0.95 
C(15)-H(15) 0.95 C(16)-C(17) 1.5374(18) 
C(17)-C(20) 1.5352(19) C(17)-C(18) 1.5387(19) 
C(17)-C(19) 1.5414(18) C(18)-H(18)A 0.98 
C(18)-H(18)B 0.98 C(18)-H(18)C 0.98 
C(19)-H(19)A 0.98 C(19)-H(19)B 0.98 
C(19)-H(19)C 0.98 C(20)-H(20)A 0.98 
C(20)-H(20)B 0.98 C(20)-H(20)C 0.98 
O(1)-S(1)-O(2) 120.24(6) O(1)-S(1)-N(1) 105.06(6) 
O(2)-S(1)-N(1) 108.11(6) O(1)-S(1)-C(1) 108.08(6) 
O(2)-S(1)-C(1) 107.97(6) N(1)-S(1)-C(1) 106.64(6) 
C(8)-N(1)-S(1) 121.85(9) C(8)-N(1)-H(1) 109.8 
S(1)-N(1)-H(1) 109.9 C(16)-N(2)-C(15) 124.34(11) 
C(16)-N(2)-C(13) 127.48(11) C(15)-N(2)-C(13) 107.20(11) 
C(2)-C(1)-C(6) 121.11(12) C(2)-C(1)-S(1) 119.56(10) 
C(6)-C(1)-S(1) 119.33(10) C(3)-C(2)-C(1) 118.73(13) 
C(3)-C(2)-H(2) 120.6 C(1)-C(2)-H(2) 120.6 
C(2)-C(3)-C(4) 121.42(13) C(2)-C(3)-H(3) 119.3 
C(4)-C(3)-H(3) 119.3 C(5)-C(4)-C(3) 118.68(12) 
C(5)-C(4)-C(7) 120.55(13) C(3)-C(4)-C(7) 120.77(13) 
C(6)-C(5)-C(4) 121.15(13) C(6)-C(5)-H(5) 119.4 
C(4)-C(5)-H(5) 119.4 C(5)-C(6)-C(1) 118.88(12) 
C(5)-C(6)-H(6) 120.6 C(1)-C(6)-H(6) 120.6 
C(4)-C(7)-H(7)A 109.5 C(4)-C(7)-H(7)B 109.5 
H(7)A-C(7)-H(7)B 109.5 C(4)-C(7)-H(7)C 109.5 
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H(7)A-C(7)-H(7)C 109.5 H(7)B-C(7)-H(7)C 109.5 
C(9)-C(8)-C(13) 117.30(12) C(9)-C(8)-N(1) 117.41(11) 
C(13)-C(8)-N(1) 125.25(11) C(10)-C(9)-C(8) 122.26(13) 
C(10)-C(9)-H(9) 118.9 C(8)-C(9)-H(9) 118.9 
C(11)-C(10)-C(9) 120.77(12) C(11)-C(10)-H(10) 119.6 
C(9)-C(10)-H(10) 119.6 C(10)-C(11)-C(12) 118.34(12) 
C(10)-C(11)-H(11) 120.8 C(12)-C(11)-H(11) 120.8 
C(11)-C(12)-C(13) 121.39(12) C(11)-C(12)-C(14) 130.48(12) 
C(13)-C(12)-C(14) 108.10(12) C(8)-C(13)-C(12) 119.85(11) 
C(8)-C(13)-N(2) 133.55(12) C(12)-C(13)-N(2) 106.51(11) 
C(15)-C(14)-C(12) 107.62(12) C(15)-C(14)-H(14) 126.2 
C(12)-C(14)-H(14) 126.2 C(14)-C(15)-N(2) 110.56(12) 
C(14)-C(15)-H(15) 124.7 N(2)-C(15)-H(15) 124.7 
O(3)-C(16)-N(2) 119.42(11) O(3)-C(16)-C(17) 120.57(12) 
N(2)-C(16)-C(17) 119.96(11) C(20)-C(17)-C(16) 106.11(10) 
C(20)-C(17)-C(18) 108.37(11) C(16)-C(17)-C(18) 112.19(11) 
C(20)-C(17)-C(19) 107.02(11) C(16)-C(17)-C(19) 111.02(11) 
C(18)-C(17)-C(19) 111.79(11) C(17)-C(18)-H(18)A 109.5 
C(17)-C(18)-H(18)B 109.5 H(18)A-C(18)-H(18)B 109.5 
C(17)-C(18)-H(18)C 109.5 H(18)A-C(18)-H(18)C 109.5 
H(18)B-C(18)-H(18)C 109.5 C(17)-C(19)-H(19)A 109.5 
C(17)-C(19)-H(19)B 109.5 H(19)A-C(19)-H(19)B 109.5 
C(17)-C(19)-H(19)C 109.5 H(19)A-C(19)-H(19)C 109.5 
H(19)B-C(19)-H(19)C 109.5 C(17)-C(20)-H(20)A 109.5 
C(17)-C(20)-H(20)B 109.5 H(20)A-C(20)-H(20)B 109.5 
C(17)-C(20)-H(20)C 109.5 H(20)A-C(20)-H(20)C 109.5 
H(20)B-C(20)-H(20)C 109.5   
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Table 7.4. Anisotropic atomic displacement parameters (Å
2
 × 10
3
) for 81a. 
The anisotropic atomic displacement factor exponent takes the form: -2π2[ h2 a*2 U11 + ... + 2 h k a
*
 b
*
 
U12] 
 U11 U22 U33 U23 U13 U12 
S(1) 12(16) 9(15) 12(15) -1(10) 0(11) 0(11) 
O(1) 14(5) 5(5) 20(5) 0(4) -2(4) 0(4) 
O(2) 18(5) 4(4) 16(5) -2.7(3) 1(4) 5(4) 
O(3) 12(5) 0(4) 28(5) -1(4) 6(4) -1(3) 
N(1) 11(5) 2(5) 12(5) 0(4) 1(4) 1(4) 
N(2) 11(5) 9(5) 15(5) -1(4) 2(4) 0(4) 
C(1) 15(6) 10(5) 10(6) 0(4) 1(5) 1(5) 
C(2) 14(6) 16(6) 13(6) 0(5) 1(5) 2(5) 
C(3) 21(7) 16(6) 13(6) 1(5) 1(5) 6(5) 
C(4) 29(8) 12(6) 8(6) -1(4) 1(5) 0(5) 
C(5) 21(7) 16(6) 12(6) -1(5) 2(5) -5(5) 
C(6) 14(6) 16(6) 14(6) -0(5) 1(5) 0(5) 
C(7) 39(9) 14(7) 17(7) 4(5) 0(6) -1(6) 
C(8) 12(6) 12(6) 10(6) 2(4) 0(5) 0(5) 
C(9) 17(7) 14(6) 14(6) (5) 0(5) 4(5) 
C(10) 14(7) 22(7) 18(6) 1(5) 0(5) 8(5) 
C(11) 11(6) 23(7) 16(6) 1(5) -1(5) 2(5) 
C(12) 13(6) 16(6) 12(6) 0(5) 2(5) -2(5) 
C(13) 10(6) 12(6) 11(6) 2(4) 2(4) 2(4) 
C(14) 14(6) 17(6) 18(7) -3(5) 1(5) -3(5) 
C(15) 16(6) 13(6) 18(6) -3(5) 2(5) -3(5) 
C(16) 12(6) 10(5) 11(6) 0(4) 4(5) 1(4) 
C(17) 15(6) 9(5) 13(6) 0(4) 3(5) 2(5) 
C(18) 26(8) 14(6) 20(7) 5(5) 8(6) 1(5) 
C(19) 22(7) 14(6) 15(6) -2(5) 6(5) 4(5) 
Appendix                                                          202 
C(20) 16(7) 18(7) 19(7) -2(5) -1(5) 7(5) 
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7.2 Abbreviations 
Ac acetyl 
acac acetylacetonate 
Ad adamantly 
Ag silver 
AIBN azobisisobutyronitrile 
aq. aqueous 
atm standard atmosphere 
Boc tert-butyloxycarbonyl 
bpy bipyridine 
BQ 1,4-benzoquinone 
Bz benzoyl 
Cbz carboxybenzyl 
CDC cross-dehydrogenative coupling 
Co cobalt 
COMAS Compound Management and Screening Center 
conc. concentrated 
Cp* pentamethylcyclopentadieny 
Cu copper 
DCBP 4,4′-dichlorobenzophenone 
DCE 1,2-dichloroethane 
DCM dichloromethane 
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DCP dicumyl peroxide 
DDQ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DG directing group 
DIAD diisopropyl azodicarboxylate 
DMAP 4-dimethylaminopyridine 
DMF dimethylformamide 
DMSO dimethylsulfoxide 
dppm bis(diphenylphosphanyl)methane 
dtb di-tert-butyl 
DTBP di-tert-butyl peroxide 
EWG electron-withdrawing group 
Fe iron 
Fw molecular weight 
HFIP hexafluoro-2-propanol 
IC50 half maximal inhibitory concentration 
Ir iridium 
NFSI N-fluorobenzenesulfonimide 
4-NHAcT
+
BF4
-
 
4-acetamido-2,2,6,6-tetramethylpiperidine-1-oxo-ammonium 
tetrafluoroborate 
Ni nickel 
NIS N-iodosuccinimide 
nm nanometer 
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o ortho 
oxone potassium peroxomonosulfate 
p para 
PAs phosphoric acid 
Pd palladium 
PhINTs N-tosyliminobenzyliodinane 
Phth phthaloyl 
PIDA (diacetoxyiodo)benzene 
piv pivaloyl 
ppy 2-phenylpyridine 
RB Rose Bengal 
Rh rhodium 
Ru ruthenium 
rt room temperature 
SET single electron transfer 
TBAI tetrabutylammonium iodide 
T
+
BF4
-
 
2,2,6,6-tetramethylpiperidine-1-oxoammonium 
tetrafluoroborate 
TBHP tert-butyl hydroperoxide 
TBPB tert-butyl peroxybenzoate 
TBTU 
2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
tetrafluoroborate 
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TEMPO 2,2,6,6-tetramethyl-1-piperidinyloxy 
TFA trifluoroacetic acid 
TMS trimethylsilyl 
Troc trichloroethyl carbamate 
Ts para-toluenesulfonyl 
UV ultraviolet 
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7.6 Spectra of Part 3.2.1.4 
 
 
 
 
 
Figure 7.2 NOE spectra of 91r (A). 
 
 
 
 
 
 
Figure 7.3 NOE spectra of 91r (B). 
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Figure 7.4 NOE spectra of 91s (A). 
 
 
 
 
 
 
Figure 7.5 NOE spectra of 91s (B). 
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Figure 7.6 H–H COSY spectra of 91t. 
 
 
 
 
Figure 7.7 NOE spectra of 91t (major). 
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